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Abstract 
 
The University of Manchester 
Kim Diane Brownhill 
Doctor of Philosophy 
Function and Regulation of Kinesin-1, -2 and -3 
27th July 2010 
 
In this work the functions of the microtubule motors kinesin-1, -2 and -3 have 
been analysed in various settings. The reconstitution of microtubule-dependent 
motor activity in vitro has been primarily used to dissect the contributions of 
individual motors to cargo motility in two specific scenarios.  
 
Initially the regulation of kinesin-1 in a cell cycle-dependent manner has been 
examined by studying the ability of rat liver endoplasmic reticulum (ER) tubules 
to move in cytosols prepared from Xenopus laevis egg extracts arrested in 
interphase, meiosis or mitosis. It was found that kinesin-1-driven ER motility is 
significantly disrupted during metaphase in vitro. This is likely due to the 
recruitment or loss of binding partners which has a concomitant influence upon 
kinesin-1 activity. This work presents the first evidence that kinesin-1-driven ER 
movement, and not simply network morphology, varies during cell division. 
Furthermore, it is postulated that the replication of such regulation of kinesin-1 
activity in vivo may contribute to the well documented changes in organelle 
positioning and cargo transit through membrane trafficking pathways which 
occur during cell division. 
 
The fungal metabolite brefeldin A (BFA) induces tubulation of several 
compartments located within the secretory and endocytic pathways in a 
microtubule-dependent fashion. The identity of the motor(s) responsible for this 
motility remains unconfirmed and controversial since several reports with 
conflicting data have been published. The contributions of kinesin-1, -2 and -3 
to these processes have been investigated using in vitro motility assays in 
which rat liver Golgi membranes were combined with Xenopus laevis egg 
extract cytosol in the presence of BFA. Function blocking antibodies and 
dominant negative proteins were used to perturb the activities of various kinesin 
motors. This data indicates a particular isoform of kinesin-3, KIF1C, is solely 
responsible for the movement of BFA-induced tubules in vitro. This work was 
complemented by in vivo immunofluorescence studies using the HeLaM 
cultured cell line. Transient transfections of dominant negative proteins, or 
siRNA-mediated depletion, were used to disrupt the activities of various kinesin 
motors, either in isolation or in combination with each other. This approach 
revealed a contribution of KIF1C and kinesin-1 to the movement of early 
endosomal BFA-induced tubules in vivo. 
10 
 
Declaration  
 
No portion of the work referred to in this thesis has been submitted in support of an application 
for another degree or qualification at this or any other university or institute of learning. 
11 
 
Copyright statement 
 
I. The author of this thesis (including any appendices and/or schedules to this thesis) 
owns any copyright in it (the “Copyright”) and she has given The University of 
Manchester the right to use such Copyright for any administrative, promotional, 
educational and/or teaching purposes.  
   
II. Copies of this thesis, either in full or in extracts, may be made only in accordance with 
the regulations of the John Rylands University Library of Manchester. Details of these 
regulations may be obtained from the Librarian. This page must form part of any such 
copies made.  
 
III. The ownership of any patents, designs, trade marks and any and all other intellectual 
property rights except for the Copyright (the “Intellectual Property Rights”) and any 
reproductions of copyright works, for example graphs and tables (“Reproductions”), 
which may be described in this thesis, may not be owned by the author and may be 
owned by third parties. Such Intellectual Property Rights and Reproductions cannot and 
must not be made available for use without the prior written permission of the owner(s) 
of the relevant Intellectual Property Rights and/or Reproductions.  
 
IV. Further information on the conditions under which disclosure, publication and 
exploitation of this thesis, the Copyright and any Intellectual Property Rights and/or 
Reproductions described in it may take place is available from the Dean of the Faculty 
of Life Sciences.  
12 
 
Acknowledgments  
 
Firstly, I would like to thank Viki for her help, guidance and encouragement throughout my 
studies. I shall always be grateful to have been given the opportunity to study in such a friendly 
and enthusiastic laboratory. I have learnt more in four years than I thought possible and have 
enjoyed my time here immensely. 
 
I have made many friends including Becky, Cécile, Jo, Marcin, Neftali and Yen Ching who have 
each helped and supported me. Without these people my PhD would have been a lot harder to 
complete. In particular Becky has been a brilliant teacher and mentor and someone I could 
always talk to when things weren‟t going as planned. Cécile has grown to be a very good friend 
as we experienced the highs and lows of studying for a PhD together and I feel sure we will 
remain close in the future. 
 
Finally, I would like to thank my Mum and Dad who have always supported and encouraged me, 
despite still not having the slightest idea what I have spent the last few years studying!    
13 
 
List of abbreviations  
 
+TIP  Plus end tracking protein 
A/S    Acetate sucrose 
AAA  ATPase associated with diverse cellular activities 
AMPA  α-amino-3-hydroxy-5-methylisoxazole-4-propionate 
ANOVA  Analysis of variance 
AP  Adaptor protein 
APC  Adenomatous polyposis coli  
ApoER2 Apolipoprotein E Receptor 2  
APS   Ammonium persulphate 
ATP  Adenosine-5'-triphosphate  
BCCP    Biotin carboxyl carrier protein  
BFA   Brefeldin A 
BicD  Bicaudal D 
BRB80  Brinkley reassembly buffer 
CDK1  Cyclin-dependent kinase-1 
C-kin    Kinesin with motor domain located at the C-terminus 
CLIMP-63 Cytoskeleton-linking membrane protein of 63 kDa  
COPI  Coat protein complex I 
COPII  Coat protein complex II 
CSF    Cytostatic factor 
DABCO  1,4-Diazabicyclo(2,2,2)octane 
DAPI  4',6-Diamidino-2-phenylindole 
DHC   Cytoplasmic dynein-1 heavy chain 
DIC    Cytoplasmic dynein-1 intermediate chain 
DLIC    Cytoplasmic dynein-1 light intermediate chain 
DMSO    Dimethyl sulfoxide 
DTT   Dithiothreitol 
EB  End binding protein 
EDTA    Ethylenediaminetetraacetic acid 
EGTA  Ethyleneglycoltetraacetic acid 
E-MAP-115   Epethial microtubule-associated protein of 115 kDa 
ER    Endoplasmic reticulum 
ERES  ER exit sites 
ERGIC  ER-to-Golgi intermediate compartment 
FEZ1  Fasciculation and elongation protein δ1 
Gadkin  γ1-Adaptin and kinesin interactor 
GFP    Green flourescent protein 
GRIF1  γ-Aminobutyric acidA receptor-interacting factor 1 
GRIP1  Glutamate receptor-interacting protein 1 
GSK3  Glycogen synthase kinase 3 
GST  Glutathione S-transferase 
GTP   Guanosine-5'-triphosphate  
HCG    Human chorionic gonadotropin 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HRP  Horseradish peroxidase 
HSC70  Heat shock cognate protein of 70 kDa 
IB  Immunoblot 
IF  Immunofluorescence  
IgG    Immunoglobulin G 
Io    Interphase Xenopus laevis egg extract membrane 
IP   Immunoprecipitation 
IPTG  Isopropyl β-D-1-thiogalactopyranoside 
Is    Interphase Xenopus laevis egg extract cytosol 
14 
 
JIP  c-Jun N-terminal kinase–interacting protein  
KAP3   Kinesin-associated protein 3 
KBP   KIF1-binding protein 
KCA-1  Kinesin cargo adaptor protein-1 
KHC   Kinesin-1 heavy chain 
KIF   Kinesin family 
KLC   Kinesin-1 light chain 
KRP(85/95) Kinesin related protein (85/95)  
LC7  Light chain 7 
LC8  Light chain 8 
M6PR  Mannose-6-phosphate receptor 
MAP    Microtubule-associated protein 
M-kin    Kinesin with motor domain located in the centre of the protein 
MMR    Marc‟s modified ringer‟s buffer 
Mo    Metaphase Xenopus laevis egg extract membrane 
MPF  Maturation-promoting factor 
Ms    Metaphase Xenopus laevis egg extract cytosol 
MTOC    Microtubule organising centre 
ND  No difference 
N-kin   Kinesin with motor domain located at the N-terminus 
NSD  No significant difference 
OIP106  O-linked N-acetylglucosamine transferase interacting protein 106 
PBS    Phosphate-buffered saline 
PCR  Polymerase chain reaction 
PFA   Paraformaldehyde  
PIPES   1,4-Piperazinediethanesulfonic acid 
PMSF    Phenylmethanesulfonyl fluoride 
PMSG    Pregnant mare serum gonadotropin 
SDS  Sodium dodecyl sulfate 
SDS-PAGE   Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
siRNA    Small interfering RNA 
SNX  Sorting nexin 
STB  Shiga toxin-B 
SUK    Sea urchin kinesin 
TAC    Tip attachment complex  
TBS  Tris-buffered saline 
TCTEX-1 T-complex testis-specific protein-1 
TEMED   N,N,N‟,N‟-Tetramethylethylenediamine   
TGN   Trans-Golgi network  
TNF  Tumour necrosis factor 
TPR  Tetratricopeptide repeat 
uKHC   Ubiquitously expressed kinesin-1 heavy chain 
VE-DIC   Video-enhanced differential interference contrast microscopy 
VSV-G  Vesicular stomatitis virus glycoprotein 
VTC  Vesicular-tubular transport carriers 
XB   Extract buffer 
XTC  Xenopus laevis tissue culture 
γ-TuRCs   γ-tubulin ring complexes 
15 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
16 
 
Organelles display a characteristic position within eukaryotic cells which is often essential to 
their function. For example, whilst the endoplasmic reticulum (ER) is distributed throughout the 
cell, the Golgi apparatus is normally restricted to a location very close to the nucleus. Moreover, 
many of these organelles are not static but are subject to a constant flux of material which is 
transiting the secretory or endocytic pathways. This transfer of cargo between compartments 
requires dynamic structures which can detect and respond to changes in their 
microenvironment as and when required. In certain situations a more radical change in 
organelle position is necessary, such as during cell division when the Golgi apparatus becomes 
scattered throughout the cell to aid correct segregation between daughter cells (see section 
1.5.3). This movement and positioning of organelles, as well as the transit of numerous cargoes 
throughout the cell is dependent upon the cytoskeleton and its associated molecular motors. 
Given the wide-ranging and crucial tasks performed by motor proteins it is perhaps not 
surprising that their activities are often regulated, both temporally and spatially.  
1.1 Cytoskeleton  
The eukaryotic cytoskeleton is composed of three major filament types, microtubules, actin and 
intermediate filaments. These dynamic networks are essential for determining the spatial 
organisation of the cell and driving intracellular transport.  
1.1.1 Actin and intermediate filaments 
Actin is a polarised filament, with a rapidly polymerising „barbed‟ end and a slower growing 
„pointed‟ end. Filaments usually adopt a specific orientation within the cell, with the barbed end 
facing the plasma membrane or organelle and the pointed end directed towards the cytoplasm. 
The subunits which constitute the actin filament are globular polypeptides which are able to bind 
and hydrolyse adenosine-5'-triphosphate (ATP). Three different types of actin are expressed in 
vertebrates, termed α, β and γ, however α-actin expression is restricted to muscle cells. The 
actin polymer consists of two extended filaments wrapped around each other to form a helix, 
and these can be bundled together in the cell to form an extremely strong structure. These 
fibres can be organised in multiple ways to give rise to microvilli, lamellipodia, filopodia and 
stress fibres. Aside from these specialised structures, further populations of actin filaments exist 
within the cell, especially in close proximity to the plasma membrane, which play prominent 
roles in driving cell movement and changes to cell shape [1]. 
  
Myosin motors move along actin filaments and in doing so transport a wide range of cargoes 
throughout the cell (reviewed in [2]). The myosin motor family is divided into eighteen classes 
on the basis of sequence homology, termed myosin I-XVIII. Humans have 40 myosin genes 
encoding motors from twelve of these classes. With the exception of myosin VI and myosin IX, 
all motors travel towards the barbed end of the actin filament. Each myosin has a highly 
conserved motor domain at the N-terminus, which interacts with actin and binds and hydrolyses 
ATP which is required to drive motor activity. The neck domain is located adjacent to the motor 
and often contains IQ domains which enable recruitment of light chains such as the calcium-
binding protein, calmodulin (reviewed in [2]). At the C-terminus of the protein is located a tail 
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domain which exhibits the most diversity between myosin motors where a variety of functional 
motifs are often located [1].  
 
In contrast to actin, intermediate filaments, whose major function is to provide mechanical 
strength and rigidity to cells, are not expressed in all eukaryotes, or even within all cell types. 
These structures are noted for their strength, conferring resistance to bending and stretching, 
whilst retaining flexibility. Intermediate filaments do not bind or hydrolyse a nucleoside 
triphosphate and motor proteins do not travel along these tracks. The monomers which 
constitute intermediate filaments are elongated polypeptides which oligomerise to form a 
staggered tetramer, the building block of the filament. These oligomers associate with each 
other in eight parallel protofilaments to form the final structure. Heterogeneity within these 
subunits gives rise to different types of intermediate filaments which are organised into six 
classes on the basis of sequence and structural homology, including nuclear lamins, 
neurofilaments and keratins, which often display a cell type-specific distribution [1]. In 
comparison to other cytoskeletal networks it is less well understood how intermediate filaments 
are polymerised and depolymerised, or how these events are regulated. The microtubule 
cytoskeleton, and associated molecular motors cytoplasmic dynein-1 and kinesin-1, have been 
implicated in influencing the organisation of intermediate filaments (see section 1.3.5) [3-5].  
1.1.2 Microtubules 
Microtubules are polar, linear structures composed of α- and β-tubulin heterodimers arranged 
into a series of protofilaments. They are extremely dynamic filaments due to the presence of so-
called „plus‟ ends which polymerise and depolymerise tubulin at a faster rate than the opposing 
„minus‟ end. The polymerisation and depolymerisation of tubulin is regulated by hydrolysis of 
guanosine-5'-triphosphate (GTP) (reviewed in [6]). To be integrated into a growing microtubule 
the β-subunit of the tubulin dimer must be GTP-bound and once incorporated, is slowly 
hydrolysed to GDP. The balance between GTP- and GDP-bound tubulin at the plus tip is 
responsible for controlling microtubule dynamics. With a GDP-bound tubulin cap the 
microtubule is more prone to shrink in a process known as catastrophe, whereas a GTP-bound 
tubulin tip promotes microtubule growth, also known as rescue (Figure 1.1). A further level of 
regulation of microtubule dynamics is provided by post-translational modifications such as 
acetylation which promotes stabilisation and reduces the probability of depolymerisation (see 
section 1.3.5) [7]. This ability to tightly regulate microtubule dynamics becomes extremely 
important during certain processes such as cell division, where microtubules are dramatically 
reorganised to form the mitotic spindle necessary to separate sister chromatids (see section 
1.5.1) (reviewed in [8]).  
 
Microtubules are organised typically in non-polarised interphase cells with most minus ends 
located at a site close to the nucleus called the microtubule organising centre (MTOC), the 
major site of microtubule nucleation, whereas the plus tips radiate out towards the cell periphery 
(Figure 1.2). In polar cells this organisation can be markedly different, for example in epithelial 
cells the majority of microtubules are organised so that plus ends are located at the basal 
surface and minus ends point towards the apical surface (reviewed in [9]). Newly polymerising  
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Figure 1.1 – Mechanism of microtubule dynamics and stability 
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Figure 1.2 – Microtubule organisation in interphase non-polar cells 
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microtubules emanate from nucleation sites containing γ-tubulin ring complexes (γ-TuRCs), 
often located close to centrosomes [10]. Interestingly, the Golgi apparatus has also been 
reported to nucleate microtubules, since γ-TuRCs interact with centrosomal matrix A kinase 
anchoring protein, which binds Golgi matrix protein of 130 kDa [11]. Plus end tracking proteins 
(+TIPs), which associate specifically with the growing end of microtubules, either directly or via 
binding to a linker protein, serve to stabilise microtubule dynamics and often link the microtubule 
to particular cellular structures such as kinetochores or the cell cortex. This group of +TIPs 
consists of particular microtubule motor proteins including cytoplasmic dynein-1, as well as non-
motor proteins such as end binding (EB) proteins (reviewed in [12]). 
1.2 Microtubule motors 
 Movement of cargo along the microtubule cytoskeleton is driven by microtubule motors which 
hydrolyse ATP to ADP and in doing so convert chemical energy into mechanical movement. 
These motors can be subdivided into two broad superfamilies, the dyneins and the kinesins. 
Dynein motors travel towards the minus end (cell centre) whereas the majority of kinesins move 
towards the plus tip (cell periphery) (Figure 1.2), although there are exceptions to this rule. 
 
Kinesin family (KIF) members, play an integral role in driving intracellular cargo transport. To 
date, 45 mammalian KIF genes have been identified, but the total number of KIF proteins 
expressed is uncertain since it is believed multiple isoforms can be generated by alternative 
mRNA splicing [13]. Kinesins are broadly separated into fifteen families based upon 
phylogenetic analyses, termed kinesin-1 to kinesin-14B (reviewed in [14]). Kinesin motors are 
also crudely subdivided based upon the location of their motor domain either C-terminal (C-kin), 
N-terminal (N-kin), or somewhere in the middle of the protein (M-kin). To date all N-kins, which 
constitute kinesin-1 to kinesin-12 families, move towards the plus end of the microtubule 
whereas all C-kins, belonging to kinesin-14A and kinesin-14B families, move towards the minus 
end. Only the kinesin-13 family contains M-kins, and when bound to microtubules these motors 
promote depolymerisation (reviewed in [15]). Members of the kinesin-1, kinesin-2 and kinesin-3 
families together with cytoplasmic dynein-1 are primarily responsible for interphase membrane 
movement and so will be discussed in further detail. The tissue-specific distributions, cell cycle-
specific functions and known splice variants of these kinesin motors in human, rat and Xenopus 
are summarised in Table 1.1.  
1.2.1 Kinesin-1 
Kinesin-1 is the founding member of the kinesin superfamily, being first characterised in 1985 
by Vale and co-workers as a protein capable of inducing microtubule movement on glass 
coverslips [16]. Metazoan kinesin-1 has been reported to transport a wide range of 
membranous cargoes such as mitochondria, lysosomes and ER (reviewed in [14]), as well as 
non-membranous cargoes including mRNAs [17] and intermediate filaments [4]. The motor also 
has well-documented roles in the secretory and endocytic pathways (see section 1.4). Not 
surprisingly, given its wide-ranging functions, perturbation of kinesin-1 expression is embryonic 
lethal in mice [18].  
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The motor conventionally has a heterotetrameric structure composed of two heavy chains 
(KHC) and two light chains (KLC) which perform distinct functions. The heavy chains are linked 
together by coiled coil interactions and to each heavy chain a single light chain is bound (Figure 
1.3 A). The N-terminal globular head domain of KHC engages with the microtubule and is the 
site of ATP binding and hydrolysis and is therefore often referred to as the motor domain. The 
motor moves in a so-called „hand-over-hand‟ mechanism, such that with every discrete 8 nm 
step taken along the microtubule the two head domains of the tetramer exchange leading and 
trailing roles [19]. A short neck linker region connects the head to the stalk of KHC, which has a 
coiled coil structure. The stalk is intersected by two hinge domains which allow kinesin-1 to flex 
and fold (see section 1.3.3). At the C-terminus of KHC is located a globular domain referred to 
as the tail. Each KLC engages with KHC via a region known as the heptad repeat [20]. Both 
KHC and KLC are capable of interacting with cargoes (see Tables 1.1 and 1.2) and it has been 
suggested that in some circumstances binding to both subunits is necessary to activate kinesin-
1 activity (see section 1.3.3). It should be noted however that there are numerous examples, 
especially in neuronal transport, in which the KLC subunit is not required for kinesin-1 function 
and where adaptor or scaffold proteins operate instead (see section 1.3.4) (reviewed in [15]). 
Furthermore, in lower organisms, such as the filamentous fungus Neurospora crassa, KLCs are 
not expressed [21].  
 
Duplication of the KHC gene, kif5, has led to the expression of three different KHC proteins in 
mammals, termed KIF5A, KIF5B and KIF5C. Whilst KIF5B is ubiquitously expressed, KIF5A and 
KIF5C expression have been reported to be limited to neurons [22, 23]. However, this finding 
has recently been questioned since both KIF5A and KIF5C mRNA has been detected in the 
human lung epithelial cell lines A549 and NHBE [24], raising the possibility that the three KHC 
isoforms are co-expressed, at least in some cell types. Similarly, there are four klc genes in 
mammals leading to expression of four KLC isoforms termed KLC1-4 [25-27]. KLC2 is 
ubiquitously expressed, whereas KLC1 has been reported to be enriched in neuronal tissue and 
KLC3 expression is restricted to spermatids [26, 27]. However, there may be multiple variants of 
each isoform due to alternative mRNA splicing. Indeed, there have been reported to be at least 
nineteen human KLC1 splicing isoforms, termed KLC1A-S, which differ only at the extreme C-
terminus, a property thought to be important in conferring the specificity of cargo binding [28]. 
Indeed, KLC1B has been found to localise to the ER and mitochondria [29, 30] whereas KLC1D 
is enriched at the Golgi apparatus [31]. Furthermore, KLC1B is required for rat liver ER tubule 
motility in vitro, whereas KLC1D is necessary to support the portion of rat liver Golgi vesicle 
motility driven by kinesin-1 in vitro [30]. However, the majority of interactions between KLC and 
cargo mapped to date are via the tetratricopeptide repeat (TPR) domain of KLC (see Table 1.3), 
which does not differ between splicing isoforms. The mechanism by which KLC1 isoforms may 
determine the specificity of kinesin-1 cargo binding therefore remains undetermined.  
1.2.2 Kinesin-2 
Kinesin-2 was originally identified in sea urchin eggs biochemically [32] and the purified protein 
was subsequently shown to support microtubule plus end-directed transport in vitro [33]. The 
motor has a heterotrimeric structure composed of two motor subunits termed KIF3A and KIF3B  
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Figure 1.3 – Structure of kinesin-1, kinesin-2, kinesin-3 and cytoplasmic dynein-1 
 
[34] 
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and a non-motor, cargo-binding subunit called kinesin-associated protein 3 (KAP3) (also known 
as KIFAP3) (Figure 1.3 B). Another KIF3 protein has been detected in human neurons termed 
KIF3C, which associates only with KIF3A. This kinesin-2 heterodimer has been reported to drive 
the dendritic transport of a subset of RNA granules [35]. However the precise functions of the 
KIF3A/C motor remains uncertain since KIF3C knockout mice have no obvious neuronal or 
developmental defects [36]. These are the only documented examples of motor subunit 
heterodimerisation within the kinesin superfamily, and the advantages that this may confer 
remain undetermined.  
 
Both KIF3A and KIF3B have a structure similar to that of KHC with an N-terminal globular head 
domain which interacts with microtubules and binds and hydrolyses ATP, a coiled coil stalk 
which mediates dimerisation, and a C-terminal globular tail domain which interacts with KAP3. 
The majority of reported interactions between kinesin-2 and cargoes are via KAP3 and these 
include the non-muscle spectrin fodrin [37], p150glued of the dynactin complex [38], and the 
tumour suppressor adenomatous polyposis coli protein (APC) [39]. Two isoforms of KAP3 are 
generated by alternative mRNA splicing within the C-terminus termed KAP3A and KAP3B [40]. 
The specific functions of these isoforms are unknown, although it has been suggested that they 
may each bind a specific subset of cargoes. Interestingly, metazoans have another kinesin-2 
family member gene, kif17, which is believed to form a homodimer and not recruit an associated 
subunit such as KAP3 [41]. KIF17 appears to be specifically expressed in neurons and its most 
well documented role is in dendritic trafficking of the neurotransmitter receptor N-methyl-
aspartate receptor subunit 2B, a process which may contribute to higher brain function in 
vertebrates linked to memory and learning [42, 43]. The KIF17 motor was not studied in this 
work and all subsequent referrals to kinesin-2 will denote the KIF3A/KIF3B/KAP3 complex.  
 
Kinesin-2 is known to function in a wide range of processes and perturbation of KIF3 motor 
activity often results in severe developmental faults. Indeed, both kif3a and kif3b knockout mice 
die during mid-gestation displaying severe defects in neurogenesis, mesoderm patterning, and 
left-right body asymmetry [44, 45]. A role for kinesin-2 as a tumour suppressor has also been 
recognised due to its interaction with APC and observations that the conditional kap3 knockout 
mouse displays brain tumours [46]. The acute defects observed following perturbation of 
kinesin-2 function may be linked to the well-documented roles of this motor within the secretory 
and endocytic pathways (see section 1.4). Kinesin-2 family members also function in the 
formation of sensory cilia and intraflagellar transport, the movement of cargoes within cilia and 
flagella (reviewed in [15]). For example, kinesin-2 is implicated in the transport of the G-protein-
coupled receptor, opsin, within the mammalian photoreceptor cilium [47]. 
1.2.3 Kinesin-3 
KIF1 forms the kinesin-3 family together with KIF13, KIF14 and KIF16. KIF1A and its 
Caenorhabditis elegans homologue Unc104 were the first kinesin-3 motors discovered by virtue 
of their homology to KHC [23, 48]. In mammals, in addition to KIF1A, two other KIF1 isoforms 
are expressed called KIF1B and KIF1C. Similar to kinesin-1 and kinesin-2, these motors have a 
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globular N-terminal motor, a coiled coil stalk, and a globular C-terminal tail domain (Figure 1.3 
C).  
 
Alternative mRNA splicing of the kif1b gene gives rise to two isoforms, with murine KIF1Bα 
lacking the C-terminal 620 amino acids in comparison to KIF1Bβ, resulting in completely 
different tail domains [49]. Differences within the tail have been proposed to direct particular 
KIF1 isoforms to specific subsets of cargoes. KIF1Bα is specifically targeted to mitochondria 
and supports mitochondrial transport in vitro [50] and positioning in vivo, a function which may 
be dependent upon an interaction with KIF1 binding protein (KBP) [51]. Indeed, when a deletion 
mutant of KBP which can no longer interact with KIF1Bα was overexpressed in the mouse 
fibroblast cell line NIH-3T3, mitochondrial aggregation was observed [51]. KBP does not 
mediate the interaction of KIF1Bα with mitochondria but appears to improve the motility of the 
motor by increasing its processivity along the microtubule. Although the precise function of KBP 
remains unclear, the protein has been shown to be required for axonal growth in zebrafish and 
mutations within the KBP gene give rise to the neurological disorder Goldberg-Shprintzen 
syndrome [52]. KIF1Bβ is targeted to synaptic vesicle precursors [53], as well as lysosomes in 
non-neuronal cells [54]. Expression of KIF1A is limited to neurons where this motor plays an 
important role in the axonal trafficking of presynaptic vesicle precursors [55, 56]. The major 
reported role of KIF1C is in trafficking of Golgi contents from the cis-Golgi to the ER in response 
to the fungal metabolite brefeldin A (BFA), although this has been contested (see section 
1.4.2.2). Both KIF1A and KIF1Bβ also contain a pleckstrin homology domain at the C-terminus 
which is proposed to be important for binding phospholipids [57], and may therefore facilitate 
membrane attachment [58].  
 
KIF1 motors are predominantly monomeric but it is has been suggested that in certain situations 
they are able to homodimerise via coiled coil interactions and thereby become capable of 
processive movement. Indeed, KIF1A was observed to dimerise in vitro and translocated along 
microtubules at a velocity similar to that observed for fluorescently labelled Unc104 in 
Caenorhabditis elegans [59, 60]. It is suggested that the oligomerisation of KIF1 motors may 
occur specifically on cargoes in vivo, perhaps in a concentration-dependent manner, meaning 
KIF1 motor function is activated specifically when membrane-bound [59]. In this scenario the 
binding of KIF1A to phosphatidylinositol-4,5-bisphosphate on cargoes would induce clustering 
of the motor, triggering dimerisation and motor activation [58, 59]. However, this model has 
recently been disputed by Hammond and co-workers who observed that both exogenously-
expressed and endogenous rat KIF1A exists in a dimeric, inactive state in COS cells [61]. 
Interestingly, a study by Okada and Hirokawa revealed monomeric KIF1A is capable of diffusive 
movement along microtubules mediated by weak electrostatic interactions between positively 
charged residues of the motor domain and negatively charged residues of tubulin, which keeps 
KIF1A in close proximity to the microtubule as it travels from one binding site to the next [62]. 
The advantages that monomeric KIF1 transport may convey compared to dimeric processive 
motility in vivo are unknown.  
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The other members of the kinesin-3 family are KIF13, KIF14 and KIF16. Two isoforms of KIF13 
and KIF16 are expressed in mice termed A and B (reviewed in [15]). KIF13A is implicated in 
driving movement of lysosomal hydrolases from the trans-Golgi network (TGN) to the endocytic 
system (see section 1.4.3). KIF13B, also known as guanylate kinase-associated kinesin, is 
involved in the transport of phosphatidylinositol-3,4,5-trisphosphate-containing vesicles to axon 
tips, which is proposed to be important for determining neuronal polarity [63]. KIF14 is 
suggested to perform essential functions during cell division, being implicated in both 
chromosome segregation [64] and cytokinesis [65]. While the function of KIF16A remains poorly 
understood, KIF16B is involved in driving plus end-directed movement of early endosomes, 
dependent upon binding of the motor to the phospholipid phosphatidylinositol 3-phosphate (see 
sections 1.3.4 and 1.4.4) [66].  
1.2.4 Cytoplasmic dynein-1 
In contrast to plus end-directed motility, cytoplasmic movement towards the microtubule minus 
end is almost entirely performed by a single motor, cytoplasmic dynein-1. The backbone of this 
motor is cytoplasmic dynein-1 heavy chain (DHC), which contains a C-terminal ring of six 
ATPase associated with diverse cellular activities (AAA) domains. The first and third AAA 
domains are the major sites of ATP binding and hydrolysis which underlie motor function [67, 
68]. A small globular structure emerges from this motor domain which allows binding to 
microtubules [69]. The tail domain, located at the N-terminus of the subunit, mediates 
homodimerisation of DHC and also provides a scaffold allowing recruitment of several non-
catalytic dimeric subunits. Cytoplasmic dynein-1 intermediate chain (DIC) and light intermediate 
chain (DLIC) bind directly to DHC. The remaining subunits, light chain 8 (LC8), light chain 7 
(LC7) (also known as roadblock) and T-complex testis-specific protein 1 (TCTEX-1) are 
recruited via DIC (Figure 1.3 D) (reviewed in [1, 70, 71]). The extremely diverse array of cargoes 
transported by cytoplasmic dynein-1 necessitates the precise spatial and temporal regulation of 
motor activity and cargo binding. This is believed to be mediated, at least in part, by the 
association of the motor with a wide range of adaptor proteins such as dynactin, Lissencephaly 
1, Bicaudal D (BicD), NudE-like, Zeste White-10, nuclear distribution protein E and Spindly 
(reviewed in [72]).  
 
Dynactin is the most studied cytoplasmic dynein-1-interacting partner. First identified using in 
vitro motility assays [73], this adaptor protein has now been shown to be essential for almost all 
cellular functions of cytoplasmic dynein-1. Indeed, perturbation of dynactin function produces a 
phenotype similar to complete loss of cytoplasmic dynein-1 [74]. A specific region of the 
p150glued subunit of dynactin, coiled coil-1, has been shown to directly bind DIC [75]. Dynactin 
has been reported to support motor function in several ways including linking the motor to 
cargoes [76] and improving motor processivity [77, 78]. However, these functions are contested 
and the exact mechanism by which dynactin supports cytoplasmic dynein-1 function remains 
uncertain [79, 80]. Interestingly, the p150glued subunit of dynactin has also been shown to 
interact with kinesin-1 [81], kinesin-2 [38] and the kinesin-5 family member Eg5 [82], raising the 
possibility that dynactin may also contribute to the regulation of bidirectional motility. 
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Additionally, DIC has also been observed to interact with KLC1 and KLC2 directly in rat brain 
cytosol [83].  
1.3 Motor regulation 
Given the varied and important tasks performed by microtubule motor proteins it is not 
surprising that their activities can be regulated. There are several common mechanisms which 
are observed recurrently to control cargo transport and these are discussed briefly below, with 
an emphasis on kinesin-1.  
1.3.1 Motor phosphorylation 
The first indication that kinesin-1 function may be influenced by its phosphorylation status was 
provided by Lee and Hollenbeck who showed that kinesin-1 isolated from chick brain existed in 
several different isoelectric isoforms [84]. Furthermore, the level of kinesin-1 phosphorylation 
was found to correlate to the cargo binding of kinesin-1, with the membrane-associated motor 
predominantly highly phosphorylated with soluble kinesin-1 less so. Several subsequent studies 
have observed changes in the phosphorylation status of both KHC and KLC in vivo which are 
proposed to regulate kinesin-1 function as described below.  
 
The unloading of cargoes once the motor complex has reached the required destination is likely 
to be a tightly regulated event. The heat shock cognate protein of 70 kDa (HSC70) has been 
shown to induce release of kinesin-1 from membranes [85] and this behaviour is suggested to 
be mediated by the phosphorylation of KLCs by glycogen synthase kinase 3 (GSK3). Morfini 
and co-workers have showed that KLCs are a substrate for GSK3 in vivo and propose a model 
in which GSK3 phosphorylation increases the accessibility of KLCs to HSC70 and leads to 
dissociation of kinesin-1 from cargoes [86]. Since GSK3 is often enriched at sites of membrane 
delivery such a mechanism could contribute to the correct deposition of cargoes at specific sub-
cellular destinations [86].  
 
Similarly, phosphorylation of a component of cytoplasmic dynein-1 promotes dissociation of the 
motor from ER cargo in Xenopus laevis eggs. Phosphorylation of DLIC by cyclin-dependent 
kinase-1 (CDK1) stimulates release of cytoplasmic dynein-1 from ER membranes, leading to 
cessation of ER motility [87, 88]. Interestingly, this mechanism operates in a cell cycle-
dependent context since DLIC phosphorylation occurs specifically in metaphase-arrested 
Xenopus laevis egg extracts and ER network formation is perturbed only in mitotic and meiotic 
extracts in vitro (see section 1.5.2) [89]. 
 
KLC phosphorylation has also been shown to be important in mediating an interaction between 
kinesin-1 and the cell signalling protein, 14-3-3. Following phosphorylation of KLC2 at serine 
575 by an as yet unidentified kinase, an interaction between kinesin-1 and 14-3-3 was induced 
in the rat neuronal cell line, PC12 [90]. The importance of this interaction has still to be 
elucidated, but it has been proposed that 14-3-3 may act as a scaffold protein linking other 
cargoes to kinesin-1, or may relay signalling information to the motor.  
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Modulation of the phosphorylation status of KHC can also induce changes in kinesin-1 activity. 
Perhaps the best studied example is the role of kinesin-1 in supporting insulin secretion from 
pancreatic β-cells in response to high blood glucose levels. Donelan and co-workers have 
shown that under basal conditions KHC present on β-granules is phosphorylated by casein 
kinase 2 [91]. However, an elevation in blood glucose levels results in an increase in 
intracellular calcium concentration, triggering dephosphorylation of KHC by protein phosphatase 
2Bβ. This is proposed to activate kinesin-1 activity and thereby promote the movement of β-
granules from the storage pool to the plasma membrane. This motility is necessary to replenish 
the readily releasable pool of β-granules and underlies a second wave of insulin secretion [91].  
 
Interestingly, phosphorylation can also regulate kinesin-1 activity whilst the motor remains 
cargo-bound. Treatment of the mouse fibroblast cell line L929 with the proinflammatory cytokine 
tumour necrosis factor (TNF) induced a switch in mitochondrial positioning from an evenly 
spread distribution throughout the cell to a polar perinuclear clustering [92]. This response is 
due to the activation of kinase pathways by TNF, possibly p38 mitogen-activated kinase-
dependent, which results in hyperphosphorylation of both KLC1 and KLC2, which is proposed to 
lead to kinesin-1 inactivation [93]. Surprisingly, phosphorylation of KLC2 is mediated by a 
kinesin-1-associated kinase, suggesting that there may be a subset of kinases permanently 
bound to the motor which are able to influence kinesin-1 function. In this study the ability of 
kinesin-1 to bind mitochondria is unaffected and it is therefore one of the few examples in which 
kinesin-1 activity is modulated without disruption of the motor-cargo interaction.  
 
It is likely that the phosphorylation status of cargoes also influences their ability to interact with 
kinesin-1. For example, the neuronal microtubule-associated protein (MAP) tau binds KLC only 
following phosphorylation by GSK3 in rat cortical neurons [94]. Treatment with GSK3 inhibitors 
leads to reduced tau phosphorylation, perturbation of the interaction with kinesin-1 and 
decreased axonal transport of the protein. The influence that cargo phosphorylation may have 
upon motor binding, and how motors recognise and respond to changes in cargo 
phosphorylation status, is a poorly understood topic. 
1.3.2 Calcium signalling  
Recent work has suggested that localised changes in intracellular calcium concentration are 
also capable regulating kinesin-1 motor activity. The adaptor protein milton associates with KHC 
independently of KLC, at least in Drosophila melanogaster [95], and this complex is important in 
moving mitochondria. Positioning of mitochondria is especially important in neurons where the 
organelle needs to be localised to subcellular regions where energy demand is highest, often 
requiring transport over long distances and frequent relocation. Under normal circumstances 
milton mediates an association between KHC and the outer mitochondrial transmembrane 
GTPase protein Miro. Two EF motifs located within Miro are capable of sensing intracellular 
calcium levels. Following high calcium influx these two domains are proposed to bind KHC, 
thereby preventing the interaction of kinesin-1 with microtubules and leading to inhibition of 
mitochondrial motility [96]. Since elevated levels of calcium influx often occur at areas of high 
metabolic demand it is thought that this mechanism may mediate the targeting of mitochondria 
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to regions of the cell where they are most needed [96]. Interestingly, both retrograde and 
anterograde mitochondrial motility is inhibited in response to calcium influx in a Miro-dependent 
manner, raising the possibility that this protein is also able to modulate cytoplasmic dynein-1 
activity.  
 
However, this model has recently been disputed by MacAskill and co-workers who observed 
that Miro interacted directly with KIF5A/B/C in cultured rat hippocampal neurons with the 
interaction disrupted by elevated calcium levels, resulting in cessation of mitochondrial 
movement [97]. Nevertheless, the rat and human homologues of milton, γ-aminobutyric acidA 
receptor-interacting factor 1 (GRIF1) and O-linked N-acetylglucosamine transferase interacting 
protein 106 (OIP106) respectively, have been shown to bind both mitochondria and KHC and 
are capable of influencing mitochondrial positioning in cultured neuronal and fibroblastic cell 
lines [95, 98].  
1.3.3 Autoinhibition of kinesin-1 
It is proposed that the binding of the KHC tail to the motor domain of kinesin-1 is the basis of an 
autoinhibitory mechanism, thought to prevent the futile hydrolysis of ATP when the motor is not 
bound to cargo and accumulation of kinesin-1 at microtubule plus ends. This concept stems 
from electron microscopy studies which showed that under physiological salt concentrations 
native bovine kinesin-1 in solution adopts a flexed conformation with KHC head and tail 
domains in close proximity [99, 100]. Later work by Coy and co-workers using recombinantly 
expressed Drosophila melanogaster KHC revealed that deletion of the tail activated the ATPase 
activity of the motor in the absence of cargo binding, whilst the addition of exogenous tail 
restored inhibition [101]. It is now thought two intramolecular interactions underlie the 
autoinhibition of kinesin-1, and are dependent upon hinge domains located within KHC which 
allow the molecule to flex. In addition to the interaction between KHC head and tail domains, the 
TPR motif of KLC pushes the motor domain of each KHC apart and likely perturbs the 
interaction between kinesin-1 and microtubules [102]. Therefore kinesin-1 adopts a default 
inactive conformation and its activation is dependent upon unfolding.  
 
This kinesin-1 autoinhibition model necessitates the docking of both KHC and KLC with cargoes 
to fully unfold kinesin-1 and thereby promote motor activity. Indeed, the transport of c-Jun N-
terminal kinase–interacting protein 1 (JIP1) by kinesin-1 requires binding of fasciculation and 
elongation protein δ1 (FEZ1) to KHC. Blasius and co-workers showed that the binding of JIP1 to 
KLC was not sufficient to induce kinesin-1 activity, whereas when both JIP1 and FEZ1 were 
bound motor activity was activated [103]. Since human FEZ1 protein is a target of protein 
kinase C in vitro [104], it is feasible that phosphorylation regulates the binding of FEZ1 to KHC. 
FEZ1 may not be a true kinesin-1 cargo but instead may function as an activator of motor 
function by cooperating with JIP1 to relieve the autoinhibitory conformation. Perhaps there are 
several proteins whose binding to kinesin-1 is intended only to aid unfolding of the motor and 
prime it for transport, and thereby operate as activators rather than genuine cargoes of kinesin-
1.  
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1.3.4 Rab GTPases 
There are numerous examples in which a kinesin motor does not interact with a particular cargo 
via an integral membrane protein, but is dependent upon peripherally-associated accessory 
proteins which are often labelled adaptors. The list of kinesin-1 adaptor proteins is extensive 
and continues to grow (reviewed in [15]). Where a clear interaction between KHC or KLC and a 
protein binding partner has been shown these are included in Tables 1.1 and 1.2. In this section 
the contribution of Rab GTPases as adaptors and potential regulators of motor function will be 
briefly discussed. 
 
Members of the Rab family of GTPases represent a broad group of proteins which are 
implicated in controlling the association of motors with particular cargoes, particularly within the 
secretory and endocytic pathways (reviewed in [105]). Rabs can exist in either GTP- or GDP-
bound forms, with various effector molecules being activated or recruited specifically by the 
GTP-bound Rab. There are several examples in which Rabs have been observed to control 
microtubule motor activity, either directly or indirectly as described below. 
 
Rabkinesin-6 activity is proposed to be regulated by Rab6 [106], a GTPase implicated in 
controlling Golgi positioning, Golgi-to-ER trafficking and constitutive exocytosis (see sections 
1.4.2.1 and 1.4.3) [107]. Rab6-GTP localises to the Golgi whereas Rab6-GDP does not and the 
artificial conversion of Rab6 into a GDP-bound form reportedly stimulates dissociation of the 
Rabkinesin-6 motor from the Golgi [106]. It should be noted, however, that the role of 
Rabkinesin-6 in Golgi positioning or trafficking remains uncertain since the motor has been 
primarily reported to play a role in cytokinesis (see section 1.4.2.1) [108, 109].  
 
The kinesin motor KIF16B functions within the endocytic pathway (see section 1.4.4) and its 
recruitment to early endosomes is proposed to be indirectly controlled by Rab5. KIF16B 
interacts with cargo by binding the phospholipid phosphatidylinositol 3-phosphate, the formation 
of which is controlled by Rab5 and its effector Vps34, a phosphatidylinositol-3-OH kinase [66]. 
In this model GTP-Rab5 modulates the generation of phosphatidylinositol 3-phosphate by its 
direct interaction with Vps34, thereby mediating the binding of KIF16B to the endosomal 
membrane [66]. 
 
There are several examples in which cytoplasmic dynein-1 function has been shown to be 
indirectly controlled by Rab GTPases. GTP-Rab7, which is associated with late endosomes and 
lysosomes, interacts with Rab7-interacting lysosomal protein, which in turn binds the p150glued 
subunit of the dynactin complex leading to recruitment of cytoplasmic dynein-1 to the vesicle 
[110, 111]. Furthermore, Rab6 indirectly regulates cytoplasmic dynein-1 function via its effector, 
BicD. GTP-Rab6 has been observed to recruit BicD to the TGN and a subset of cytoplasmic 
vesicles in HeLa cells, with BicD subsequently recruiting cytoplasmic dynein-1 [112]. This 
binding has been suggested to be important for cargo transport within the coat protein complex I 
(COPI)-independent ER-to-Golgi trafficking pathway (see section 1.4.2.1). 
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1.3.5 Microtubule modifications 
Assorted microtubule post-translational modifications as well as the binding of MAPs are known 
to influence the ability of various motors to bind and move along the microtubule cytoskeleton. It 
is possible that particular modifications demarcate distinct sub-populations of microtubules and 
in doing so are able to exert control over motor-dependent trafficking.  
 
Microtubule acetylation, the addition of an acetyl group to the lysine 40 residue of α-tubulin, has 
been shown to promote the microtubule binding and motility of kinesin-1 in vitro [113]. This is 
proposed to be important for the trafficking of JIP1 to a specific subset of neurites in cultured 
mouse hippocampal neurons. Following treatment with trichostatin A, a drug with inhibits 
histone deacetylases and thereby leads to an increase in tubulin acetylation, JIP1 was 
unusually targeted to all neurite tips. Similarly, kinesin-1 has been shown to specifically interact 
with detyrosinated tubulin in extracts prepared from bovine brain [114]. Detyrosination, the 
removal of the C-terminal tyrosine residue from α-tubulin, enhances the binding of kinesin-1 and 
this may be important in mediated the interaction between vimentin intermediate filaments and 
the microtubule cytoskeleton. This data is corroborated by the observation that fluorescently 
labelled KIF5C preferentially moves along detyrosinated microtubules in vivo [115]. 
 
MAPs are proteins which interact with microtubules and by doing so influence their stability. The 
binding of a particular isoform of MAP4 to microtubules in vitro has been shown to inhibit 
kinesin-1 microtubule gliding [116]. This is due to the failure of kinesin-1 to translocate efficiently 
along the microtubule whilst the microtubule-binding capabilities of the motor remain unaffected. 
The association of the neuronal MAP, tau, with microtubules is suggested to modulate both 
kinesin-1 and cytoplasmic dynein-1 function. Single molecule assays have indicated that tau 
induces detachment of kinesin-1 from microtubules and pausing and reversal of cytoplasmic 
dynein-1 movement [117].  
 
Another MAP implicated in controlling kinesin-1 activity is epithelial-associated protein of 115 
kDa (E-MAP-115), also known as ensconsin and MAP7. E-MAP-115 is a stabilising MAP whose 
binding to microtubules is proposed to be modulated in a cell cycle-dependent manner [118]. 
During early prophase E-MAP-115 is hyperphosphorylated in HeLa cells leading to its 
dissociation from microtubules and a concomitant increase in microtubule dynamics, thought to 
be necessary for mitotic spindle formation. From prometaphase onwards E-MAP-115 is 
dephosphorylated, leading to its progressive reassociation with microtubules and stabilisation of 
the cytoskeleton. Recently, the Drosophila melanogaster homologue of this protein, ensconsin, 
has been shown to be required for all studied kinesin-1 functions in the polarised fly oocyte 
[119]. Ensconsin is proposed to exert this control by promoting the microtubule binding and 
motility of kinesin-1. It is unknown whether a similar mechanism operates in mammalian cells 
but this study highlights E-MAP-115 as a potential regulator of kinesin-1 function.  
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1.4 Transport in the secretory and endocytic pathways 
The role of microtubule motors in assisting the transit of cargoes through the secretory and 
endocytic pathways in metazoan cells will be discussed here with an emphasis on kinesin 
motors.  
1.4.1 ER-to-Golgi traffic 
The main compartments within the secretory pathway in higher eukaryotes are the ER, the ER-
to-Golgi intermediate compartment (ERGIC), and the Golgi apparatus which lies in close 
proximity to microtubule minus ends. Secretory and membrane proteins as well as those which 
function within the exocytic and endocytic pathways are synthesised, correctly folded and 
oligomerised as necessary within rough ER. These proteins exit the ER at specialised areas 
known as ER exit sites (ERES) usually in coat protein complex II- (COPII) coated vesicles. 
Material leaving ERES sheds the COPII coat and undergoes homotypic fusion before being 
delivered to the ERGIC in vesicular-tubular transport carriers (VTCs) and subsequently to the 
cis face of the Golgi apparatus in a microtubule- and COPI-dependent fashion [120]. It should 
be noted that this is not necessarily the route taken by all cargoes since procollagen has been 
reported to move to the Golgi in carriers lacking ERGIC markers, indicating it bypasses this 
intermediary compartment [121].  
 
Since these processes involve movement towards the cell centre, a role for the minus end-
directed motor cytoplasmic dynein-1 has been proposed. Perturbation of cytoplasmic dynein-1 
inhibited ER-to-Golgi trafficking of vesicular stomatitis virus glycoprotein (VSV-G) in COS cells 
[122]. Furthermore, a transitory direct interaction between the dynactin subunit p150glued and 
the COPII component Sec23 has been observed [123]. However, the importance of this 
association in delivering material from ER to ERGIC remains uncertain given the COPII coat is 
thought to be shed soon after budding [120]. The interaction may contribute to the entry of 
cargo into ERES as well as ERES tethering, perhaps by mediating the association of ERES with 
microtubules [123, 124]. It is possible that cytoplasmic dynein-1 mediates trafficking of VTCs 
towards the cell centre via the association of dynactin with other membrane receptors such as 
spectrin, which is often present on the surface of organelles and has been proposed to anchor 
dynactin to the Golgi apparatus [76].  
 
An interaction between cytoplasmic dynein-1 and budding COPI vesicles is important in driving 
cargo transport through the ERGIC compartment as well as Golgi-to-ER trafficking (see section 
1.4.2). The recruitment of the motor to COPI vesicles is regulated by the small GTPase Cdc42, 
a regulator of actin dynamics. The current model proposes that binding of Cdc42 during vesicle 
budding prevents the recruitment of cytoplasmic dynein-1 to the vesicle. Following coat 
formation the γ-COP subunit of COPI displaces Cdc42 allowing association of the motor and 
initiation of vesicle motility [125].  
 
Kinesin-1 has also been localised to ERES and has been implicated in controlling ERES 
biogenesis and positioning and, surprisingly, ER-to-Golgi trafficking. Sar1-GTP, the small 
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GTPase which triggers COPII coat formation, has been suggested to influence kinesin-1 
recruitment to ERES in a permeabilised cell system [126]. Furthermore, depletion of KIF5B in 
HeLa cells caused clustering of COPII components close to the nucleus and a delay in ER-to-
Golgi trafficking of VSV-G protein potentially as a result of abnormal VTC formation [124]. 
1.4.2 Golgi-to-ER traffic 
Proteins exiting the Golgi are either moved forward through the secretory pathway or are 
trafficked back to the ER via one of at least two known routes, termed COPI-dependent and -
independent (Figure 1.4).  
1.4.2.1 COPI-dependent and –independent pathways 
Cargoes which are moved back to the ER from the Golgi include escaped ER-resident proteins 
and Golgi-resident glycosylation enzymes. The COPI-dependent and -independent pathways 
represent distinct routes via which material is trafficked, with COPI coat formation being 
necessary in the former, and each requires the activity of a different subset of microtubule 
motors.  
 
The COPI-dependent pathway stems mainly from the cis-Golgi and requires kinesin-2 activity, 
at least in HeLa cells where depletion of KAP3 resulted in perturbation of the COPI-dependent 
retrograde trafficking of KDEL-containing cargoes [127]. Whether the interactions between 
COPI, Cdc42 and cytoplasmic dynein-1 as described in section 1.4.1 function in this pathway, 
as well as in forward trafficking of COPI vesicles towards the Golgi, is uncertain. Interestingly, 
COPI-positive membranes are only rarely observed moving away from the Golgi in vivo perhaps 
indicating that the coat is shed soon after budding in this retrograde pathway [128, 129].  
 
The COPI-independent retrieval pathway originates from the TGN and is used to transport 
cargoes such as Shiga toxin-B (STB). The motor responsible for this motility remains elusive but 
it is not kinesin-2 since no abrogation of Shiga-like toxin-1 transport to the ER was observed 
following KAP3 depletion [127]. Rabkinesin-6 has been implicated in this pathway since motility 
is known to be dependent upon the activity of the small GTPase Rab6 [130]. However, the 
major documented role of this motor is in cytokinesis, with protein expression levels shown to 
be lower during interphase [108, 109]. The contribution of Rabkinesin-6 to cargo motility in this 
pathway remains uncertain and the involvement of other microtubule motors is undetermined. 
Rab6-positive fluorescently labelled tubules are often observed to move bidirectionally in vivo 
[112] suggesting cytoplasmic dynein-1 may also contribute to their motility. Indeed, the 
p150glued subunit of dynactin is known to interact with Rab6 directly [131], and indirectly via 
BicD [132]. Interestingly, kinesin-1 has also been shown to interact with BicD, albeit weakly, 
making this motor a candidate for moving Rab6-positive tubules towards microtubule plus ends 
[133]. The purpose of such bidirectional motility is unknown, although it appears to be a 
common feature within membrane trafficking pathways.  
1.4.2.2 BFA 
Yet another form of ER-to-Golgi trafficking is observed in cells treated with the fungal metabolite 
BFA. BFA causes a block in trafficking from the Golgi to the ER [134], as well as the tubulation  
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Figure 1.4 – Motor function within the secretory and endocytic pathways 
[34] 
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of several compartments located within the secretory and endocytic pathways including the cis-, 
medial- and trans-Golgi, TGN, early endosomes, recycling endosomes, late endosomes and 
lysosomes (Figure 1.4) [135-139]. This results in accumulation of material in the ER and loss of 
the Golgi as a discrete organelle. Tubules positive for cis-, medial- and trans-Golgi markers fuse 
with the ER [140], whereas tubules emanating from the TGN mix with the early endocytic 
system [141]. BFA exerts these effects primarily by inhibiting the activities of Sec7-type GTP-
exchange factors including GBF1, thereby preventing activation of the small GTPase Arf1 
leading to perturbation of COPI coat formation [142]. The BFA target which causes inhibition of 
ER-to-Golgi transport is undetermined, although it is proposed to interfere with cargo export 
from the ER.  
 
BFA-induced tubulation of secretory and endocytic organelles is known to be dependent upon 
the microtubule cytoskeleton and ATP [138], but the motor(s) responsible for this motility is 
uncertain. Since tubules move away from the Golgi, a plus end-directed motor is implicated in 
these processes. Indeed, initial studies identified kinesin-1 as being required for the motility of 
BFA-induced cis-Golgi tubules since an anti-KHC antibody, H1, blocked cis- and medial-Golgi 
tubule formation [143]. BFA-induced tubulation can be reconstituted in vitro by mixing a fraction 
enriched in Golgi membranes isolated from rat liver with cytosol prepared from Xenopus laevis 
egg extracts in the presence of BFA. In agreement with the in vivo data, pre-incubation of Golgi 
membranes with the H1 antibody caused a profound inhibition of tubule formation [144]. 
However, when kinesin-1 function was perturbed using the well characterised function-blocking 
anti-KHC antibody sea urchin kinesin (SUK)4, no inhibition of motility was observed. 
Subsequently, the H1 antibody was found to recognise two polypeptides by western blotting 
neither of which are kinesin-1, raising doubts over the specificity of this reagent and the validity 
of the in vivo data. Indeed, Feiguin and co-workers observed that suppression of KHC 
expression in cultured rat hippocampal neurons had no effect upon the BFA-induced 
redistribution of the cis/medial Golgi marker mannosidase II or the trans-Golgi marker NBD-
ceramide back to the ER [145]. Instead, this study reported that tubules positive for the TGN-
localised mannose-6-phosphate receptor (M6PR) did not form in the absence of KHC, indicating 
that different motors may be responsible for the motility of specific subsets of BFA-induced 
tubules.  
 
Another motor implicated in driving the motility of BFA-induced tubules is the kinesin-3 family 
member, KIF1C. Overexpression of a dominant negative form of KIF1C, KIF1C305-9, which 
lacks the ability to bind ATP while retaining the ability to bind cargoes, prevented the retrograde 
flow of cis-Golgi contents to the ER in response to BFA in the NIH-3T3 cultured embryonic 
mouse fibroblastic cell line [146]. However, this data was refuted by studies on the KIF1C 
knockout mouse which displayed a normal response to BFA [147]. It is possible that other 
motors are able to compensate for the absence of KIF1C in the knockout mouse which is not 
possible when dominant negative proteins are used. A link between the kinesin-4 family 
member KIF21A and tubule motility has been recently made since this motor binds another 
target of BFA, BFA-inhibited guanine nucleotide-exchange protein [148]. However, the 
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importance of this interaction remains to be determined since KIF21A is reported not to 
associate with membranes, at least in neurons [149].  
 
The identity of the motor(s) responsible for moving BFA-induced tubules remains a contentious 
and poorly understood area. The motility of endosomal and lysosomal tubules has been studied 
very little and it is unknown whether a single motor is responsible for all tubule motility or a 
cohort of motors function, perhaps co-ordinately, to drive these large scale changes in 
membrane organisation. The situation is further complicated by the observation that 
perturbation of myosin II function caused a delay in BFA-induced fusion of the cis-Golgi with ER 
[150], implying actin motors may also play important roles in these transport processes. It is 
undetermined whether the transfer of material between ER, Golgi and the endocytic system 
observed following BFA treatment represents an enhanced version of trafficking pathways 
which operate normally in untreated cells or whether this motility is specifically induced by the 
drug. Interestingly, tubules positive for the KDEL receptor have been observed to extend away 
from the Golgi in untreated cells in a microtubule-dependent fashion with similar dynamics to 
those induced by BFA treatment, before retracting back towards the Golgi or breaking away and 
travelling towards the cell periphery [151].  
1.4.3 Post-Golgi trafficking 
Proteins delivered to the Golgi from the ER which do not undergo retrograde trafficking back to 
the ER are either moved forward through the secretory pathway or are sorted to the endocytic 
system (Figure 1.4).  
 
Certain cargoes are delivered from the TGN to the endocytic pathway, either directly or via the 
plasma membrane, in a process dependent upon clathrin and its associated adaptor protein 
(AP) complexes. Lysosomal hydrolases are transported to the late endosome from the TGN in 
complex with M6PR. The kinesin-3 family member KIF13A is implicated in this process since it 
has been observed to interact directly with the β1-adaptin subunit of AP1 and its overexpression 
resulted in the mislocalisation of AP1 and M6PR [152]. Following deposition of lysosomal 
hydrolases at the late endosome M6PR is trafficked back to the Golgi, although the motor 
responsible for this movement remains unidentified. Kinesin-1 has also been linked to trafficking 
between the Golgi and endocytic system via its interaction with γ1-adaptin and kinesin interactor 
(Gadkin), an accessory factor of AP1 [153]. A model is proposed in which Gadkin mediates the 
motility of a subset of TGN-derived vesicles positive for the recycling endosomal marker, 
transferrin receptor, dependent upon its direct interactions with KLC2 and AP1.  
 
Cargoes destined for the secretory pathway traverse the Golgi stack undergoing any necessary 
modifications before reaching the TGN where they are sorted and packaged into a variety of 
transport carriers. During constitutive exocytosis, which all cell types perform, following release 
from the TGN carriers move to and fuse with the plasma membrane in a microtubule-dependent 
manner (reviewed in [71]). A function for myosin II in carrier budding from the TGN in vertebrate 
cells has been proposed although this remains controversial [154, 155]. Myosin VI and Rab8, 
together with the effector protein optineurin, are implicated in the initial movement of cargoes 
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away from the Golgi [156]. Indeed, fibroblast cells isolated from the Snell‟s Waltzer myosin VI 
knockout mouse exhibited a defect in alkaline phosphatase secretion [157]. Transport of 
carriers towards the plasma membrane is dependent upon the activity of kinesin-1, another 
unidentified plus end-directed microtubule motor, and unexpectedly cytoplasmic dynein-1 [133]. 
Furthermore, when Rab6 expression was depleted carrier motility became disorganised, 
suggesting this GTPase may coordinate the activities of multiple motors which function within 
this transport step [133]. The latter stages of transport through the actin rich cell cortex, 
enabling docking and fusion of carriers with the plasma membrane, is likely to require the 
activities of myosin motors. Interestingly, Rab6 is also suggested to control docking of exocytic 
vesicles to the plasma membrane by interacting with the cortical protein ELKS [133]. During 
regulated secretion, which is performed only by certain cell types, cargoes are still sorted and 
packaged into vesicles at the TGN and move away using kinesin-1 [158], but they are then 
stored within the cell and only dock and fuse with the plasma membrane in response to a 
specific extracellular stimulus. Roles for myosin Va [159] and kinesin-1 [91] in this final transport 
step have been suggested.  
 
The situation is considerably more complex in polarised cells where cargoes must be directed to 
specific regions of plasma membrane and will only be discussed briefly here (reviewed in [160]). 
In neurons, TGN-derived carriers can be either targeted to the axon or the dendrite. The Reelin 
receptor, Apolipoprotein E Receptor 2 (ApoER2), which interacts indirectly with KLC1 via JIP1 
and JIP2, is directed specifically to axons [161]. Other cargoes such as the α-amino-3-hydroxy-
5-methylisoxazole-4-propionate (AMPA) receptor, which interacts indirectly with KHC via 
glutamate receptor-interacting protein 1 (GRIP1), are directed to dendrites [162]. The 
mechanism underlying the ability of kinesin-1 to recognise and target these cargoes to different 
regions of the plasma membrane is poorly understood, but it is hypothesised that scaffold 
molecules may convey information to the motor regarding the appropriate destination of the 
cargo. In epithelial cells, where microtubules are organised longitudinally, carriers can be 
directed to the apical or basolateral membranes. Minus end-directed motors including 
cytoplasmic dynein-1 [163] and the kinesin-14B family member KIFC3 [164], as well as kinesin-
1 [24], have been implicated in the targeting of cargoes to the apical membrane.  
1.4.4 Endocytosis 
Endocytosis involves the uptake of material, such as nutrients and signalling molecules, from 
outside the cell. During clathrin-mediated endocytosis the binding of proteins to cell surface 
receptors initiates a cascade of events which trigger the invagination of the plasma membrane 
into clathrin-coated vesicles. These vesicles initially deliver their contents to the early endosome 
where material is then sorted (Figure 1.4). This initial inward movement of cargoes through the 
actin rich cell cortex has been proposed to driven by propulsion generated by actin 
polymerisation [165] and myosin VI activity [166]. The positioning and rapid motility of early 
endosomes is controlled by cytoplasmic dynein-1 [167] and the kinesin-3 family member 
KIF16B [66], enabling both inward and outward movement [167]. 
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Cargoes which are to be returned to the plasma membrane, such as transferrin and its receptor, 
undergo fast or slow recycling where they are trafficked directly to the cell surface or indirectly 
via the recycling endosome, respectively. The myosin Va and Vb motors appear integral to 
recycling endosome positioning and motility and the transport of transferrin receptor to the cell 
surface was delayed when the function of these two motors was perturbed [168]. Kinesin-1 has 
also been implicated in this transport step since perturbation of kinesin-1 function was observed 
to slow cycling of transferrin to the plasma membrane in Chinese hamster ovary cells [169]. 
Meanwhile, those cargoes which are to be degraded remain within early endosomes, which 
subsequently mature into late endosomes and fuse with lysosomes. Alternatively, a specific 
subset of proteins, including STB, are delivered directly from early endosomes to the TGN in a 
process linked to the activities of cytoplasmic dynein-1 and Cdc42 [170, 171]. Interestingly, it 
appears trafficking from the endocytic system to the Golgi is not always dependent upon 
microtubules since the cargo receptor TGN38 has been shown to move from early endosomes 
to the TGN following treatment with the microtubule depolymerising agent nocodazole [172], 
perhaps pointing to myosin function in this pathway.  
 
Members of the sorting nexin (SNX) protein family also perform important functions during 
endocytosis and endosomal sorting, implicated in driving membrane curvature and providing a 
link to microtubule motors. SNX proteins each contain a Phox-homology domain, a 
phosphoinositide-binding motif, which mediates binding to membranes enriched in particular 
phosphoinositides (reviewed in [173]). Perhaps the best characterised function of SNX proteins 
is in the retrieval of cargoes from the endocytic system to the TGN. This is dependent upon a 
protein complex called retromer, which in mammals consists of several SNX proteins including 
SNX1, SNX2, SNX5 and SNX6 (reviewed in [174]). This complex is proposed to link cargoes to 
cytoplasmic dynein-1 since both SNX5 and SNX6 have been shown to interact with the 
p150glued subunit of dynactin [175]. Additionally, SNX4, a protein involved in transport between 
the early and recycling endosome has been observed to associate with cytoplasmic dynein-1 
[176, 177]. Other members of the SNX family are implicated in cargo recycling from the 
endocytic system to the plasma membrane and in clathrin-mediated endocytosis (reviewed in 
[174]).  
 
Both late endosomes and lysosomes are highly motile and move bidirectionally [178] with 
inward movement dependent upon cytoplasmic dynein-1 [179]. Perturbation of kinesin-2 
function resulted in the clustering of late endosomes around the MTOC [180], suggesting the 
motor contributes to the outward movement of this organelle. A variety of plus end-directed 
motors have been linked to driving lysosome motility including kinesin-1 [181], kinesin-2 [180], 
and KIF1Bβ3 [54]. The contribution of actin motors to late endosome and lysosome motility and 
positioning has not been investigated in detail, although myosin VIIa has been found associated 
with lysosomes [182].  
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1.5 Organelle dynamics in mitosis 
1.5.1 Cell cycle 
The vertebrate cell cycle is comprised of a series of sequential and tightly regulated events 
which are separated into four discrete stages termed G1, S, G2 and M phases. G1, G2 and S 
phases are collectively referred to as interphase during which cell growth and DNA replication 
occur to prepare the cell for division. During mitotic M phase the cell divides to generate two 
diploid daughter cells, whereas meiotic M phase comprises two rounds of division resulting in 
four haploid daughter cells [1].  
 
M phase can be further subdivided into five distinct phases called prophase, prometaphase, 
metaphase, anaphase and telophase. During prophase chromatin condenses and each 
centrosome, which is duplicated during S phase, moves to opposite poles of the cell. In higher 
eukaryotes, the nuclear envelope disassembles during prometaphase allowing highly dynamic 
microtubules to contact a specialised region of each chromosome known as the kinetochore. 
This is in contrast to yeast where the nuclear envelope remains intact throughout cell division. 
This connection underlies the alignment of chromosomes during metaphase at the metaphase 
plate, located equidistant between each centrosome. Sister chromatids are separated during 
anaphase and pulled towards opposite poles of the cell and the nuclear envelope reforms and 
chromatids unfold during telophase. Cytokinesis is necessary to separate the cytoplasm and 
plasma membrane and once completed marks the end of M phase [1].  
 
The serine/threonine cyclin-dependent protein kinases (CDKs), and their cyclin binding partners 
have essential regulatory roles in these processes, with different CDKs operating at various 
points of the cell cycle (reviewed in [183]). When in complex with their relevant cyclin binding 
partner, CDKs each phosphorylate a specific set of substrate proteins, triggering cell cycle 
progression. CDK1, the master regulator of cell division, associates with cyclin B during mitosis 
leading to phosphorylation of multiple target proteins (reviewed in [1, 183]). The complex of 
CDK1 and cyclin B is required for the transition from G2 to M phase, whereas exit from M phase 
requires inactivation of CDK1 (reviewed in [184]). The association with cyclins is partly 
responsible for regulating CDK1 function, with binding required for CDK1 activity, and as such is 
tightly regulated. This is achieved by strict control of cyclin synthesis and degradation leading to 
fluctuation in cyclin levels during the cell cycle. Cyclins are targeted for proteasome-mediated 
degradation by the addition of poly-ubiquitin tags [185]. There are two mammalian B-type 
cyclins, termed B1 and B2, which both bind CDK1 specifically during M-phase [186]. Cyclin B1 
is more highly expressed then cyclin B2, and is essential for survival [187].  
 
During the transformation from interphase to mitosis several fundamental changes in membrane 
organisation and organelle dynamics occur, which are closely linked to changes in microtubule 
motor function (reviewed in [188]), some of which are discussed below.   
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1.5.2 ER motility and inheritance 
The ER typically adopts an extended tubular-lamellar network characterised by the formation of 
three-way junctions between neighbouring tubules. Continuous with the nuclear envelope, the 
ER network is concentrated around the nucleus but extends to the periphery of the cell lying in 
close proximity to the plasma membrane. Rough and smooth ER is differentiated by the 
presence or absence of ribosomes on the membrane surface respectively. In recent years it has 
become apparent that the ER is not a static organelle, but is constantly moving and remodelling. 
In plant cells this motility is largely dependent upon the actin cytoskeleton and its associated 
myosin motors (reviewed in [189]). Contrastingly, in animal cells microtubule-dependent 
transport and anchoring plays a much larger role with a smaller contribution from actin 
filaments. Several complementary studies, comprising a wide range of cultured epithelial cell 
lines, have observed that when the microtubule cytoskeleton is depolymerised the ER network 
slowly retracts towards the cell centre [190-193], highlighting the close relationship between 
these two networks. There are a variety of means by which the ER network is linked to the 
microtubule cytoskeleton. Some of these are stable long-lived connections believed to be 
necessary to maintain the ER structure and morphology, whereas others are much more 
dynamic and underlie movement of ER tubules. 
 
Early studies observing fluorescently labelled ER in living cultured epithelial cells indicated that 
the majority of ER motility is in an outward direction from the cell centre towards the cell 
periphery, thus implicating a plus end-directed microtubule motor [193, 194]. The major plus 
end-directed motor studied in relation to ER motility is kinesin-1 and several studies have linked 
this motor to the outward movement of ER tubules. A role for kinesin-1 in driving ER movement 
was first proposed in 1988 by Dabora and Sheetz following the observation that the in vitro 
motility of ER membranes isolated from chick embryo fibroblasts was dependent upon 
microtubules and ATP, although no evidence specifically linking kinesin-1 to ER motility was 
provided [195]. This hypothesis was supported by data showing that suppression of KHC 
expression in cultured rat hippocampus neurons promoted retraction of the ER towards the 
nucleus [145], and a reduction in ER motility [196]. Recently, inhibition of kinesin-1 function 
using the dominant negative kinesin-1 protein KHCct was shown to potently inhibit ER motility in 
vitro [30], and a portion of outward-directed ER tubule movements in the monkey kidney 
epithelial cell line, VERO [197].  
 
The binding of kinesin-1 to ER cargo is dependent upon at least two ER-associated proteins, 
kinectin and p180. Kinectin is an integral ER membrane protein initially identified by Toyoshima 
and co-workers as interacting with the KHC tail [198]. When the interaction between kinectin 
and kinesin-1 was disrupted in HeLa cells, either via small interfering RNA (siRNA)-mediated 
depletion of kinectin or overexpression of the binding regions necessary for the interaction, 
collapse of the ER towards the cell centre was observed [199]. Interestingly, kinectin does not 
simply anchor kinesin-1 to the ER but is also capable of promoting the ATPase activity of the 
motor, indicating it may aid unfolding of the kinesin-1 molecule (see section 1.3.3) [200]. 
Another integral ER membrane protein, p180, has also been reported to bind KHC [201]. p180 
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is specifically located on rough ER since it associates with ribosomes and its interaction with 
kinesin-1 remains tenuous since all data to date is in vitro and no in vivo association between 
the two proteins has been observed. The influence this association has upon ER morphology 
remains to be investigated, and the ability of p180 to bind both kinesin-1 and ribosomes 
simultaneously may indicate the interaction is more important in controlling mRNA localisation 
rather than ER positioning. Recent data showing that the exogenous addition of a particular 
isoform of KLC, KLC1B, inhibited ER motility in vitro [30], indicates KLC also binds ER and that 
engagement of KLC with an ER localised receptor is required for motility. However, the 
identities of any KLC binding partners on the ER remain elusive.  
 
Several observations suggest kinesin-1 activity is not solely responsible for driving ER motility. 
Instead, it is believed several distinct mechanisms operate, perhaps co-ordinately, to move and 
anchor the ER to the microtubule cytoskeleton, making the situation decidedly more complex. 
Indeed, fixed cell analysis of fibroblasts isolated from the kif5b knockout mouse embryo 
revealed no apparent defects in ER morphology [18], and kinectin knockout mice displayed 
normal ER positioning [202]. Furthermore, inhibition of kinesin-1 function in VERO cells had 
only a subtle effect on ER distribution, resulting in a slight decrease in ER intensity at the cell 
periphery and a switch towards a more lamellar morphology, while a subset of outward tubule 
movements persisted even when kinesin-1 function has been perturbed [197]. Other motors, 
including cytoplasmic dynein-1 [89, 197] and myosin V [203], have been reported to contribute 
to ER motility in certain situations. Furthermore, the microtubule +TIP EB1 interacts directly with 
the ER transmembrane protein stromal interaction molecule 1 to form a tip attachment complex 
(TAC) [204]. This allows ER tubules to elongate together with the EB1-positive plus end of a 
growing microtubule. In this situation ER tubules link selectively to the growing plus tips of 
microtubules and ER tubule extension is driven by microtubule polymerisation and is 
independent of motor activity.  
 
The integral rough ER membrane protein, cytoskeleton-linking membrane protein of 63 kDa 
(CLIMP-63), binds microtubules directly and provides a stable connection between the two 
networks [205]. This interaction is important to the correct positioning of the ER network since 
overexpression of CLIMP-63 in cultured cells results in ER collapse towards the cell centre. 
There are several other proteins which have been reported to bind both microtubules and ER 
and may thereby contributed to ER positioning and morphology, including the calcium-binding 
protein p22 [206]. 
 
Changes are known to occur to ER positioning and morphology during cell division, although a 
high degree of variability between cell types and organisms is apparent. Whilst it is known that 
the CLIMP-63-mediated interaction between ER and microtubules is regulated in a cell cycle-
dependent manner, with the protein becoming hyperphosphorylated at three serine residues 
causing dissociation from microtubules and perturbation of ER positioning [207], how ER 
motility is modulated during cell division is poorly understood. The major reported changes that 
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occur to ER positioning and morphology during mitosis in mammalian cells and budding yeast 
will be briefly outlined.  
 
The main structural change to occur to the ER during cell division in mammalian cells is the 
breakdown of the nuclear envelope during prometaphase, dependent upon the activity of 
cytoplasmic dynein-1, leading to spreading of nuclear envelope components throughout the ER 
[208]. The rest of the network remains continuous during cell division and does not breakdown 
into vesicles or fragments but is reported to be excluded from the region occupied by the mitotic 
spindle with stochastic partitioning between daughter cells thought to occur during anaphase 
[209-211] (Figure 1.5). Normally, ER membrane fusion events are mediated partially by the 
activities of the AAA ATPase p97 and its cofactor p47 [212]. Semi-intact cell assays indicated 
that p47 is a substrate of CDK1 leading to perturbation of p97 function and the mitotic inhibition 
of ER tubule fusion [211]. Additional changes in the organisation of the ER during mitosis have 
also been observed in a range of cultured cell lines and developing Caenorhabditis elegans 
embryos. There appears to be a switch from the reticular interphase ER structure consisting of 
relatively short tubules which are highly branched, to a more cisternal, sheet-like morphology 
during mitosis, with very few tubules remaining [213, 214]. This change is proposed to be driven 
by the dramatic reorganisation of the microtubule cytoskeleton during cell division. 
 
By contrast, in budding yeast nuclear envelope breakdown does not occur and the mitotic 
spindle forms inside the nucleus, meaning the nuclear envelope and perinuclear ER are 
separated together with DNA in a microtubule-dependent fashion. The rest of the ER network 
which lies just beneath the plasma membrane extends into the growing bud where it becomes 
anchored at the tip by a multiprotein tethering complex called the exocyst, before spreading 
throughout the cortex (reviewed in [215]). The inheritance of cortical ER is dependent upon the 
myosin V family member, Myo4, and its adaptor protein, She3, which travel along actin 
filaments positioned along the mother-bud axis [216]. 
 
Since cells round up considerably during division, the imaging of ER tubule motility during 
mitosis is a difficult procedure. However, progress has been made in studying changes to ER 
motility during the cell cycle by reconstituting motility in vitro using Xenopus laevis egg extracts. 
When membrane and cytosol fractions from interphase extracts are mixed together an 
extensive ER network is able to form which is solely dependent upon the activity of cytoplasmic 
dynein-1. However, if an identical assay is performed using cytosol prepared from metaphase-
arrested extracts, the network fails to form [217]. This inhibition of motility is due to the 
metaphase-specific phosphorylation of DLIC by CDK1, which triggers dissociation of the motor 
from ER membranes and thereby inhibits movement [89].  
 
This dependence of ER motility in Xenopus laevis eggs upon cytoplasmic dynein-1 may appear 
at odds with the previously described data indicating kinesin-1 plays a prominent role in ER 
movement. In fact kinesin-1 is present on ER in Xenopus laevis eggs but is inactive and 
evidence suggests that kinesin-1-driven ER motility is activated during development. When
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Figure 1.5 – ER inheritance in mammalian cells 
 
[215] 
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membranes isolated from Xenopus laevis eggs were mixed with cytosol prepared from somatic 
Xenopus laevis tissue culture (XTC) cells a portion of ER motility was supported by kinesin-1 
[218]. This was reliant upon the activation of membrane-bound kinesin-1 and was not simply 
due to recruitment of the motor from the cytosol to the ER cargo. It is probable that the relative 
contributions of cytoplasmic dynein-1 and kinesin-1 to ER movement are precisely controlled 
and under certain situations one motor may take prominence thus allowing the tight temporal 
and spatial regulation of ER network remodelling. The movement of Xenopus laevis egg ER 
exclusively by a single motor likely represents an extreme situation where the opposing motor 
has been completely inactivated, but is still responsive to particular stimuli and can be activated 
under certain situations.  
 
Despite these advances, how the ER is correctly segregated between daughter cells and 
whether ER motility changes during cell division remains a contentious and poorly understood 
area, especially in mammalian cells. 
1.5.3 Golgi inheritance and trafficking processes 
Unlike the ER network, the Golgi apparatus undergoes major structural changes in its 
organisation during cell division. In mammalian cells the lateral connections between adjacent 
Golgi stacks are lost during prophase allowing conversion of the compact interphase Golgi 
structure into small vesicles as well as larger vesicular and tubular structures during metaphase 
[219]. Two models exist to explain the fate of these fragments whereby they are either 
stochastically partitioned between daughter cells during anaphase [220], or subsequently fuse 
with the ER and are inherited together with this organelle [221] (reviewed in [215]). Fusion of 
Golgi fragments occurs during telophase leading to reformation of the interphase perinuclear 
Golgi ribbon. In budding yeast the Golgi is organised into numerous units dispersed throughout 
the cytoplasm during interphase. A de novo model of Golgi inheritance is proposed in which 
complete intact Golgi structures are produced anew, emanating from ERES (reviewed in [215]).  
 
Given the drastic alterations in morphology and positioning of organelles within the secretory 
pathway during mitosis it is perhaps not surprising that the flux of material through trafficking 
pathways is subject to alteration during cell division. Protein synthesis, secretion, pinocytosis, 
and clathrin-mediated endocytosis are all downregulated during cell division. Warren and co-
workers showed that the transport of newly synthesised VSV-G protein to the plasma 
membrane is blocked during mitosis and resumes during telophase [222], and subsequent work 
revealed cargo transit is inhibited early in the secretory pathway with the protein being retained 
in the ER [223]. Indeed, ERES have been observed to disassemble during mitosis resulting in a 
block in ER-to-Golgi transport [224]. Reconstitution of this process in semi-intact cell assays has 
indicated that this inhibition is dependent upon the phosphorylation of p47 by CDK1. Both fluid 
endocytosis, phagocytosis and clathrin-mediated endocytosis are completely suppressed 
throughout mitosis in a range of cultured cell lines [225, 226], while the in vitro formation of 
BFA-induced tubules is blocked in the presence of metaphase Xenopus laevis egg extract 
cytosol [144].  
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Due to the integral role kinesin-1 plays in these processes it is possible that regulation of the 
activity of this motor may contribute to the large scale changes in cargo trafficking and organelle 
motility which occur during cell division. Unlike cytoplasmic dynein-1, kinesin-1 has no 
documented roles specifically in mitosis. The motor is reported to contribute to the translocation 
and orientation of the female meiotic spindle in Caenorhabditis elegans and this is dependent 
upon the interaction of KLC1 and KLC2 with kinesin cargo adaptor protein-1 (KCA-1) [227]. 
However, no KCA-1 homologues exist outside of nematodes and actin-dependent transport 
appears to play a much more prominent role in mammalian cells [228]. Therefore, if kinesin-1 is 
controlled in a cell cycle-dependent manner it is likely that rather than switching from 
interphase- to mitotic-specific functions, the activity of the motor may be downregulated or even 
inhibited specifically during cell division.  
1.5.4 Xenopus laevis egg extracts 
Membrane motility can be reconstituted using cytoplasmic extracts prepared from Xenopus 
laevis eggs in cell-free motility assays. These extracts have several distinct advantages over 
other in vitro assays or in vivo studies, especially when investigating microtubule motor 
regulation (reviewed in [229]). The cytosol is diluted very little during preparation meaning 
extracts with a high concentration of motors are generated, capable of supporting a high level of 
microtubule-dependent motility at room temperature which is easily visualised using video-
enhanced differential interference contrast (VE-DIC) microscopy. Furthermore, several protein 
modifications such as phosphorylation are supported, meaning membrane motility can be 
correlated to post-translational modifications under virtually identical assay conditions. The 
activity of a single microtubule motor can often be studied in isolation, allowing the contribution 
that a motor makes to a complex process to be investigated without the effects of other motors 
distorting results. This is an increasingly useful attribute as it becomes apparent that often 
motors do not work in isolation in vivo but cooperate and coordinate with each other, with 
bidirectional motility a common feature [230, 231]. This often makes in vivo studies a difficult 
means of trying to identify how a particular motor may be regulated. Interestingly, the ability to 
reconstitute membrane motility in these assays is not limited to Xenopus laevis since rough ER- 
and Golgi-enriched fractions isolated from rat liver are both motile when mixed with cytosol 
prepared from interphase Xenopus laevis egg extracts [89, 232].  
 
Importantly, the natural conversion of Xenopus laevis eggs between cell cycle states can be 
utilised to generate extracts arrested in meiosis, mitosis and interphase. Xenopus laevis eggs 
are naturally arrested in metaphase II of meiosis when laid. This is due to the high level of 
cytostatic factor (CSF) which maintains a high level of maturation-promoting factor (MPF) [233]. 
MPF is a complex of cyclin B and CDK1 [234, 235]. Fertilisation triggers a high level of calcium 
influx into the egg and calcium release from intracellular stores, which subsequently inactivates 
CSF, triggering cyclin B degradation and thereby inactivation of MPF. These events lead to 
release from the meiotic arrest and entry into interphase, allowing embryonic development to 
progress [236]. 
Figure 1.6 – Generation and conversion of Xenopus laevis egg extracts  
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Extracts prepared from Xenopus laevis eggs can be arrested in different cell cycle states by 
artificially manipulating the events which control the transition between interphase and 
metaphase (Figure 1.6). By injecting Xenopus laevis frogs with hormones which induce the  
laying of eggs, a high number of unfertilised eggs arrested in metaphase II of meiosis are 
obtained. If extract preparation is performed in the presence of calcium chelators, to eliminate 
any free calcium capable of triggering conversion to interphase, meiotic metaphase II-arrested  
extracts can be generated [237]. Due to the high level of MPF and CSF present in these 
samples which underlie the meiotic arrest, they are often referred to as CSF extracts. Treatment 
of CSF extracts with exogenous calcium simulates the events which occur following fertilisation 
and thereby prompts conversion into interphase. If cycloheximide is included during the 
activation step the extract will be arrested in interphase due to an inability to regenerate 
metaphase cyclins [237].  
 
Alternatively, extracts arrested in interphase can be made directly from meiotic eggs. The 
simplest method is to perform the preparation in the absence of calcium chelators, meaning any 
calcium present in buffers or released from eggs following crushing will stimulate conversion 
into interphase. Extracts prepared in this manner are termed Newmeyer in reference to Donald 
Newmeyer who initially documented this protocol [238]. Interphase Newmeyer extracts can be 
converted to a mitotic metaphase arrest by treatment with a mutant form of the cyclin B1 
protein, termed cyclin B1 Δ90 [236]. Cyclin B1 regulates the activity of the key mitotic kinase 
CDK1, with binding of the cyclin required for CDK1 function (see section 1.5.1) [233, 236]. 
Normally the level of cyclin B1 is tightly regulated and to inactivate CDK1, the cyclin is targeted 
for degradation by the proteasome by the addition of ubiquitin tags [185]. Cyclin B1 Δ90 is a 
truncated version of the wild-type protein lacking 90 amino acids from the N-terminus, rendering 
the protein unable to be ubiquitinated whilst retaining the ability to interact CDK1 [236]. 
Therefore the mutant cyclin B1 is non-degradable rendering CDK1 constitutively active, 
meaning the extract is arrested in mitotic metaphase.  
1.6 Aims of the studies 
This study was comprised of two major sections, both examining the function and regulation of 
kinesin motors. Firstly, the regulation of kinesin-1 in a cell cycle-dependent manner will be 
investigated, and secondly the identity of the motor(s) responsible for moving BFA-induced 
tubules will be probed. 
1.6.1 Cell cycle regulation of kinesin-1 
The initial aim of this project is to determine if, similar to cytoplasmic dynein-1 [89], kinesin-1-
driven ER motility is regulated in a cell cycle dependent manner in vitro. To answer this question 
rough ER isolated from rat liver will be combined with cytosol prepared from interphase, meiotic 
metaphase or mitotic metaphase Xenopus laevis egg extracts. It is known that rat liver rough 
ER is motile in interphase cytosol in vitro, where it forms an extensive network characterised by  
the formation of three-way junctions between neighbouring tubules [232]. Importantly, this 
motility is known to be exclusively dependent upon kinesin-1 [30], meaning any perturbation of 
movement in metaphase cytosols can be attributed to modulation of kinesin-1 activity.  
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If ER motility is affected following incubation with metaphase cytosols, it is aimed to identify the 
mechanism underlying this modulation. There are a number of potential scenarios by which this 
may occur and these are outlined in Figure 1.7. These include modulation of the interaction 
between kinesin-1 and ER cargo, or between the motor and the microtubule, specifically in 
metaphase cytosol. Phosphorylation of kinesin-1 may occur specifically in the interphase or 
metaphase assay, which has a corresponding effect upon motor function. Alternatively, the 
ability of kinesin-1 to bind or hydrolyse ATP may be regulated in a cell cycle-dependent manner. 
The interaction between KHC and KLC subunits of kinesin-1 following incubation with 
interphase or metaphase cytosol will also be investigated. Finally, it is possible that binding 
partners interact with kinesin-1 specifically following incubation with interphase or metaphase 
cytosol which are capable of modulating motor activity. Each of these possibilities will be 
investigated in turn to identify which, if any, is responsible for controlling kinesin-1 activity in a 
cell cycle-dependent manner in vitro.  
1.6.2 Motility of BFA-induced tubules 
The aim of the project is to identify the motor(s) responsible for the motility of BFA-induced 
tubules. Initially, in vitro motility assays will be performed using Golgi membranes isolated from 
rat liver to reconstitute the motility of BFA-induced tubules which has been used successfully in 
similar previous studies [144]. The activities of kinesin-1, kinesin-2 and KIF1C, which play 
prominent roles in driving membrane motility in interphase metazoan cells (see sections 1.2.1, 
1.2.2 and 1.2.3), will be perturbed in vitro using dominant negative proteins and function-
blocking antibodies. The contribution of KIF1C to this process will be investigated in detail due 
to the controversy surrounding the role of this motor in driving retrograde trafficking from the 
Golgi to the ER in response to BFA (see section 1.4.2.2) [146, 147]. 
 
This in vitro approach will be complemented by in vivo studies using the human epithelial cell 
line, HeLaM. The activities of kinesin-1, kinesin-2 and KIF1C will be disrupted using transient 
transfection of dominant negative constructs and siRNA-mediated depletion. The ability of cis-
Golgi, TGN, endosomal and lysosomal tubules to form will be assessed using 
immunofluorescence studies incorporating antibodies raised against markers for each of these 
compartments.  
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Figure 1.7 – Potential mechanisms of kinesin-1 regulation
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Table 1.1 – Expression of kinesin-1, -2 and -3 motors in various species 
Kinesin 
family 
Motor/ 
subunit 
Isoform 
Splice 
variants 
Tissue-
specific 
expression 
Cell cycle-
specific 
function(s) 
Human accession 
number 
Rat accession 
number 
Xenopus 
accession 
number/reference 
Kinesin-
1 
KIF5 
KIF5A 
 
Neuronal 
[23]* 
None known NM004984 NM212523.1 NM001102745.1 
KIF5B Ubiquitous 
The 
Caenorhabditis 
elegans 
homologue of 
KIF5B, UNC-116, 
has been reported 
to be involved in 
the translocation 
of the female 
meiotic spindle to 
the egg cortex 
[227] 
NM004521.2 NM057202.1 NM001128654.1 
KIF5C 
Neuronal 
[22]* 
None known NM004522.1 NM001107730.1 Unknown 
KLC 
KLC1 
KLC1A Unknown 
The 
Caenorhabditis 
elegans 
homologue of 
KLC1 has been 
reported to be 
involved in the 
translocation of 
the female meiotic 
spindle to the egg 
cortex [227] 
BK000678  NM001081972.1 NM001087151.1 
KLC1B Unknown BK001166 NM001081973.1 Unknown 
KLC1C Unknown AY180164 NM001081974.1 Unknown 
KLC1D Unknown BK001163 Unknown Unknown 
KLC1E Unknown BK001164  Unknown Unknown 
KLC1F Unknown BK000680 Unknown Unknown 
KLC1G Unknown BK001170  Unknown Unknown 
KLC1H Unknown BK000682  Unknown Unknown 
KLC1I Unknown BK000681 Unknown Unknown 
KLC1J Unknown BK001172 Unknown Unknown 
KLC1K Unknown BK001167 Unknown Unknown 
KLC1L 
Absent from 
human liver 
tissue [28] 
ENST00000303439 Unknown Unknown 
KLC1M Unknown BK000683 Unknown Unknown 
KLC1N Unknown BK001168 Unknown Unknown 
KLC1O Unknown BK000679 Unknown Unknown 
KLC1P Unknown BK001169 Unknown Unknown 
KLC1Q Unknown BK000684 Unknown Unknown 
KLC1R Unknown BK001171 Unknown Unknown 
KLC1S Unknown BK001165 Unknown Unknown 
KLC2 
KLC2A 
Ubiquitous 
The 
Caenorhabditis 
elegans 
homologue of 
KLC2 has been 
reported to be 
involved in the 
translocation of 
the female meiotic 
spindle to the egg 
cortex [227] 
NM022822.2 BC166555.1 Unknown 
KLC2B NM001134774.1  Unknown Unknown 
KLC2C NM001134775.1 Unknown Unknown 
KLC2D NM001134776.1  Unknown Unknown 
KLC3  
Enriched in 
mouse 
spermatids 
[26] 
None known NM177417.2 NM138520.1 [239] 
KLC4 
KLC4A Unknown None known NM201521.1  NM001009601.1 Unknown 
KLC4B Unknown None known NM201522.1 Unknown Unknown 
KLC4C Unknown None known NM201523.1  Unknown Unknown 
KLC4D Unknown None known NM138343.2 Unknown Unknown 
Kinesin-
2 
KIF3A 
 
Ubiquitous Localised to the 
mitotic spindle 
and centrosomes 
in mitotic HeLa 
cells [240] 
NM007054 NM053486.1 NM001090799.1 
KIF3B Ubiquitous NM004798 NM001106529.1  XM002939655.1 
KIF3C 
Neuronal 
[241]*  
NM002254 NM053486.1 XM002942110.1 
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KAP3  
 
Ubiquitous 
Overexpression of 
mutant KIF3B in 
NIH-3T3 cells 
results in aberrant 
mitosis [240]  
NM014970.2 NM001105964.1 NM001092562 
KIF17 
KIF17A Neuronal 
[42]* 
None known NM020816.2  Unknown Unknown 
KIF17B None known NM001122819.1 Unknown Unknown 
Kinesin-
3 
KIF1 
KIF1A 
Neuronal 
[55]* 
None known NM004321 XM343630.4 XM002933334.1 
KIF1B 
KIF1Bα Unknown None known NM183416.3 NM057200.1 XM002939557.1 
KIF1Bβ 
Enriched in 
mouse 
motor 
neurons 
[242]* 
None known NM015074.3 Unknown Unknown 
KIF1C  
Enriched in 
human brain 
and skeletal 
muscle [146]  
None known NM006612.5 NM145877.1 XM002942910.1 
KIF13 
KIF13A 
KIF13Aa Enriched in 
mouse 
brain, lung, 
heart, 
kidney, and 
testes [243] 
None known NM022113.4 NM001107462.1 Unknown 
KIF13Ab None known NM001105566.1 Unknown Unknown 
KIF13Ac None known NM001105567.1 Unknown Unknown 
KIF13Ad None known NM001105568.1 Unknown Unknown 
KIF13B 
 
Ubiquitous None known AF279865 NM213626.1 Unknown 
KIF14  
Enriched in 
mouse brain 
and kidney 
[243] 
Implicated in 
cytokinesis and 
chromosome 
segregation [64, 
65]  
NM014875.2 Unknown Unknown 
KIF16 
KIF16A 
Enriched in 
mouse lung, 
heart, 
kidney and 
testes [243] 
None known AK122666 Unknown Unknown 
KIF16B 
Enriched in 
mouse lung 
[243] and 
testes [13] 
None known NM024704.3 NM001107783.2 Unknown 
 
* It should be noted that the tissue-specific distribution of several kinesin motors, especially 
those which are reported to be specifically expressed in neurons, is controversial and the 
mRNA of several of these motors has recently been detected in human epithelial cell lines [24].  
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Table 1.2 – KHC interacting partners 
Cargo 
KHC isoform 
and/or 
binding 
region 
Species Reference Notes 
 Disrupted-In-
Schizophrenia-1 
KIF5A 
Within amino 
acids 706-829 
Rat [244] 
The interaction is responsible for linking kinesin-1 to 
a complex of NudE-like/Lissencephaly 1/14-3-3. This 
is important for axonal localisation of the complex. 
Enabled 
Within amino 
acids 714-975 
Drosophila  [245] 
Enabled is an actin polymerisation factor. The 
interaction is proposed to negatively regulate 
kinesin-1 activity. 
FEZ1 
KIF5B 
Within amino 
acids 750-955 
Rat [103] 
FEZ1 binding to KHC is required for JIP1 transport. 
See section 1.3.3. 
GRIF1 
KIF5B and 
KIF5C 
Rat [98] 
GRIF1 is the rat homologue of the Drosophila 
melanogaster protein milton. It is proposed to be 
important in mitochondrial positioning. See section 
1.3.2. 
GRIP1 
KIF5A, KIF5B 
and KIF5C 
Within amino 
acids 807-934 
Mouse [162] 
The interaction may be important for the dendritic 
targeting of AMPA receptors. See section 1.4.3. 
Kinectin 
KIF5A, KIF5B 
and KIF5C 
Within amino 
acids 828-900 
Human [198, 200] 
Kinectin is an integral ER membrane protein. Binding 
of kinectin to KHC increases the ATPase activity of 
the motor. See section 1.5.2. 
Milton 
Within amino 
acids 810-891 
Drosophila [95, 246] 
Milton links KHC to mitochondria independently of 
KLC. It is homologous to OIP106 and GRIF1. See 
section 1.3.2.  
Myosin Va 
KIF5B  
Within amino 
acids 763-856 
Mouse [247] 
The interaction may be important in coordinating 
actin and microtubule transport. It is proposed that 
both motors may bind a subset of the same cargoes. 
OIP106 
KIF5B and 
KIF5C 
Human [98] 
OIP106 is the human homologue of the Drosophila 
melanogaster protein milton. It is proposed to be 
important in mitochondrial positioning. See section 
1.3.2. 
p120 catenin 
KIF5B and 
KIF5C 
Mouse [248, 249] 
p120 catenin is a component of adherens junctions. 
The interaction is proposed to be important for the 
cell surface trafficking of cadherins. 
p180 
KIF5B 
Within amino 
acids 867-907 
Human [201] 
p180 is an integral ER membrane protein with the 
ability to bind ribosomes. The interaction is proposed 
to be important for the correct localisation of mRNA. 
See section 1.5.2. 
Ran-binding protein 2 
KIF5B and 
KIF5C 
Within amino 
acids 640-964 
Mouse [250] 
The interaction is observed in retina and brain tissue. 
It is proposed that kinesin-1 may be delivering 
unknown cargoes to Ran-binding protein 2. No 
interaction seen with KIF5A. 
Synaptosome-
associated protein of 23 
kDa and 25 kDa 
KIF5B  
Within amino 
acids 814-907 
Human [251] 
Synaptosome-associated protein of 25 kDa is 
specifically neuronally expressed.  
Syntabulin 
Within amino 
acids 814-963 
Rat [252] 
It is proposed that syntabulin may link kinesin-1 to 
syntaxin and thereby mediate its axonal transport. 
UNC-76 
Within amino 
acids 675-975 
Drosophila [253] 
UNC-76 is the Drosophila melanogaster homologue 
of FEZ1. UNC-76 may regulate kinesin-1 activity to 
facilitate axonal transport. 
α-Dystrobrevin 
β-Dystrobrevin 
KIF5A and 
KIF5B 
Within amino 
acids 804-934 
Mouse [254] 
The interaction may be important for transport of the 
dystrophin-associated protein complex in neurons. 
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Table 1.3 – KLC interacting partners 
Cargo 
KLC 
isoform 
and/or 
binding 
region 
Organism Reference Notes 
Amyloid precursor 
protein 
KLC1 and 
KLC2  
Within 
amino acids 
167-541 
Mouse [255] 
Amyloid precursor protein plays a key role in 
Alzheimer‟s disease. The interaction with 
KLC is proposed to be important in the 
axonal transport of the protein. 
Calsyntenin-1 KLC1 Mouse [256] 
Calsyntenin-1 is a neuronal transmembrane 
protein belonging to the cadherin 
superfamily. The interaction may link other 
cargoes to kinesin-1. 
Collapsin response 
mediator protein-2  
KLC2 
Within 
amino acids 
168-542 
Mouse [257] 
This interaction links tubulin to kinesin-1 and 
may be important in driving the transport of 
soluble tubulin into the axon. 
DIC 
KLC1 and 
KLC2 
Rat [83] 
The interaction is proposed to be important 
for localising cytoplasmic dynein-1 to 
particular sites of function.  
Frat KLC1 Mouse [239] 
Frat is homologous to the Xenopus protein 
GBP and is a GSK3-binding protein. The 
interaction is proposed to be important for 
transport of Wnt signalling complexes. 
Gadkin KLC2 Rat [153] 
Gadkin associates with kinesin-1 and AP1 
and may be important in mediating trafficking 
between the TGN and endocytic system. See 
section 1.4.3. 
GBP 
XKLC4 
Within 
amino acids 
1-44 
Xenopus [239] 
 GBP is homologous to the vertebrate protein 
Frat. Kinesin-1 may compete with GSK3 to 
bind GBP. The interaction may be important 
for targeting of GBP to the dorsal side of the 
embryo and cortical rotation. 
GLUT4 KLC1 Rat [258] 
GLUT4 is a glucose transporter protein. The 
interaction is proposed to be important for the 
translocation of intracellular vesicles to the 
plasma membrane in response to insulin. 
HSC70 KLC1 Mouse [85] 
The phosphorylation of KLC by GSK3 
promotes binding of HSC70 which aids cargo 
removal from kinesin-1. See section 1.3.1. 
JIP1 
KLC1 
Within 
amino acids 
1-176 
Mouse [161] 
The concentration of JIP1 protein at the 
nerve terminal is dependent upon the 
interaction with kinesin-1. It is involved in the 
axonal targeting of ApoER2 (see sections 
1.3.3 and 1.4.3) and amyloid precursor 
protein. 
JIP2 
KLC1 
Within 
amino acids 
1-176 
Mouse [161] 
Involved in the axonal targeting of ApoER2. 
See section 1.4.3. 
JIP3 
KLC1 
Within 
amino acids 
1-176 
Mouse [161] 
JIP3 can form oligomeric complexes with 
itself and JIP2.  
JIP4 
KLC1 
Within 
amino acids 
192-422 
Mouse [259] 
The interaction between KLC and JIP4 is 
decreased when cells are serum starved. 
Kinase D-interacting 
substrate of 220 
kDa/ankyrin repeat-
rich membrane 
spanning 
KLC1  
Within 
amino acids 
83-296 
Rat [260] 
The cargo is a conserved transmembrane 
protein mainly expressed in brain and 
neuroendocrine cells. The interaction is 
proposed to mediate the recruitment of other 
cargoes to kinesin-1. 
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KCA-1 
KLC1 and 
KLC2 
Caenorhabditis 
elegans 
[227] 
The interaction is proposed to be important 
for orientation of the female meiotic spindle. 
See section 1.5.3. 
Outer dense fibre-1 KLC3 Rat [261] 
The interaction is proposed to be important 
during spermatogenesis.  
Sunday driver 
KLC1 and 
KLC2 
Within 
amino acids 
4-163 
Drosophila [262] 
It is proposed that sunday driver acts as an 
adaptor protein linking kinesin-1 with a 
subset of neuronal vesicles. Homologous to 
JIP3. 
Tau 
KLC1 and 
KLC2 
Rat [263] 
Kinesin-1 is important for the axonal 
transport of tau, a protein implicated in 
Alzheimer‟s disease. 
TorsinA 
KLC1 
Within 
amino acids 
251-332 
Rat [264] 
Mutation of torsinA gives rise to early torsion 
dystonia, which may be linked to the 
intracellular trafficking of the protein.  
UNC-14 KLC2 
Caenorhabditis 
elegans 
[265] The protein is involved in neurite outgrowth.  
UNC-16 
KLC2 
Within 
amino acids 
1-174 
Caenorhabditis 
elegans 
[265] 
UNC-16 is the Caenorhabditis elegans 
homologue of JIP3. The axonal localisation 
of UNC-16 is dependent upon its interaction 
with kinesin-1. 
14-3-3 protein 
KLC2 
Within 
amino acids 
354-599 
Rat [90] 
14-3-3 proteins constitute a diverse family 
implicated in several signal transduction 
pathways. The interaction is dependent upon 
phosphorylation of KLC. See section 1.3.1. 
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2. Materials and Methods
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2.1 Solutions/reagents 
The following reagents were purchased from Sigma-Aldrich, Gillingham, UK:  
1,4-Diazabicyclo(2,2,2)octane (DABCO), 1,4-piperazinediethanesulfonic acid (PIPES), 4',6-
diamidino-2-phenylindole (DAPI), ammonium persulphate (APS), ampicillin, aprotinin, ATP, 
bromophenol blue, casein, chymostatin, colloidal Coomassie, Coomassie brilliant blue, creatine 
phosphate, creatine phosphokinase, cycloheximide, cysteine, D-biotin, dimethyl sulfoxide 
(DMSO), dithiothreitol (DTT), ethidium bromide, ethyleneglycoltetraacetic acid (EGTA), fish skin 
gelatine, glass wool, GTP, histone H1, isopropyl β-D-1-thiogalactopyranoside (IPTG), 
kanamycin, Kodak BioMax MR Film, leupeptin, N,N,N‟,N‟-Tetramethylethylenediamine 
(TEMED), Na-β-glycerophosphate, nocodazole, paraformaldehyde (PFA), pepstatin, 
phenylmethanesulfonyl fluoride (PMSF), Ponceau S, reduced L-glutathione, sodium 
borohydride, sodium azide, sterile phosphate-buffered saline (PBS), sterile trypsin containing 
ethylenediaminetetraacetic acid (EDTA), taxol, Triton X-100, Tween-20, β-mercaptoethanol.  
 
The following reagents were purchased from Fisher Scientific, Leicestershire, UK:  
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), acetic acid, CaCl2, EDTA, ethanol, 
glutaraldehyde, glycerol, glycine, HCl, K-acetate, KCl, KH2PO4, methanol, MgCl2, MgSO4, 
Na2HPO4, Na-acetate, NaCl, sodium dodecyl sulfate (SDS), sucrose, trichloroacetic acid, Tris-
HCl. 
 
The following reagents were purchased from VWR International, West Sussex, UK: Chloroform, 
KOH, Mg-acetate, Na-acetate, NaOH, Na-pyrophosphate, phenol.  
 
Acetate buffer 
100 mM K-acetate, 3 mM Mg-acetate, 5 mM EGTA, 10 mM HEPES, pH 7.4 with KOH 
Acetate sucrose buffer (A/S) 
100 mM K-acetate, 3 mM Mg-acetate, 5 mM EGTA, 10 mM HEPES, pH 7.4 with KOH, 150 mM 
sucrose 
Activation mix 
100 mM KCl, 1 mM MgCl2, 4 mM CaCl2 
ATP 
100 mM stock made with 100 mM MgCl2, pH 7.0 with NaOH  
Bacterial lysis buffer 
1 mM PMSF, 1 % (v/v) Triton X-100, 0.2 % (v/v) Tween-20 in PBS 
Brinkley reassembly buffer (BRB80) 
80 mM PIPES, 1 mM MgCl2, 1 mM EGTA, pH 6.8 with KOH 
BFA 
10 mg/ml stock in methanol (Enzo Life Sciences, Exeter, UK) 
Complete media 
Dulbecco‟s Modified Eagle Medium (Biowhittaker, Lonza, Berkshire, UK), 1 % (v/v) L-Glutamine 
(200 mM in 0.85 % (w/v) NaCl solution) (Biowhittaker), 10 % (v/v) HyClone Foetal Calf Serum 
(Perbio, Northumberland, UK) 
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Coomassie stain 
50 % (v/v) ethanol, 7.5 % (v/v) acetic acid, 0.2 % (w/v) Coomassie brilliant blue 
Coomassie destain 
40 % (v/v) methanol, 10 % (v/v) acetic acid 
Cycloheximide 
10 mg/ml stock in DMSO 
Energy mix (20x) 
150 mM creatine phosphate, 20 mM ATP, 20 mM MgCl2, 2 mM EGTA, pH 7.7 
Extraction buffer 
80 mM Na-β-glycerophosphate, 15 mM MgCl2, 20 mM EGTA, pH 7.3 with NaOH. The following 
additions were made just before use: 1 mM DTT, 1 μg/ml protease inhibitors 
Human chorionic gonadotropin (HCG) 
1500 U/ml in phosphate-buffered water (Intervet, Cambridgeshire, UK) 
Histone H1  
20 mg/ml stock in water (type III-S from calf thymus) 
Histone kinase cocktail  
2 mg/ml histone H1, 0.1 mM 
32
P-γ-ATP (PerkinElmer, Cambridgeshire, UK) in extraction buffer 
Immunoprecipitation (IP) buffer 
10 mM Tris-HCl, 80 mM Na-β-glycerophosphate, 10 mM Na-pyrophosphate, pH 7.7, 1 % (v/v) 
Triton X-100. Just before use 10 μg/ml protease inhibitors was added 
Laemmli sample buffer (3x) 
180 mM Tris-HCl, 20 % (v/v) glycerol, 6 % (w/v) SDS, 15 % (v/v) β-mercaptoethanol, 0.01 % 
(w/v) bromophenol blue 
LB medium 
25 g of granulated LB (Melford Laboratories, Suffolk, UK) per litre of distilled water 
Marc’s modified ringer’s (MMR) buffer (1x) 
0.1 M NaCl, 2 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 5 mM HEPES, 0.1 mM EGTA, pH 7.8 with 
NaOH 
Mock activation mix 
100 mM KCl, 1 mM MgCl2 
Motility buffer 
20 mM PIPES, 10 mM K-acetate, 4 mM MgSO4, pH 6.7 with KOH. The following additions were 
made just before use: 10 μM taxol, 1 mg/ml casein, 4 mM ATP, 7.5 mM creatine phosphate, 4 
U/ml creatine phosphokinase, 0.5 % (v/v) β-mercaptoethanol 
Mowiol mounting solution 
25 % (v/v) glycerol, 0.1 g/ml Mowiol 4-88 (Calbiochem, Nottingham, UK), 0.1 M Tris-HCl, pH 
8.5, 2.5 % (w/v) DABCO 
NET buffer 
150 mM NaCl, 5 mM EGTA, 50 mM Tris-HCl, 0.05 % (v/v) Triton X-100, pH 8.0 
NET-G buffer 
150 mM NaCl, 5 mM EGTA, 50 mM Tris-HCl, 0.05 % (v/v) Triton X-100, 0.25 % (v/v) fish skin 
gelatine, pH 8.0 
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Nocodazole 
10 mM stock in DMSO 
PBS 
137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4, pH 7.4 
Phosphocellulose column buffer 
0.1 M PIPES, 1 mM KOH, 1 mM MgSO4, 1 mM EGTA, pH 6.9 with KOH. The following 
additions were made just before use: 0.1 mM GTP, 1 mM DTT 
Pregnant mare serum gonadotropin (PMSG) 
200 U/ml in phosphate-buffered water (Intervet, Buckinghamshire, UK) 
Ponceau S stain 
0.2 % (w/v) Ponceau S, 3 % (w/v) trichloroacetic acid 
Protease inhibitors 
10 mg/ml leupeptin, 10 mg/ml chymostatin, 10 mg/ml pepstatin, 10 mg/ml aprotinin in DMSO 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) resolving 
buffer 
1.5 M Tris-HCl, pH 8.8, 10 % (w/v) SDS 
SDS-PAGE stacking buffer 
0.5 M Tris-HCl, pH 6.8, 10 % (w/v) SDS 
SDS-PAGE running buffer 
25 mM Tris-HCl, 25 mM glycine, 0.1 % (w/v) SDS, pH 8.3 
TE buffer 
10 mM Tris-HCl, pH 7.5, 1 mM EDTA 
T-Tris-buffered saline (T-TBS) 
20 mM Tris-HCl, 150 mM NaCl, pH 7.7 with HCl, 0.1 % (v/v) Tween-20 
Transfer buffer 
25 mM Tris-HCl, 0.2 M glycine, 20 % (v/v) methanol, 0.02 % (w/v) SDS, pH 8.3 
Tubulin purification buffer A 
0.1 M PIPES, pH 6.9 with KOH, 25 % (v/v) glycerol. The following additions were made just 
before use: 0.1 % (v/v) β-mercaptoethanol, 0.1 mM GTP 
Tubulin purification buffer B 
0.1 M PIPES, pH 6.9 with KOH. The following additions were made just before use: 0.1 % (v/v) 
β-mercaptoethanol, 0.2 mM GTP, 0.1 mM PMSF 
Tubulin purification buffer C 
0.5 M PIPES, 1 mM EGTA, 1 mM MgSO4, pH 6.9 with KOH. The following additions were made 
just before use: 10 mM β-mercaptoethanol, 0.1 mM GTP 
Extract buffer (XB) 
100 mM KCl, 1 mM MgCl2, 0.1 mM CaCl2, 10 mM HEPES, 50 mM sucrose, pH 7.7 with KOH 
2.2 Cell-based assays 
2.2.1 Cell culture  
HeLaM cells were obtained from Graham Warren, EMBL, Heidelberg, Germany and are a 
subclone of the human cervical cancer cell line, HeLa. HeLaM cells were cultured in complete 
58 
 
media in 8 % CO2 and passaged in T75 flasks (Corning, Flintshire, UK) using PBS and 0.5 
mg/ml trypsin and 0.2 mg/ml EDTA.  
2.2.2 Transient transfection 
HeLaM cells were plated at a density of 70,000 cells per well in a 12-well plate (Corning) on 13 
mm coverslips (no. 1.5 thickness) to give a confluency of approximately 70 % the following day. 
Transfection was performed using the cationic transfection reagent JetPEI (QBiogene, 
Cambridgeshire, UK) in accordance with manufacturer‟s „Quick protocol‟, where 2 μg of DNA 
and 4 μl of JetPEI are used per well of a 12-well plate. However, when transfecting mApple-
Golgi DNA, it was necessary to titrate the amount of DNA used, since perturbation of Golgi 
structure was observed when the protein was highly expressed (data not shown). To this end, 
20 ng of mApple-Golgi DNA was used per well of a 12-well plate along with 1.98 μg of the other 
construct being transfected. mApple is a monomeric fluorophore with a maximal excitation and 
emission spectra of 568 nm and 592 nm, respectively [266]. It was generated by the mutation of 
18 amino acids of the mOrange fluorophore and is listed under the accession number 
DQ336160. The Golgi targeting tag is the N-terminal 81 amino acids of the human beta 1,4- 
galactosyltransferase protein, a Golgi-resident glycosylation enzyme, which is linked to mApple 
at the C-terminus. A similar fragment of the bovine form of the enzyme has previously been 
shown to be sufficient for retention of the protein within the Golgi [267].  
2.2.3 KIF1C siRNA 
An ON-TARGETplus siRNA SMARTpool containing four duplexes directed against human 
KIF1C RNA (catalogue number L-010354, accession number NM006612) and a siGENOME 
non-targeting siRNA control (catalogue number D-001210) were purchased with target 
sequences listed below (Dharmacon, Thermo Fisher Scientific, Northumberland, UK). To 
analyse whether KIF1C protein levels were efficiently reduced following siRNA treatment, 
HeLaM cells were plated in 10 cm dishes (Corning) at a density of 800,000 cells per dish to give 
a confluency of approximately 60 % the following day. Transfection of SMARTpool KIF1C 
siRNA at a final concentration of 0.5 nM, 1 nM, 5 nM, 10 nM and 20 nM was performed using 
INTERFERin (Autogen Bioclear, Wiltshire, UK) in accordance with the manufacturer‟s 
instructions and OptiMEM (Invitrogen, Paisley, UK) was used as a source of reduced serum 
media. All four duplexes were present in each transfection at an equal concentration. After 72 
hours, cells were placed on ice and washed twice with ice cold PBS. To lyse the cells 500 μl of 
BRB80 containing 0.5 % (v/v) Triton X-100 and 10 μg/ml protease inhibitors was added and left 
on ice for 10 minutes with gentle agitation. The cells were scraped into the buffer using a cell 
scraper (Greiner Bio One, Gloucestershire, UK) and transferred to a 1.5 ml microfuge tube. 
Samples were centrifuged at 14,000 rpm (22,800 gav) at 4 °C for 10 minutes in a microcentrifuge 
to remove cell nuclei and debris, and the supernatant was recovered. The protein concentration 
was determined using a bicinchoninic acid assay (Pierce, Thermo Fisher Scientific, 
Northumberland, UK) in accordance with manufacturer‟s instructions and samples were stored 
at -80 °C. To perform western blotting 25 μg of each sample was run on an 8 % SDS-PAGE gel 
as described in section 2.4.1 and immunoblotted with anti-KIF1C and anti-TAT1 antibodies as 
described in sections 2.3 and 2.4.4.  
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For all subsequent experiments treatment with KIF1C-specific and non-targeting siRNA at a 
final concentration of 0.5 nM was performed, with 13 mm coverslips (no. 1.5 thickness) added to 
the dishes as appropriate. All four duplexes of the SMARTpool were included in each 
experiment at an equal concentration (i.e. 0.125 nM to give a final siRNA concentration of 0.5 
nM). This concentration of siRNA was chosen because it was determined to be the lowest 
concentration which maximally reduced KIF1C protein levels in HeLaM cells. If necessary, after 
48 hours coverslips were transferred to a 12-well plate and transfection with dominant negative 
kinesin constructs was performed as described in section 2.2.2. 
 
KIF1C-specific siRNA Target Sequence 
Duplex 1 GCAGCAAGGCAUCGACAUA 
Duplex 2 GGAGCUGUGUCGCACCUAU 
Duplex 3 CGAAUGAGACGGCAGCGUU 
Duplex 4 GAACCAGAGUGCUCAGCUA 
Non-targeting siRNA Duplex sequence 
Duplex 1 UAGCGACUAAACACAUCAA 
 
2.2.4 BFA treatment  
For labelling with anti-transferrin receptor, anti-EEA1, anti-TGN46 antibodies, or when co-
transfected with mApple-Golgi, HeLaM cells were treated with 2 μg/ml BFA for 10 minutes, 8 
minutes, 12 minutes, or 10 minutes respectively, since these time points were judged to give the 
maximum number of cells displaying tubules positive for these markers in untransfected cells 
(data not shown). Cells were fixed and immunolabelled as appropriate (see sections 2.2.5 and 
2.3).  
 
To determine whether microtubule dynamics play a role in moving cis-Golgi tubules, low doses 
of nocodazole were used to inhibit microtubule dynamics without depolymerising microtubules. 
Cells were treated with 100 nM nocodazole for 5 minutes and then with 100 nM nocodazole and 
2 μg/ml BFA for 10 minutes, fixed in methanol as described in section 2.2.5.1 and 
immunolabelled as necessary. The concentration of nocodazole required to inhibit microtubule 
dynamics was optimised using live cell imaging of HeLaM cells transfected with tomato-EB3 
(see section 2.5.1), a microtubule plus end tracking protein, and green fluorescent protein 
(GFP)-tubulin (data not shown).  
 
To quantify the effects of motor inhibition upon the tubulation of the various compartments 
investigated, the absence or presence of tubules in 100 cells per condition was counted. Each 
experiment was repeated two additional times to obtain three average values per condition. 
These values were then used for statistical analysis. SPSS 15.0 (SPSS, Surrey, UK) was used 
to perform a one-way analysis of variance (ANOVA) test followed by a two-sided Dunnett‟s post-
hoc test, allowing the comparison of multiple test groups to a single control group 
simultaneously. This was used in preference to multiple student t-tests since analysis is faster 
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and the probability of performing a type I error i.e. rejecting the null hypothesis when it is 
actually true is reduced.   
2.2.5 Immunofluorescence 
2.2.5.1 Methanol fixation 
Coverslips were washed in PBS and excess liquid was removed using filter paper (Whatman, 
Kent, UK) before placing in -20 °C methanol for 5 minutes. Coverslips were washed once in 
PBS for 5 minutes and then immunolabelled as necessary. 
2.2.5.2 PFA fixation 
Coverslips were washed in PBS and dried on filter paper and transferred to 3 % (w/v) PFA in 
PBS and incubated at room temperature for 30 minutes. Coverslips were washed 3 x 5 minutes 
in PBS with the first wash containing 0.1 M glycine to block reactive groups. Cells were 
permeabilised to allow subsequent entry of the antibody by incubating in 0.1 % (v/v) Triton X-
100 in PBS for 5 minutes. Coverslips were washed 3 x 5 minutes with PBS and then 
immunolabelled as necessary.  
2.2.5.3 PFA/Glutaraldehyde fixation 
Coverslips were processed as described in section 2.2.5.2 except 0.25 % (w/v) glutaraldehyde 
was included in the incubation with 3 % (w/v) PFA. To block reactive groups, coverslips were 
washed 3 x 5 minutes with a freshly made 1 mg/ml sodium borohydride solution in PBS.  
2.2.5.4 Antibody labelling 
Antibodies were diluted to the appropriate concentration as described in section 2.3.1 in 25 μl 
PBS. The solution was placed on a sheet of parafilm and the coverslip was dried on filter paper 
and placed cells facing down onto the drop of antibody for 30 minutes in the dark. Excess 
primary antibody was removed with 3 x 5 minutes washes in PBS in a 12-well plate. Coverslips 
were placed cells facing down onto a drop of appropriately diluted secondary antibody in PBS 
as described in section 2.3.2 and left for 30 minutes in the dark. Again, coverslips were washed 
3 x 5 minutes in PBS in a 12-well plate to remove excess secondary antibody, with the first 
wash containing 100 μl of a 1 μg/ml DAPI solution to stain cell nuclei. After the final wash 
coverslips were dipped in distilled water to prevent the formation of salt crystals on the surface 
of the coverslip, dried thoroughly on filter paper, and mounted with cells facing down on 6 μl of 
Mowiol mounting solution on a microscope slide. Coverslips were left in the dark overnight at 
room temperature to allow the mounting solution to set.  
 
The Alexa594-conjugated phalloidin dye (Invitrogen) was used to stain actin at a dilution of 1 in 
40 in PBS. Cells were fixed in PFA as described in section 2.2.5.2 and coverslips were 
processed identically as described above except no incubation with secondary antibody was 
necessary.  
2.2.5.5 Imaging 
Images were taken using a BX60 microscope (Olympus, Watford, UK) fitted with a 60x 1.40 
N.A. PlanApo objective and a Roper Scientific CoolSnap ES camera (Photometrix, Arizona, 
USA). The camera was controlled using MetaVue software (Molecular Devices, California, 
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USA). Images were captured in 16-bit greyscale and subsequent figure preparation was 
performed using PhotoShop CS2 (Adobe, California, USA) and Adobe Illustrator CS2 (Adobe).  
2.3 Antibodies 
2.3.1 Primary antibodies 
Antibody Antigen 
Host 
species 
Usage Fixation 
Blocking 
buffer 
Source 
Calreticulin Calreticulin Rabbit 1:100 (IF) 
PFA/ 
Glutaraldehyde 
N/A 
Affinity Bioreagents, Thermo 
Fisher Scientific, Northumberland, 
UK 
DLIC DLIC Sheep 
1:1000 
(IB) 
N/A 5 % milk Laboratory generated 
EEA1 
Early endosome 
antigen 1 
Mouse 1:500 (IF) PFA N/A BD Transduction Laboratories 
ERGIC53 
ERGIC protein 
of 53 kDa 
Mouse 1:500 (IF) PFA N/A Axxora UK, Nottingham, UK 
Hsp70 
Heat shock 
protein of 70 
kDa 
Mouse 1:250 (IF) PFA N/A 
Affinity Bioreagents, Thermo 
Fisher Scientific 
IC74 DIC Mouse 
1:1000 
(IB) 
N/A 5 % milk Chemicon, Millipore,  
k2.4 
KIF3A subunit 
of kinesin-2 
Mouse 1:500 (IB) N/A 5 % milk 
Hybridoma Bank, University of 
Iowa, Iowa, USA 
KIF1C KIF1C Rabbit 
1:1000 
(IB) 
N/A NET-G Abcam, Cambridge, UK 
KIF1C serum KIF1C Rabbit 1:300 (IF) 
PFA or 
methanol 
N/A 
Dr. Marcin Wozniak, The Bristol 
Institute of Transfusion Sciences, 
Bristol UK 
L1 KLC Mouse IP N/A N/A Chemicon, Millipore 
L2 KLC Mouse IP N/A N/A Chemicon, Millipore 
LAMP1 
Lysosomal-
associated 
membrane 
protein 1 
Mouse 1:300 (IF) Methanol N/A 
Hybridoma Bank, University of 
Iowa 
Myc Myc Rabbit 
1:150  
(IF) 
PFA or 
methanol 
N/A Chemicon, Millipore 
p150glued p150glued Mouse 
1:2000 
(IB) 
N/A NET-G BD Transduction Laboratories 
SUK4 KHC Mouse IP N/A N/A 
Hybridoma Bank, University of 
Iowa 
TAT1 α-tubulin Mouse 
1:1000 
(IB) 
N/A NET-G Prof. Keith Gull, University of 
Oxford, Oxford, UK 
1:100 (IF) Methanol N/A 
TGN46 TGN46 Sheep 1:500 (IF) Methanol N/A 
Dr. Martin Lowe, University of 
Manchester, Manchester, UK 
Transferrin 
receptor 
Transferrin 
receptor 
Mouse 1:100 (IF) Methanol N/A Zymed, Invitrogen 
Ubiquitously 
expressed 
KHC (uKHC) 
KHC Rabbit 
1:2000 
(IB) 
N/A NET-G 
Prof. Ron Vale, UCSF, San 
Francisco, USA 
 
The abbreviations used to denote antibody usage are immunoblot (IB), immunofluorescence 
(IF) and immunoprecipitation (IP).  
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2.3.2 Secondary antibodies 
Conjugated tag Anti-species Host species Usage Source 
Alexa594 
Mouse Donkey 1:800 
Molecular Probes, Invitrogen 
Rabbit Donkey 1:800 
Alexa488 
Mouse Donkey 1:400 
Molecular Probes, Invitrogen 
Rabbit Donkey 1:400 
Cy3 
Mouse Donkey 1:800 
Jackson ImmunoResearch, Stratech, Suffolk, UK Rabbit Donkey 1:800 
Sheep Donkey 1:800 
Cy5 
Mouse Donkey 1:800 
Jackson ImmunoResearch 
Rabbit Donkey 1:800 
Horseradish peroxidise (HRP) 
Mouse Donkey 1:3000 
DakoCytomation, Cambridgeshire, UK Rabbit Donkey 1:3000 
Sheep Donkey 1:3000 
2.4 Protein analysis 
2.4.1 SDS-PAGE 
Mini protean III hand cast 1 mm thick resolving gels were made using SDS-PAGE resolving 
buffer, polyacrylamide (ProtoGel, National Diagnostics, Atlanta, USA), distilled water, TEMED 
and 10 % (w/v) APS and overlaid with 100 % ethanol. Once the resolving gel had set, the 
ethanol was poured away and any excess was removed with filter paper. Stacking gels were 
made with SDS-PAGE stacking buffer, polyacrylamide, distilled water, TEMED and 10 % (w/v) 
APS and poured on top of the resolving gel and a 15-well comb was inserted. Once the stacking 
gel was set the comb was removed and samples loaded, including 5 μl of protein marker 
(Benchmark 10 kDa protein ladder – Invitrogen). Samples were heated at 95 °C for 5 minutes 
prior to loading, except if stated otherwise. Gels were run at 100 Volts until the dye front had 
reached the bottom of the gel and then stained with Coomassie (see section 2.4.2), colloidal 
Coomassie (see section 2.4.3) or transferred to nitrocellulose membrane for western blotting 
(see section 2.4.4). 
2.4.2 Coomassie stain 
Following SDS-PAGE, the stacking gel was discarded and the resolving gel was transferred to 
Coomassie stain and left for 1 hour with gentle rocking. The gel was washed with Coomassie 
destain solution until all background staining was removed.  
2.4.3 Colloidal Coomassie stain 
Following SDS-PAGE, the stacking gel was discarded and the resolving gel was fixed in 40 % 
(v/v) methanol and 7 % (v/v) acetic acid for 1 hour with gentle rocking. Four parts colloidal 
Coomassie was combined with 1 part methanol, shaken vigorously to mix, and added to the gel 
to stain for 2 hours with gentle rocking. The gel was then de-stained in 25 % (v/v) methanol and 
10 % (v/v) acetic acid for 30 seconds and then in 25 % (v/v) methanol with gentle rocking until 
background staining had been fully removed. 
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2.4.4 Western blot 
Following SDS-PAGE, gels were transferred onto Protran nitrocellulose membrane (Whatman) 
in transfer buffer using a Mini Trans-Blot Electrophoretic Transfer Cell (Bio-Rad Laboratories, 
Hertfordshire, UK) for 90 minutes at 100 Volts. The nitrocellulose was stained with Ponceau S 
solution to visualise proteins, excess stain was removed with distilled water, and protein 
markers were marked using ink. The membrane was incubated with NET-G solution or 5 % 
(w/v) non-fat milk (Marvel) in T-TBS for 1 hour with gentle rocking to block any non-specific 
antibody binding. The membrane was then incubated with the primary antibody (made up in 
NET-G solution or 5 % (w/v) non-fat milk in T-TBS as appropriate) and left for 1 hour with gentle 
rocking. The membrane was washed 3 x 5 minutes with NET buffer or T-TBS and then the 
HRP-conjugated secondary antibody (made up in the same solution as the primary antibody) 
was added for a further hour with gentle rocking. The membrane was washed 3 x 5 minutes 
with NET buffer or T-TBS and then briefly with equal volumes of the two chemiluminescence 
reagents (Super Signal West Pico Stable peroxide solution, Pierce, Thermo Fisher Scientific). 
Finally, the membrane was wrapped in cling film, exposed to single emulsion photographic film 
(Kodak BioMax MR Film) and processed. 
2.4.5 IP 
A volume of 20 μl of protein G dynabeads (Invitrogen) were transferred to 1.5 ml microfuge tube 
and washed once with 500 μl IP buffer, using a magnet (Invitrogen) to re-isolate the beads. The 
beads were incubated with 5 μg of antibody for 1 hour at 4 °C with rotation. The antibody was 
then removed and the beads were washed once with 500 μl of IP buffer to remove any unbound 
antibody. The lysate was made up to 500 μl with IP buffer, incubated on ice for 10 minutes, and 
then centrifuged at 14,000 rpm (22,800 gav) at 4 °C for 10 minutes in a microcentrifuge to 
remove any debris. After incubation of beads with lysate for 3 hours at 4 °C with rotation, 
unbound material was removed and the beads were washed four times with 500 μl of IP buffer. 
The bound material was eluted from the beads with 10 μl of 2x sample buffer, and samples 
were heated at 100 °C for 5 minutes and subject to SDS-PAGE electrophoresis and western 
blotting as described in sections 2.4.1 and 2.4.4.  
2.5 Molecular biology 
2.5.1 Constructs 
Name Source 
K430-BCCP Prof. Rob Cross, University of Warwick, Coventry, UK 
Cyclin B1 Δ90 Prof. Tim Hunt, CRUK, London Research Institute, London, UK 
EB3-tomato Dr. Anne Straube, University of Warwick, Coventry, UK  
GFP Clontech, California, USA  
GFP-KBPΔ250-81 Mr. Yen Ching Yang, University of Manchester, Manchester, UK 
GFP-KHCct Mr. Yen Ching Yang 
GFP-tubulin Prof. Roger Tsien, University of California, San Diego, USA  
Glutathione S-transferase (GST) GE Healthcare, Buckinghamshire, UK 
GST-E-MAP-115 See section 2.5.9.2 
GST-KAP3Bct Dr. Marcin Wozniak 
GST-KBPΔ250-81 See section 2.5.9.1 
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GST-KHCct Dr. Marcin Wozniak 
KAP3B-Myc Dr. Marcin Wozniak 
KIF1CΔ305-9 Dr. Reiner Lammers, University of Tϋbingen, Tϋbingen, Germany 
mApple-Golgi Dr. Michael Davidson, University of Florida, Florida, USA 
 
2.5.2 Primers 
Name Sequence 
GST-KBPΔ250-281 Forward ATCATGGGAATTCTGGCGAACGTTCCGTGG 
GST-KBPΔ250-281 Reverse ATCATGCTCGAGTTAAGTCAGGGCCATC 
GST-E-MAP-115 Forward ATCATGGGAATTCTGGCGGAGCTAGGAG 
GST-E-MAP-115 Reverse ATCATGCTCGAGTCATATAACTTCTGCAGT 
E-MAP-115 Sequencing 1 CAGGAACGAATGTGTGGGC 
E-MAP-115 Sequencing 2 CAGCGTTGTTAACAGACTCC 
E-MAP-115 Sequencing 3 ACATCCGCCCTGTCAAGAG 
E-MAP-115 Sequencing 4 TGAAGAGAGGACGACTCG 
pGex-3 (sequencing) CCGGGAGCTGCATGTGTCAGAGG 
pGex-5 (sequencing) GGGCTGGCAAGCCACGTTTGGTG 
 
2.5.3 Polymerase chain reaction (PCR)  
Each PCR reaction contained 0.1 μg of template DNA, forward and reverse primers at 300 nM 
final concentration, 1 μl of 0.5 M β-mercaptoethanol (10 mM final concentration), 5 μl of 10x Pfu 
buffer (Stratagene, Agilent Technologies, Cheshire, UK), 0.4 μl dNTPs (200 μM of each) 
(Bioline, London, UK), 1 μl (2.5 U) Pfu turbo DNA polymerase (Stratagene), and was made up 
to 50 μl with autoclaved distilled water. The reactions were then subject to the following cycle in 
a PCR machine: 
 
95 °C for 5 minutes 
And 35 cycles of: 
95 °C for 1 minute 
? °C (5 °C below the lowest primer melting temperature) for 1 minute   
72 °C for 1 minute per kb of the desired product 
Followed by: 
72 °C for 5 minutes 
4 °C hold 
 
A volume of 5 μl of the product was run on a 1 % (w/v) agarose gel (Lonza, Berkshire, UK), 
along with 5 μl of 1 kb DNA ladder (GeneRuler, Fermentas, York, UK) and stained in 1 % (v/v) 
ethidium bromide solution to determine whether the PCR had been successful. 
2.5.4 DNA digestion 
The PCR product was purified using a PCR purification kit (QIAGEN, Crawley, UK) in 
accordance with the manufacturer‟s instructions and eluted in 20 μl of elution buffer. The PCR 
product was incubated with the appropriate restriction enzymes for 2 hours at 37 °C. The vector 
was incubated with restriction enzymes for 90 minutes at 37 °C, after which 1 μl alkaline 
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phosphatase (Roche, Hertfordshire, UK) was added to minimise the vector re-annealing, and 
the incubation was continued for a further 30 minutes.  
2.5.5 DNA gel extraction 
The restriction digests were run on a 1 % (w/v) agarose gel, stained in ethidium bromide 
solution as described in section 2.5.3 and the correct bands were excised under low-intensity 
ultraviolet light. To purify DNA, the agarose slice was placed into a 500 μl microfuge tube with 
the base pierced and containing a small amount of glass wool. The tube was snap frozen in 
liquid nitrogen and placed inside a 1.5 ml microfuge tube. The DNA was centrifuged through the 
glass wool at 11,000 rpm (12,800 gav) at 4 °C for 15 minutes in a microcentrifuge, after which 
the collection tube was replaced and the centrifugation was repeated. The eluted DNA was 
made up to 300 μl with TE buffer and half of this was added to 150 μl of phenol, vortexed briefly 
and centrifuged at 11,000 rpm (12,800 gav) for 1 minute in a microcentrifuge. The upper phase 
was taken and added to 150 μl chloroform, vortexed and centrifuged as before. The upper 
phase was again taken and added to 30 μl 3 M Na-acetate. This protocol was repeated with the 
other 150 μl of eluted DNA using the same tubes of phenol, chloroform and Na-acetate. Finally 
900 μl of 100 % ethanol was added to the Na-acetate and DNA mixture, vortexed briefly and 
centrifuged at 14,000 rpm (22,800 gav) at 4 °C for 15 minutes in a microcentrifuge. The pellet 
was washed with 70 % (v/v) ethanol and centrifuged at 14,000 rpm (22,800 gav) at 4 °C for 10 
minutes in a microcentrifuge, air-dried for 5 minutes and resuspended in 10 μl of autoclaved 
distilled water. 
2.5.6 Ligation 
Purified vector and insert were combined at a 3:1 molar ratio, along with 1 μl T4 DNA ligase 
(Roche) and 1 μl 10x ligation buffer (Roche), and made up to 10 μl with autoclaved distilled 
water. The ligation mixture was incubated at 4 °C for 48 hours.  
2.5.7 Transformation of ligation 
A 5 μl measure of the ligation mixture was added to 100 μl of TOP10 competent cells 
(Invitrogen), left on ice for 30 minutes and heat shocked at 42 °C for 90 seconds. The cells were 
placed back on ice for 2 minutes, after which 400 μl of LB was added and then incubated at 37 
°C for 1 hour. The mixture was plated on LB agar plates containing the appropriate selection 
antibiotic (either 100 μg/ml ampicillin or kanamycin) and incubated at 37 °C overnight. Colonies 
from the plates were picked and cultured in 5 ml LB containing 100 μg/ml of the relevant 
selection antibiotic at 37 °C with agitation overnight. The cells were centrifuged at 5,100 rpm 
(5,525 gav) at 4 °C for 10 minutes in a benchtop centrifuge to pellet and plasmid DNA was 
isolated using a QIAprep spin miniprep kit (QIAGEN) in accordance with manufacturer‟s 
instructions. 
2.5.8 DNA Sequencing 
Each sequencing reaction contained 400 ng template, 4 picomoles sequencing primer, 2 μl 
BigDye v1.1 (Applied Biosystems, Warrington, UK), 4 μl 5x BigDye reaction buffer (Applied 
Biosystems), and was made up to 20 μl with autoclaved distilled water. The reactions were then 
subject to the following cycle in a PCR machine: 
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98 °C for 2 minutes 
And 30 cycles of: 
98 °C for 30 seconds   
50 °C for 15 seconds   
60 °C for 4 minutes 
4 °C hold 
 
To precipitate the DNA 1 μl of glycogen carrier (Roche), 10 μl of 3 M Na-acetate, 250 μl of 100 
% ethanol and 80 μl of distilled water were added to the reaction which was then vortexed and 
placed on ice for 30 minutes. To pellet the DNA the mixture was centrifuged at 14,000 rpm 
(22,800 gav) at 4 °C for 30 minutes in a microcentrifuge. The supernatant was removed and the 
pellet was washed with 750 μl of 70 % (v/v) ethanol and centrifuged for a further 2 minutes as 
before. The pellet was air-dried for 5 minutes and sent for analysis at the University of 
Manchester Sequencing Facility, Stopford Building.  
2.5.9 Constructs generated 
2.5.9.1 pGex-KG-KBPΔ250-81 
KBPΔ250-81 is a deletion mutant of human KBP, lacking residues 250-81 resulting in an 
inability to interact with KIF1B and KIF1C and consequently having an inhibitory effect upon 
these motors [51]. The KBP sequence is listed under the accession number KIAA1279. The 
KBPΔ250-81 clone was kindly provided by Dr. Marcin Woźniak, and engineered to encode 
EcoR1 and XhoI sites at the 5‟ and 3‟ ends, respectively, using primers as described in section 
2.5.2 and inserted into the pGex-KG vector, which was kindly provided by Dr. Sabine Hilfiker, 
Rockefeller University, New York, USA. This vector was initially described by Guan and Dixon 
[268] and differs from commercially available pGex vectors by having a glycine linker sequence 
between the tag and the multiple cloning site, which is thought to aid correct folding of the 
recombinant protein and allow more efficient cleaving of the GST tag. DNA sequencing with 
primers pGex-5 and pGex-3 was performed as described in section 2.5.8 to ensure the insert 
was in the correct reading frame.  
2.5.9.2 pGex-KG-E-MAP-115 
RNA was isolated from HeLaM cells using an RNA purification kit (Stratagene) and transcribed 
to form a cDNA library using a First Strand cDNA Synthesis Kit for RT-PCR (Roche) in 
accordance with manufacturer‟s instructions. Primers to amplify human E-MAP-115 from the 
library were designed based upon the sequence detailed by Masson and Kreis [269] (accession 
number X73882). PCR was performed using the HeLaM cDNA library as a template and GST-
E-MAP-115 forward and reverse primers as described in section 2.5.2, meaning EcoR1 and 
XhoI sites were engineered at the 5‟ and 3‟ ends, respectively. The product was initially inserted 
into the PCR blunt vector (Invitrogen) and then into the pGex-KG vector. The entire E-MAP-115 
DNA was sequenced as described in section 2.5.8 using four sequencing primers as listed in 
section 2.5.2 to ensure no errors had occurred during PCR amplification.  
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2.6 Recombinant protein expression 
2.6.1 Protein expression and purification 
GST, GST-KHCct, GST-KAP3Bct and GST-E-MAP-115 proteins were expressed as follows. A 
measure of 50 ng of vector was transformed into BL21-CodonPlus competent cells (Invitrogen) 
and plated onto ampicillin-containing LB-agar plates as described in section 2.5.7. A single 
colony was picked and transferred to 10 ml ampicillin-containing LB and grown overnight at 37 
°C with agitation. This starter culture was added to 1 litre of ampicillin-containing LB and grown 
at 37 °C with agitation until OD600 was reached between 0.5 and 0.6, after which 0.1 mM IPTG 
was added and bacteria were grown for a further 3 hours at 37 °C. Bacteria were pelleted by 
centrifuging at 5,100 rpm (5,525 gav) at 4 °C for 10 minutes in a benchtop centrifuge and the 
pellets were stored at -20 °C. On the day of the purification the pellets were thawed and 
resuspended in 25 ml of bacterial lysis buffer and then passed three times through a French 
press (Thermo Fisher Scientific, Northumberland, UK) to lyse bacterial membranes. The lysate 
was centrifuged in an F21 rotor (Sorvall, Thermo Fisher Scientific) at 18,000 rpm (38,500 gav) at 
4 °C for 30 minutes. The supernatant was incubated for 2 hours at 4 °C with gentle agitation 
with 1 ml of Fast Flow glutathione sepharose beads (GE Healthcare, Buckinghamshire, UK), 
which had been washed three times with bacterial lysis buffer. The beads were pelleted by 
centrifugation at 1,000 rpm (210 gav) in a benchtop centrifuge, and washed three times with 
bacterial lysis buffer. Beads were transferred to a 1.5 ml microfuge tube and bound proteins 
were eluted by the addition of 1 ml of 50 mM reduced L-glutathione, pH 8.0 prepared in 
bacterial lysis buffer, for 1 hour at 4 °C with gentle agitation. Beads were pelleted by 
centrifugation at 1,000 rpm (210 gav) at 4 °C for 5 minutes in a benchtop centrifuge and the 
supernatant was collected. The protein was dialysed into acetate buffer using a Slide-A-Lyzer 
kit (Pierce, Thermo Fisher Scientific) in accordance with manufacturer‟s instructions, with three 
changes of dialysis buffer over 24 hours.  
2.6.2 GST-KBPΔ250-81 
Protein expression and purification were performed as described in section 2.6.1 except 5 mM 
β-mercaptoethanol was included in all buffers. The omission of β-mercaptoethanol from the 
purification process resulted in the failure of GST-KBPΔ250-81 to bind glutathione beads (data 
not shown). Finally, the protein was dialysed into acetate buffer (without β-mercaptoethanol) as 
described in section 2.6.1.  
2.6.3 K430-BCCP 
K430-BCCP encodes the first 430 amino acids of rat KIF5C and is tagged at the C-terminus to 
the N-terminus of a 127 amino acid fragment of biotin carboxyl carrier protein (BCCP) [270]. 
Protein expression was induced as described in section 2.6.1 except 50 μM D-biotin was added 
to the culture together with IPTG to biotinylate the expressed protein. Bacterial lysis was 
performed as described in section 2.6.1 except following bacterial lysis and the clarifying 
centrifugation the supernatant was removed and stored in 1 ml aliquots. To assess whether the 
protein could be purified, 50 μl of soluble bacterial lysate was incubated with 15 μl of 
streptavidin-coated agarose beads (Ademtech, Novagen, Merck Chemicals, Nottingham, UK), 
which had been washed once with PBS containing 0.5 % (v/v) Triton X-100, for 15 minutes at 
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room temperature. The beads were washed four times with PBS containing 0.5 % (v/v) Triton X-
100 and 10 μl of 2x sample buffer was added to elute bound proteins. 
2.7 Xenopus laevis egg extracts 
Xenopus laevis laid eggs are stably arrested in metaphase II of meiosis due to the presence of 
CSF. Following natural fertilisation of Xenopus laevis eggs, a transient increase in calcium 
concentration triggers the degradation of CSF, causing the fertilised egg to enter interphase 
[233]. This process is mimicked in vitro by adding calcium-containing activation mix to CSF-
arrested extracts.  
2.7.1 Preparation of Xenopus laevis egg extracts 
2.7.1.1 Meiotic metaphase-arrested Xenopus laevis egg extracts 
Extracts were prepared from laid eggs as described by Murray [237]. Female Xenopus laevis 
frogs (NASCO, California, USA) were injected subcutaneously into the dorsal lymph sac with 50 
units PMSG 3-7 days before extract preparation. The day before extract preparation, frogs were 
injected with 500 units HCG and transferred to isolated tanks containing 100 mM NaCl in 
distilled water with no food. Approximately 16 hours later eggs were collected, transferred to 
glass crystallisation dishes and washed three times with MMR buffer. After the final wash as 
much MMR buffer as possible was removed and 2 % (w/v) cysteine (made immediately before 
use, pH 7.8 with NaOH) was added to remove the outer jelly coat. The cysteine solution was 
repeatedly removed and replaced until the eggs were fully de-jellied, as indicated by eggs 
becoming very compact. Eggs were washed once more with MMR buffer, and then transferred 
to fresh glass Petri dishes containing XB and washed four times with XB, and then twice with 
XB containing 5 mM EGTA and 1 mM MgCl2 extra. Eggs were transferred to SW50 tubes 
(Beckman Coulter) containing 1 ml XB with 10 μg/ml protease inhibitors and 10 μg/ml 
cytochalasin D. Once the eggs had settled, as much buffer as possible was removed and 1 ml 
Versilube F-50 oil (GE Healthcare) was layered on top. Eggs were centrifuged at 1,000 rpm 
(210 gav) for 1 minute then 2,000 rpm (850 gav) for 1 minute at room temperature in a benchtop 
centrifuge, using 12 ml round-bottom tubes (BD Transduction Laboratories, Oxfordshire, UK) as 
adaptors. The buffer and oil were removed and eggs were centrifuged at 10,000 rpm (10,700 
gav) at 16 °C for 10 minutes in a HB6 rotor (Sorvall, Thermo Fisher Scientific) to crush, using 12 
ml round-bottom tubes as adaptors. Extracts were kept on ice and the cytoplasm was removed 
by piercing the tube with an 18 gauge needle and collected using a 2 ml syringe. Care was 
taken not to remove any of the egg lipid which sits just above the cytoplasm layer. Protease 
inhibitors were added to a final concentration of 10 μg/ml, cytochalasin D to 1 μg/ml, sucrose to 
150 mM and energy mix to 1x. Extracts were snap frozen in 100 μl aliquots and stored in liquid 
nitrogen. 
2.7.1.2 Newmeyer Xenopus laevis egg extracts 
Newmeyer extracts were prepared as initially described by Newmeyer and Wilson with some 
slight modifications [238]. Briefly, extracts were made as described in section 2.7.1.1 except 
neither extra EGTA nor 1 mM MgCl2 were added to the final washes with XB and the final 
centrifugation was performed at 4 °C instead of 16 °C. This generates extracts that are in 
interphase, since CSF is degraded during the preparation due to the lack of EGTA.  
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2.7.2 Manipulation of Xenopus laevis egg extracts 
2.7.2.1 CSF Xenopus laevis egg extract activation 
CSF extract was thawed quickly in the hands and then placed immediately on ice. Activation 
mix or mock activation mix was added to 1/20
th
 of the volume of the extract and left for 1 hour at 
room temperature. When treating extracts with activation mix, 100 μg/ml cycloheximide was 
added to prevent the synthesis of metaphase cyclins.  
2.7.2.2 Conversion of Newmeyer Xenopus laevis egg extract to mitotic metaphase 
Newmeyer extract was thawed quickly in the hands and sea urchin cyclin B1 Δ90 was added to 
a final concentration of 0.13 mg/ml and energy mix to 1x and left for 1 hour at room temperature 
[89]. An identical volume of distilled water was added in a duplicate experiment as a negative 
control.  
2.7.2.3 Cytosol and membrane preparation 
A 100 μl aliquot of extract was thawed and split into two, with 50 μl being treated with the 
activation mix or cyclin B1 Δ90 protein, and the other 50 μl with mock activation mix or distilled 
water as appropriate. Two volumes of A/S containing 1x energy mix was added to the extract 
which was then centrifuged in a TLA100 rotor (Beckman-Coulter) at 55,000 rpm (116,700 gav) at 
4 °C for 30 minutes. This separated the extract into a supernatant (cytosol) and a very compact 
pellet, on top of which sits a delicate layer of membranes. The cytosol was collected 
immediately (approximately 120 µl), avoiding the membrane layer. The membranes were 
resuspended in 50 μl 2 M A/S and layered onto a sucrose gradient made up as follows: 50 μl 2 
M A/S, 50 μl membranes in 2 M A/S, 50 μl 1.4 M A/S, 50 μl 0.25 M A/S. The samples were 
centrifuged in 200 µl thick-walled polycarbonate tubes in a TLS55 rotor (Beckman Coulter) at 
50,000 rpm (166,200 gav) at 4 °C for 30 minutes using TLS55 adaptors (Beckman Coulter). The 
membranes were collected from the 1.4 M/0.25 M A/S interface in 20 μl A/S. When performing 
biochemical analyses of these fractions, 0.4 μl of membranes and 2.4 μl of cytosol were loaded 
per lane on an 8 % SDS-PAGE gel, each being the equivalent of 1 μl of crude extract. 
2.7.2.4 DLIC immunoblot assay 
Xenopus laevis egg extracts were converted between cell cycle states as outlined in sections 
2.7.2.1 and 2.7.2.2 and 5 μl samples were taken at specified time points and added to 45 μl 
sample buffer. Samples were heated at 55 °C for 10 minutes and 5 μl was run on 8 % SDS-
PAGE gels (the equivalent of 0.5 μl crude extract) and subject to western blotting with an anti-
DLIC antibody. 
2.7.2.5 Histone kinase assay 
Xenopus laevis egg extracts were converted between cell cycle states as described in sections 
2.7.2.1 and 2.7.2.2 and 2 μl samples were taken at specified time points and added to 38 μl of 
extraction buffer, mixed well and immediately snap frozen in liquid nitrogen and stored at -80 
°C. Following thawing, 5 μl of each sample was added to a 500 μl microfuge tube in duplicate 
and 5 μl of extraction buffer was used as a blank. A measure of 5 μl of histone kinase cocktail 
was added to each tube and the mixture was pipetted up and down twice to mix and left at room 
temperature for 30 minutes. The samples were pipetted onto small squares of phosphocellulose 
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P81 cation exchange paper (Whatman), left to air-dry for 5 seconds and washed 3 x 15 minutes 
in 150 mM phosphoric acid (in a beaker, stirring) to remove any unincorporated 
32
P-γ-ATP. The 
papers were then placed in acetone for 2 minutes, allowed to air dry and transferred to 
scintillation vials and counted on the 
32
P channel of a scintillation counter. The addition of 
histone kinase cocktail to each tube was staggered to ensure the incubation was exactly 30 
minutes in each case.  
 
The average counts per minute was calculated for each extract and the background reading 
(calculated from the extraction buffer-only controls) was subtracted from this value. The specific 
activity of the 
32
P-γ-ATP was calculated by adding 5 μl histone kinase cocktail directly onto P81 
paper and measuring the counts per minute without any washes. The histone kinase activity of 
each extract was then calculated as picomoles of 
32
P incorporated per μl of extract per minute.  
2.7.2.6 Conversion of Newmeyer Xenopus laevis egg extract to mitotic metaphase in the 
presence of 
32
P-γ-ATP 
A measure of 60 μl (approximately 1.8 mg) of Newmeyer extract was treated with cyclin B1 Δ90 
or an equal volume of water as described in section 2.7.2.2, except energy mix was omitted. 
After 30 minutes 200 μCi of 
32
P-γ-ATP (150 mCi/ml, PerkinElmer) was added and the incubation 
was continued for a further 30 minutes at room temperature. A measure of 1.5 ml of IP buffer 
was added to each tube and IP with SUK4 or IC74 antibodies or mouse immunoglobulin G (IgG) 
was performed as described in section 2.4.5. Samples were run on an 8 % SDS-PAGE gel, 
which was stained with colloidal Coomassie, dried and exposed to single emulsion photographic 
film.  
2.7.2.7 Incubation of interphase and metaphase Xenopus laevis egg extract cytosols with 
32
P-γ-ATP 
Both interphase and metaphase cytosols were prepared from CSF and Newmeyer extracts as 
described in section 2.7.2.3. A measure of 60 μl (approximately 1.2 mg) of each cytosol was 
each incubated with 80 μCi of 
32
P-γ-ATP for 30 minutes at room temperature. A measure of 1 
ml of IP buffer was added to each tube and IP with the SUK4 antibody or mouse IgG was 
performed as described in section 2.4.5. Samples were run on an 8 % SDS-PAGE gel, which 
was stained with colloidal Coomassie, dried and exposed to single emulsion photographic film. 
2.8 Preparation of rat liver membrane fractions 
2.8.1 Golgi apparatus  
A Golgi apparatus enriched fraction was prepared from rat liver as described by Allan and Vale 
[217]. Solutions of 0.25 M, 1.1 M, 1.25 M, 1.4 M and 2 M sucrose were prepared in acetate 
buffer. The livers of four adult female rats were dissected and placed in PBS on ice. Livers were 
weighed, chopped up using a razor blade and homogenised using a Polytron homogeniser in 1 
volume of 0.25 M A/S containing 10 μg/ml protease inhibitors. The homogenate was centrifuged 
at 1680 rpm (600 gav) at 4 °C for 10 minutes in a benchtop centrifuge. The supernatant was 
removed and gradients were created in SW28 tubes (Beckman Coulter) as follows: 5 ml 1.4 M 
A/S, 10 ml membranes, 30 ml 0.25 M A/S. The gradient was centrifuged in a SW28 rotor 
(Beckman Coulter) at 27,500 rpm (100,000 gav) at 4 °C for 1 hour. Membranes at the interface 
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were removed and their sucrose molarity measured using a hand-held refractometer (Thermo 
Fisher Scientific), and adjusted to 1.25 M using 2 M A/S as required. Gradients were created in 
SW28 tubes as follows: 15 ml extract, 15 ml 1.1 M A/S, 15 ml 0.25 M A/S and centrifuged at 
22,000 rpm (65,000 gav) at 4 °C for 90 minutes in a SW28 rotor. Membranes at the 0.25 M/1.1 M 
A/S interface were collected and the protein concentration measured using a Bradford assay in 
accordance with manufacturer‟s instructions (Bio-Rad Laboratories). Golgi membranes were 
diluted to 10 mg/ml with A/S as required, snap frozen in 100 μl aliquots and stored in liquid 
nitrogen. 
2.8.2 ER 
A similar method to that described in section 2.8.1 was used to prepare a membrane fraction 
enriched in rough ER from rat liver. Following centrifugation of the homogenate at 1,680 rpm 
(600 gav) at 4 °C for 10 minutes, another centrifugation was performed in an F21 rotor at 9,200 
rpm (10,000 gav) at 4 °C for 10 minutes and the supernatant was collected. Gradients were 
created in SW28 tubes as follows: 10 ml 1.7 M A/S, 10 ml 1.4 M A/S, 6 ml 1.1 M A/S, 6 ml 
membranes. The gradient was centrifuged in a SW28 rotor at 27,500 rpm (100,000 gav) at 4 °C 
for 2 hours. Membranes were collected from the 1.7 M/1.4 M A/S interface and their sucrose 
molarity measured using a hand-held refractometer and adjusted to 0.4 M using acetate buffer 
as required. Membranes were then centrifuged in a SW28 rotor at 27,500 rpm (100,000 gav) at 4 
°C for 1 hour. The pelleted membranes were resuspended in 10 ml of A/S containing 10 μg/ml 
protease inhibitors, and the protein concentration was measured using a Bradford assay in 
accordance with manufacturer‟s instructions. ER membranes were diluted and stored as 
described in section 2.8.1. 
2.9 Incubation of rat liver ER with Xenopus laevis egg extract cytosols 
2.9.1 Incubation and recovery of rat liver ER with interphase and metaphase Xenopus 
laevis egg extract cytosols 
Interphase and metaphase cytosols were prepared from either Newmeyer or CSF extracts as 
described in section 2.7.2.3 and samples were taken to perform histone kinase assays or to 
assess DLIC phosphorylation to ensure the cytosols were in the correct cell cycle state. A 
measure of 10 μl (100 μg) of rat liver ER was added to 90 μl of the appropriate cytosol, and left 
for 1 hour at room temperature and then centrifuged through a 100 μl cushion of 0.8 M A/S in 
200 µl thick-walled polycarbonate tubes in a TLS55 rotor at 50,000 rpm (166,200 gav) at 4 °C for 
30 minutes using TLS55 adaptors. The supernatant from above the cushion was removed and 
10 μl was added to 40 μl of sample buffer. The cushion itself was then removed and 100 μl A/S 
was added to the pellet to wash. The pellet was centrifuged in a TLS55 rotor at 50,000 rpm 
(166,200 gav) at 4 °C for 20 minutes using TLS55 adaptors. The pellet was resuspended in 25 μl 
A/S and then 25 μl 2x sample buffer was added. A volume of 10 μl (the equivalent of 2 μl crude 
ER membranes or cytosol) was run per lane on 8 % SDS-PAGE gels and subject to western 
blotting. 
 
When attempting to determine whether the method of re-isolating ER reduces the level of 
kinesin-1 immunoprecipitated, 100 μl (1 mg) of rat liver ER was added to 200 μl of interphase 
72 
 
cytosol prepared from Newmeyer Xenopus laevis egg extracts as described in section 2.7.2.3. 
This mixture was centrifuged through a 250 μl cushion of 0.8 M A/S in a TLS55 rotor at 50,000 
rpm (166,200 gav) at 4 °C for 30 minutes. The supernatant and cushion were removed and the 
pelleted membranes were resuspended in 500 μl of IP buffer or in 200 μl of A/S, which was 
added to 300 μl IP buffer. Alternatively, the membrane and cytosol mixture was added to 300 μl 
2 M A/S and layered onto a sucrose gradient made as follows: 300 μl 2 M A/S, 300 μl 
membranes in 2 M A/S, 300 μl 1.4 M A/S, 300 μl 0.25 M A/S. The samples were centrifuged in a 
TLS55 rotor at 50,000 rpm (166,200 gav) at 4 °C for 30 minutes. The membranes were collected 
from the 1.4 M/0.25 M A/S interface and made up to 500 μl with IP buffer. As a control 100 μl (1 
mg) of ER membranes were added directly to 500 μl IP buffer. Kinesin-1 was 
immunoprecipitated with the SUK4 antibody as described in section 2.4.5. Samples were run on 
an 8 % SDS-PAGE gel and stained with colloidal Coomassie as described in sections 2.4.1 and 
2.4.3. 
2.9.2 Incubation and recovery of rat liver ER with interphase and metaphase Xenopus 
laevis egg extract cytosols in the presence of 
32
P-γ-ATP 
Interphase and metaphase cytosols were made from Newmeyer extracts as described in 
section 2.7.2.3, and samples were taken to perform histone kinase assays or to assess DLIC 
phosphorylation to ensure each cytosol was in the correct cell cycle state. A measure of 120 μl 
of cytosol was incubated with 40 μl (400 μg) ER membranes and 160 μCi of 
32
P-γ-ATP for 30 
minutes at room temperature. This mixture was then centrifuged through a 100 μl cushion of 0.8 
M A/S in a TLS55 rotor at 50,000 rpm (166,200 gav) at 4 °C for 30 minutes using TLS55 
adaptors. The supernatant from above the sucrose cushion was removed and made up to 1 ml 
with IP buffer. The sucrose cushion was removed and the membranes were resuspended in 1 
ml of IP buffer, transferred to 1.5 ml microfuge tubes and left for 10 minutes on ice. The lysates 
were clarified by centrifuging in a microcentrifuge at 14,000 rpm (22,800 gav) at 4 °C for 10 
minutes. IP from the ER and cytosol samples was performed as described in section 2.4.5. 
Samples were run on an 8 % SDS-PAGE gel, stained with colloidal Coomassie, dried and 
exposed to single emulsion photographic film.  
2.10 Motility assays 
2.10.1 Purification of pig brain tubulin 
2.10.1.1 Phosphocellulose column preparation 
A measure of 10.3 g of phosphocellulose powder was dissolved in 250 ml of 0.5 M NaOH and 
left for 5 minutes. The mixture was filtered through a sintered glass funnel and washed with 
distilled water until the pH of the liquid flowing through was below pH 10.0, as assessed by pH 
strips (Whatman). The resin was then scraped into 250 ml of 0.5 M HCl, gently stirred and left 
for 5 minutes. The mixture was again filtered through a sintered glass funnel and washed with 
distilled water until the pH of the liquid flowing through was above pH 3.0. The resin was 
scraped into 50 ml of 0.5 M PIPES, pH 6.9, stirred gently and allowed to drip through the funnel 
(without any suction). The resin was then scraped into 50 ml 0.1 M MgSO4, stirred gently and 
allowed to drip through the funnel as before. Finally, the resin was scraped into 50 ml 
phosphocellulose column buffer and carefully poured into a 25 cm x 10 cm column (GE 
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Healthcare) and 200 ml of phosphocellulose column buffer containing 10 µg/ml sodium azide 
was layered on top. After 50 ml of buffer had been allowed to flow through, the tap was sealed 
and the column was stored at 4 °C.  
2.10.1.2 Tubulin purification 
Microtubules were isolated from pig brain based on the method detailed by Weisenberg and 
Cianci with some slight modifications [271]. Six fresh pig brains were obtained from the 
slaughterhouse (Dalehead Foods, Lancashire, UK) and transported to the laboratory in PBS on 
ice. The rest of the preparation was performed at 4 °C. The brains were rinsed with PBS, the 
meninges were removed, and the brain was chopped into small pieces. The material was 
weighed, homogenised in an equal volume of tubulin purification buffer A using a Waring 
blender and Polytron homogeniser (Thermo Fisher Scientific) and centrifuged in a JA-14 rotor 
(Beckman Coulter) at 12,000 rpm (13,900 gav) at 4 °C for 30 minutes. The supernatant was 
removed and centrifuged in a Ti45 rotor (Beckman Coulter) at 30,000 rpm (70,400 gav) at 4 °C 
for 1 hour. Again, the supernatant was removed and 2 mM EGTA, 1 mM MgSO4, 0.5 mM GTP 
and 25 % (v/v) glycerol were added and the preparation was incubated at 37 °C for 30 minutes 
to polymerise microtubules. The material was centrifuged in a Ti45 rotor at 40,000 rpm (125,200 
gav) at 30 °C for 1 hour, after which the supernatant was discarded and the pellet was 
resuspended in 90 ml of tubulin purification buffer B, left on ice for 30 minutes to depolymerise 
microtubules and then 30 ml of glycerol was added. At this stage the material was snap frozen 
and stored at -80 °C. The following day the material was centrifuged in a Ti70 rotor (Beckman 
Coulter) at 40,000 rpm (117,700 gav) at 4 °C for 20 minutes. The supernatant was removed and 
2 mM EGTA, 1 mM MgSO4 and 0.5 mM GTP were added and the preparation was incubated at 
37 °C for 30 minutes to allow microtubules to polymerise. The material was centrifuged in a Ti45 
rotor at 40,000 rpm (125,200 gav) at 30 °C for 1 hour, after which the supernatant was discarded 
and the pellet was resuspended in 45 ml of tubulin purification buffer C, left on ice for 30 
minutes and 12 ml glycerol was added. The preparation was separated into 15 ml aliquots, snap 
frozen in liquid nitrogen and stored at -80 °C. When needed, an aliquot was thawed and 
centrifuged in a Ti70 rotor at 42,300 rpm (131,700 gav) at 4 °C for 1 hour. The supernatant was 
removed and DMSO was added to 10 % (v/v) and then incubated at 37 °C for 30 minutes. The 
preparation was centrifuged in a Ti90 rotor (Beckman Coulter) at 47,000 rpm (137,000 gav) at 30 
°C for 1 hour. The pellet was resuspended in 2 ml of phosphocellulose column buffer. 
 
Tubulin was further separated from any remaining contaminating proteins, especially MAPs, 
using a phosphocellulose column. The buffer in the pre-prepared column was drained and 
another 200 ml of phosphocellulose column buffer was added and allowed to flow through. The 
flow through should have a pH of 6.9 and this was checked using a pH meter. The column was 
run until the buffer level was just above the resin and then 2 ml of microtubule protein was 
added. The protein was allowed to enter the resin and then 150 ml of phosphocellulose column 
buffer was added. Fractions of 3 ml were collected and the OD280 of each fraction was 
measured, with the purity of the protein assessed by running samples on a 10 % SDS-PAGE 
gel and staining with colloidal Coomassie as described in section 2.4.3. Fractions were snap 
frozen in liquid nitrogen and stored at -80 °C until needed.  
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2.10.1.3 Microtubule polymerisation from purified tubulin  
The purified tubulin prepared as described in 2.10.1.2 was thawed and 1 mM GTP was added. 
Following centrifugation in a TLS55 rotor at 44,000 rpm (130,000 gav) at 4 °C for 30 minutes, the 
supernatant was removed and taxol was added to a concentration of 20 μM and then incubated 
at 37 °C for 15 minutes. The material was then layered over a 10 % (w/v) sucrose cushion 
prepared in BRB80 containing 20 μM taxol, and centrifuged in a SW60 rotor (Beckman Coulter) 
at 17,200 rpm (30,000 gav) at 30 °C for 25 minutes. The supernatant and cushion were removed 
and the pellet was washed with BRB80 containing 1 mM GTP and then centrifuged as before. 
The supernatant was removed and the pellet was resuspended in 300 μl of phosphocellulose 
column buffer. A Bradford assay was performed to determine the protein concentration and the 
microtubules were then diluted to 2 mg/ml with phosphocellulose column buffer, separated into 
20 μl aliquots, snap frozen and stored in liquid nitrogen until needed.  
2.10.2 Motility of rat liver ER membranes with interphase and metaphase Xenopus laevis 
egg extract cytosols 
A flow cell was generated by drawing two strips of Apiezon M grease (M&I materials, 
Lancashire, UK) down either side of a microscope slide, with selotape used as a spacer, and an 
18x18 mm
2
 (no. 1.5 thickness) coverslip (Corning) placed on top. Pig brain microtubules were 
diluted to a final concentration of 0.2 mg/ml in BRB80 containing 5 μM taxol. The solution was 
added to the flow cell and incubated upside down in a humid chamber for 10 minutes to coat the 
coverslip with microtubules. Unbound microtubules were flushed away with A/S containing 1x 
energy mix. Interphase and metaphase cytosols were prepared from CSF and Newmeyer 
extracts as described in section 2.7.2.3. A measure of 1 μl (10 μg) of rat liver ER membranes 
was added to 9 μl of cytosol, applied to the flow cell and left in a humid chamber for 1 hour to 
allow an ER network to form. Flow cells were viewed using an Olympus BX60 microscope fitted 
with a 60x 1.4 N.A. PlanApo objective, a 1.4 N.A. oil immersion condenser and differential 
interference contrast optics, as described in [218]. Light from a 100 W mercury vapour lamp was 
passed through water and glass filters and a 546 nm interference filter then directed to the 
microscope through a 1 mm optical silica filter. Differential interference contrast images were 
projected onto a Hamamatsu Newvicon camera. A Hamamatsu Argus 10 image processor was 
used to perform background subtraction and image contrast enhancement in real time. 
Sequences for analysis were recorded onto DVD using a Panasonic DVD recorder. For 
quantification analysis twenty fields were chosen at random and the number of three-way 
junctions per field was counted. From this the average number of three-way junctions per field 
was calculated. Each experiment was repeated two additional times to obtain three average 
values per condition. These data were statistically analysed using SPSS 15.0 to perform 
independent student t-tests. 
2.10.3 Motility of rat liver Golgi membranes in the presence of BFA 
The assay was performed in a similar manner to that described by Robertson and Allan [144]. 
Interphase cytosol was prepared from Newmeyer extracts as described in section 2.7.2.3 and 
then diluted 5-fold with acetate buffer including 100 μg/ml BFA. This mixture was then added to 
flow cells and incubated for 10 minutes as described in section 2.10.2 to coat the coverslip with 
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microtubules that polymerised spontaneously in interphase Xenopus laevis egg extract cytosol. 
The BFA was taken from a 2 mg/ml stock diluted in acetate buffer immediately before use. A 
volume of 1 μl (10 µg) of rat liver Golgi membranes was incubated with 4 μl (4 μg) of antibody 
for 45 minutes on ice [144] or 2.9 μl (2 μg) of protein for 20 minutes on ice [30]. Incubation with 
mouse IgG or GST was used as a negative control. When combining incubations with 
antibodies and GST-KBPΔ250-81, a volume of 2 µl (20 µg) of rat liver Golgi membranes was 
incubated with 4 µl (4 µg) of antibody and 2.9 µl (2 µg) of GST-KBPΔ250-81 for 45 minutes on 
ice. Incubation with mouse IgG and GST was used as a negative control.  
 
Of these mixtures, 1 μl was taken and added to 8.5 μl of interphase cytosol prepared from 
Newmeyer extract and 0.5 μl of freshly diluted 2 mg/ml BFA (i.e. to a final concentration of 100 
μg/ml), applied to the flow cell and left inverted in a humid chamber for 1 hour. Flow cells were 
imaged as described in section 2.10.2. To analyse motility twenty fields were chosen at random 
and the total length of tubules per field was measured using a map measuring tool. Each 
experiment was repeated two additional times to obtain three average values per condition. 
Data was statistically analysed as described in section 2.2.4. 
 
To assess the effects of GST-KBPΔ250-81 upon Golgi vesicle motility, a volume of 1 µl (10 µg) 
of rat liver Golgi membranes were incubated with 2.9 µl (2 µg) of GST-KBPΔ250-81, or GST as 
a negative control, for 20 minutes on ice. Of this mixture, 1 µl was taken and added to 9 µl of 
interphase cytosol prepared from Newmeyer extract, and added to flow cells which had been 
coated with microtubules as described above. The flow cells were left inverted for 10 minutes in 
a humid chamber. Twenty randomly chosen fields were imaged using VE-DIC microscopy and 
each filmed for 30 minutes. The total number of moving vesicles in these fields (i.e. in 10 
minutes) was counted. Each experiment was repeated two additional times to obtain three 
average values per condition. Data was statistically analysed as described in section 2.10.2. 
2.10.4 Motility of interphase Xenopus laevis egg extract membranes or rat liver ER 
following incubation with GST-E-MAP-115 
Flow cells were coated with microtubules as described in section 2.10.3, except BFA was 
omitted. A membrane fraction was prepared from Newmeyer extract as described in section 
2.7.2.3, except flotation through a sucrose gradient step was not performed. Once pelleted the 
membranes were resuspended directly into 20 µl of A/S. A volume of 1 μl of these interphase 
Xenopus laevis egg extract membranes, or rat liver ER membranes, was incubated with 1 μl 
(0.5 μg) of GST or GST-E-MAP-115 protein which had been dialysed into acetate buffer, for 20 
minutes on ice. It was found that incubating both interphase Xenopus laevis egg extract 
membranes and rat liver ER membranes with larger amounts of GST-E-MAP-115 such as those 
described in section 2.10.3 reduced microtubule polymerisation and increased bundling in the 
assay. Of this mixture, 1 μl was taken and added to 9 μl of interphase cytosol prepared from 
Newmeyer extract, applied to the flow cell and left inverted in a humid chamber for 1 hour. The 
final concentration of GST-E-MAP-115 in the assay was approximately 980 nM. Flow cells were 
viewed as described in section 2.10.2 and images were captured on DVD. Image preparation 
was performed using PhotoShop CS2 and Adobe Illustrator CS2. 
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2.10.5 Kinesin-1 bead assays 
2.10.5.1 Motility of beads along microtubules polymerised from interphase or metaphase 
Xenopus laevis egg extract cytosol 
Microtubules prepared as described in section 2.10.1.3 were passed through a 23.5 gauge 
needle to shear, and diluted to 1.25 μg/ml in interphase or metaphase cytosol prepared from 
Newmeyer extract as described in section 2.7.2.3. The solution was applied to a microscope 
flow cell and left inverted in a humid chamber for 10 minutes. The exogenously-added brain 
microtubules acts as nucleation sites for microtubule polymerisation which is necessary in 
metaphase cytosol which is unable to support de novo microtubule polymerisation [217]. Any 
unbound material was flushed away with 40 μl of motility buffer. A volume of 6 μl of K430-BCCP 
bacterial lysate was incubated with 2 μl of streptavidin-coated magnetic beads (Ademtech, 
Pessac, France) which have a diameter of 200 nm, which had been washed once with motility 
buffer. The beads were incubated for 15 minutes at room temperature and then re-isolated 
using a magnet, and any unbound material was removed by washing the beads once with 50 μl 
of motility buffer. The beads were diluted in 40 μl of motility buffer and 10 μl was applied to the 
flow cell and viewed immediately. As a positive control, flow cells were also pre-coated with 
microtubules polymerised exclusively from pig brain tubulin as described in section 2.10.2 
except unbound material was flushed away with motility buffer. To analyse motility, twenty fields 
were chosen at random and filmed for 30 seconds each and the number of moving beads per 
field was counted. Each experiment was repeated two additional times to obtain three average 
values per condition. Data was statistically analysed as described in section 2.10.2.  
2.10.5.2 Motility of beads in the presence of interphase or metaphase Xenopus laevis egg 
extract cytosols 
Flow cells were pre-coated with microtubules polymerised from purified pig brain tubulin and 
magnetic streptavidin-coated beads were coated with K430-BCCP as described in section 
2.10.5.1. The beads were then diluted in 40 μl of interphase or metaphase cytosol prepared 
from Newmeyer extract as described in section 2.7.2.3, or A/S containing 1x energy mix, all 
including 4 mM ATP, 4 U/ml creatine phosphokinase and 0.5 % (v/v) β-mercaptoethanol. A 10 
μl volume of this bead suspension was applied to the flow cell and viewed immediately. Motility 
was quantitated and analysed as described in section 2.10.5.1. 
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3. Results – Cell cycle 
regulation of kinesin-1 
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The aim of this work was to determine if kinesin-1-dependent motility is regulated in a cell cycle-
dependent manner, and if so, to determine the mechanism of this regulation.  
3.1 Use of Xenopus laevis egg extracts in in vitro motility assays 
Previous studies have performed in vitro motility assays using extracts prepared from Xenopus 
laevis eggs as a means of studying microtubule motor regulation (see section 1.5.4) [89, 188, 
218, 272]. These assays, in which motor activity is reconstituted in the absence of cells, have 
several advantages that often make them more amenable and their results easier to interpret 
than alternative systems or in vivo analyses. Xenopus laevis egg extracts polymerise 
microtubules de novo and have a relatively high concentration of motors meaning a high level of 
motor-dependent motility is supported, with both vesicular and tubular membrane movements 
generated [272]. It has also been shown that at least some regulatory post-translational 
modifications, such as phosphorylation and dephosphorylation, are supported by this system 
[89, 217, 272]. Moreover, the activity of a single motor can often be studied in isolation. For 
example, ER membranes from Xenopus laevis egg extracts are moved solely by cytoplasmic 
dynein-1 in this system, whereas a rat liver ER fraction is moved exclusively by kinesin-1 [30, 
272]. This is especially beneficial as it becomes increasingly obvious that motors often do not 
work in isolation in vivo but cooperate and coordinate with each other, making it difficult to 
unravel how an individual motor is regulated [34, 231, 273]. Indeed reconstitution of membrane 
motility in this simplified in vitro system has been used to dissect mechanisms behind intricate 
processes such as nuclear membrane breakdown [274].  
 
Perhaps the most important facet of Xenopus laevis egg extracts in terms of this project is their 
ability to interconvert between different cell cycle stages [233] (Figure 1.6), allowing monitoring 
of changes to motor-dependent motility during both mitosis and meiosis. It was therefore 
decided to combine cytosols prepared from Xenopus laevis egg extracts with rat liver ER 
membranes in motility assays to determine if, and how, the kinesin-1 motor is regulated during 
the cell cycle.  
3.1.1 Assessment of Xenopus laevis egg extract quality 
In order to ensure Xenopus laevis egg extracts could be reliably converted between cell cycle 
states, rigorous tests were employed to assess extract quality. Since the phosphorylation status 
of DLIC is known to change in Xenopus laevis egg extracts between interphase and metaphase 
[89], the mobility of DLIC on SDS-PAGE gels was used as an indicator of cell cycle status. 
Indeed, DLIC purified from mitotic metaphase extracts has been shown to run with a slower 
mobility compared to protein isolated from interphase extracts, and this is due to metaphase-
specific hyperphosphorylation of DLIC [89].  
 
A CSF Xenopus laevis egg extract was treated with activation mix containing calcium to 
stimulate conversion from meiotic metaphase II into interphase, or with mock activation mix 
lacking calcium as a negative control, and left for 1 hour at room temperature. Addition of high 
levels of exogenous calcium simulates the sharp rise in calcium concentration and inactivation 
of CSF triggered in the egg following fertilisation (see section 1.5.4 and Figure 1.6) [237]. 
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Samples were taken every 15 minutes of the time course, and then run on SDS-PAGE gels and 
subjected to western blotting with an anti-DLIC antibody. It was necessary to check the 
phosphorylation status of DLIC at various time points following calcium activation or mock 
activation since CSF extracts are notoriously difficult to arrest in metaphase II and often convert 
to interphase, or an intermediary cell cycle state, spontaneously [229]. When a CSF extract was 
treated with activation mix, there was a gradual downward shift in DLIC mobility from 
approximately 67 kDa to 62 kDa (Figure 3.1 A), indicating DLIC was dephosphorylated and the 
extract converted from meiotic metaphase II into interphase. In contrast, following extract mock 
activation DLIC continued to migrate at the higher molecular weight of approximately 67 kDa, 
indicating the extract was able to sustain its meiotic metaphase II arrest for up to 1 hour at room 
temperature.  
 
In a parallel experiment a Newmeyer Xenopus laevis egg extract was incubated with 
recombinantly expressed cyclin B1 Δ90 protein, a non-degradable form of cyclin B1 which 
stimulates conversion from interphase to mitotic metaphase, or with water as a negative control 
and left for 1 hour. Cyclin B1 ∆90, initially described by Murray and co-workers in 1989 [236], is 
sea urchin cyclin B1 protein lacking the first 90 amino acids from the N-terminus. This renders 
the protein resistant to ubiquitination necessary for its degradation, but still able to interact with 
CDK1 leading to phosphorylation of histone H1 [185, 236]. Western blotting of extract samples 
revealed an upward shift in DLIC mobility from approximately 62 kDa to 67 kDa following cyclin 
B1 Δ90 treatment (Figure 3.1 A). This indicated DLIC phosphorylation had occurred and the 
extract had converted from interphase into mitotic metaphase. Conversely, when the extract 
was treated with water, DLIC mobility was unchanged remaining at approximately 62 kDa 
suggesting the extract stayed in interphase. 
 
Another method employed to assess extract quality was the histone kinase assay. This assay 
allows the activity of the key metaphase kinase CDK1 to be measured, by monitoring the 
phosphorylation of histone H1. Since CDK1 phosphorylates histone H1, a higher level of histone 
H1 phosphorylation indicates a higher level of CDK1 activity [275]. Again, CSF and Newmeyer 
Xenopus laevis egg extracts were converted to interphase or mitotic metaphase respectively, by 
treatment with activation mix or cyclin B1 ∆90 protein. Samples were taken every 10 minutes up 
to 1 hour and analysed for histone kinase activity (see section 2.7.2.5). When the CSF extract 
was activated there was a decrease in histone kinase activity (Figure 3.1 B), from 4.6 
pmol/μl/min at the beginning of the assay to 1.6 pmol/μl/min after 1 hour, suggesting CDK1 
activity had fallen and the extract had converted from meiotic metaphase II into interphase. 
Conversely, when the CSF extract was mock activated, histone kinase activity was sustained at 
a higher level, ranging from 4.5 pmol/μl/min to 6 pmol/μl/min, indicating CDK1 activity was 
maintained and a meiotic metaphase II arrest was retained for up to 1 hour at room 
temperature.  
 
Following treatment of a Newmeyer Xenopus laevis egg extract with cyclin B1 Δ90 protein there 
was a gradual increase in histone kinase activity over time, from 0.3 pmol/μl/min at the  
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Figure 3.1 – Assessment of Xenopus laevis egg extract quality using immunoblotting of DLIC and histone kinase assays 
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beginning of the assay to 11 pmol/μl/min after 1 hour (Figure 3.1 B), suggesting CDK1 activity 
had increased and the extract had converted from interphase to meiotic metaphase II. Following 
treatment with water, histone kinase activity was maintained at a lower level indicating the 
extract remained in interphase.  
3.1.2 Changes in the level of cytoplasmic dynein-1 and dynactin on Xenopus laevis egg 
extract membranes during meiosis and mitosis 
Both cytoplasmic dynein-1 and dynactin are known to be released from membranes in Xenopus 
laevis egg extracts upon conversion from interphase into mitotic metaphase [89]. This release is 
believed to underpin the cell cycle regulation of cytoplasmic dynein-1 in Xenopus laevis egg 
extracts, resulting in profound inhibition of membrane motility during mitosis in vitro [89, 217]. 
Cytoplasmic dynein-1-dependent motility is also known to be inhibited in meiotic metaphase II 
Xenopus laevis egg extracts [217], but the mechanism by which this occurs has not been fully 
verified. In order to test whether mitotic Xenopus laevis egg extracts were behaving as 
expected, and also to determine whether cytoplasmic dynein-1 and/or dynactin are released 
from membranes in meiotic metaphase II extracts, it was decided to recapitulate these original 
experiments.  
 
CSF and Newmeyer Xenopus laevis egg extracts were converted to interphase or mitotic 
metaphase respectively, by treatment with activation mix or cyclin B1 ∆90 protein. Membranes 
and cytosol were first crudely separated by ultracentrifugation. Membranes were then floated 
through a sucrose gradient to ensure they were free of any contaminating non-membranous 
cytoplasmic dynein-1 or dynactin which had co-sedimented during the first pelleting step. 
Samples of each fraction, equivalent to 1 μl of crude extract, were immunoblotted for DLIC, DIC 
or p150glued. Proportional loading, and not equal protein loading, was used to allow the fairest 
comparison of cytoplasmic dynein-1 and dynactin levels between fractions. In Newmeyer 
Xenopus laevis egg extracts, a reduced level of both DIC and p150glued on membranes was 
seen in mitotic metaphase with a corresponding increase in the cytosolic fraction (Figure 3.2 A). 
Immunoblotting for DLIC, whilst displaying the expected changes to DLIC mobility between 62 
kDa and 67 kDa, and thus showing the extract was correctly converted between cell cycle 
states, did not reveal an increased signal in mitotic cytosol. This is probably because the 
antibody preferentially recognises dephosphorylated DLIC (Addinall and Allan, unpublished 
data) and therefore gave a reduced signal in the metaphase samples, where the protein is 
hyperphosphorylated. These results, in agreement with previously published data, reveal 
cytoplasmic dynein-1 and dynactin are released from membranes into the cytosol upon 
conversion of Xenopus laevis egg extract from interphase into mitotic metaphase [89].  
 
When an identical experiment was performed with CSF Xenopus laevis egg extracts, 
immunoblotting for DLIC revealed the expected band shifts, indicating the extract had converted 
from meiotic metaphase II into interphase, but no release of either DIC or p150glued from 
meiotic membranes was observed (Figure 3.2 B). The level of both DIC and p150glued 
appeared similar on membranes isolated from interphase and meiotic metaphase II extracts. 
This data suggests that neither cytoplasmic dynein-1 nor dynactin are released from  
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Figure 3.2 – Cytoplasmic dynein-1 and dynactin are released from membranes in mitotic metaphase but not meiotic metaphase II Xenopus laevis egg extracts 
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membranes in meiotic metaphase II extracts. Therefore membrane release of cytoplasmic 
dynein-1 and/or dynactin is not responsible for inhibition of membrane motility in meiotic CSF 
Xenopus laevis egg extracts. 
3.1.3 Changes to kinesin-1-dependent rat liver ER motility during meiosis and mitosis in 
vitro 
To determine whether kinesin-1-dependent motility is regulated in a cell cycle-dependent 
manner, an ER-enriched membrane fraction isolated from rat liver was mixed with metaphase or 
interphase Xenopus laevis egg extract cytosols. Rat liver ER was used since it has been shown 
to be motile in interphase Xenopus laevis egg extract cytosol [232], where it forms an ER 
network characterised by three-way junctions between tubules, and importantly, is known to be 
moved exclusively by kinesin-1 in vitro [30]. Therefore any ER motility observed in this assay 
can be attributed to the activity of kinesin-1. The mixture of ER and cytosol was applied to 
microscope flow cells which had been pre-coated with microtubules polymerised from purified 
pig brain tubulin, a commonly used source of microtubules in in vitro motility assays [276]. After 
1 hour, twenty fields of each flow cell were visualised using VE-DIC microscopy and the level of 
ER motility was quantified by counting the number of three-way junctions observed per field. 
This is a widely used method of measuring ER tubule motility in vitro and provides a simple and 
quick means of assessing cargo movement, albeit lacking more detailed quantification of the 
speed or duration of tubule movement [272]. This analysis parameter was chosen in preference 
to counting the number of moving tubules per field or the speed of tubule movement since it 
was found to be much faster and easier to perform, and has been previously reported to provide 
an accurate estimate of ER motility in this in vitro assay [272]. Both meiotic and mitotic 
metaphase cytosols significantly reduced the mean number of three-way junctions observed per 
field compared to the interphase cytosol control (Figure 3.3). This data suggests kinesin-1 
activity is regulated in a cell cycle-dependent manner, at least in vitro. 
3.2 Investigating potential mechanisms responsible for the cell cycle regulation of 
kinesin-1-dependent ER motility 
There are a number of potential mechanisms by which kinesin-1 activity may be inhibited in 
metaphase cytosols (see section 1.6.1 and Figure 1.7) and it was decided to investigate each 
scenario in turn to determine which, if any, are responsible for the cell cycle regulation of ER 
motility observed in this assay. It should be noted that the mechanism of regulation was 
assumed to be the same in both meiotic and mitotic cytosols and consequently some 
experiments were performed with just one type of metaphase extract.  
3.2.1 Interaction of kinesin-1 with the ER membrane  
Since regulation of the motor-cargo interaction has been previously shown to underlie cell cycle 
regulation of cytoplasmic dynein-1 in a similar assay [89], perhaps the most obvious explanation 
for inhibition of ER motility is that metaphase cytosols stimulate release of kinesin-1 from the rat 
liver ER. To determine whether this was the case, ER was incubated with interphase, meiotic 
metaphase II or mitotic metaphase cytosol for 1 hour at room temperature, the same amount of 
time flow cells are left for when performing the motility assay. ER membranes were then 
recovered by pelleting through a sucrose cushion, followed by a single wash with A/S to remove  
84 
 
Figure 3.3 – Kinesin-1-driven rat liver ER motility is inhibited by meiotic and mitotic metaphase Xenopus laevis egg extract cytosol in vitro 
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any contaminating non-membranous kinesin-1 which may have co-sedimented during pelleting. 
Samples of this purified ER, along with crude untreated ER, and cytosol fractions were 
immunoblotted for kinesin-1 using the anti-KHC antibody, uKHC, and with the k2.4 antibody 
which recognises the KIF3A motor subunit of kinesin-2 [33].  
 
Following treatment with interphase cytosol or meiotic metaphase II cytosol the level of KHC on 
the re-isolated ER, which runs at approximately 120 kDa, was unchanged compared to the 
crude ER sample, indicating meiotic metaphase II cytosol does not stimulate release of rat KHC 
from the membrane (Figure 3.4 A). Xenopus laevis KHC ran as a doublet at approximately 120 
kDa in both Xenopus laevis egg extract cytosol samples. The reason for this is unknown but the 
upper band does not seem to represent a phosphorylated version of the lower band (Lane and 
Allan, unpublished data). Importantly, this data suggests that Xenopus laevis KHC is not 
recruited to the rat liver ER membrane since no doublet was observed in the re-isolated ER 
samples (Figure 3.4 A) [30, 218]. This indicates all ER motility observed in interphase cytosol is 
driven solely by rat kinesin-1. However, the possibility that the lower running Xenopus laevis 
KHC band is interchanging with the rat liver ER KHC band cannot be excluded. In summary, 
this data suggests that the inhibition of kinesin-1 driven ER motility is not due to modulation of 
the interaction between kinesin-1 and ER cargo.  
 
Samples were also blotted for the KIF3A subunit of kinesin-2, a motor which is known to play no 
role in ER motility in this assay [30]. The amount of KIF3A on the ER, which runs as a doublet, 
was unchanged following treatment with interphase or meiotic metaphase II cytosol and was 
similar to that observed in the untreated ER sample. This data indicates kinesin-2 is not lost 
from, nor recruited to, the ER following treatment with interphase or meiotic metaphase II 
cytosol.  
 
These experiments were repeated comparing rat liver ER membranes incubated with 
interphase or mitotic metaphase cytosols prepared from Newmeyer Xenopus laevis egg 
extracts and identical results were obtained (Figure 3.4 B), again supporting the conclusion that 
disruption of the interaction between kinesin-1 and the ER cargo is not responsible for the 
metaphase inhibition of motility.  
3.2.2 Interaction between rat KHC and KLC  
The interaction between the KHC and KLC components of the kinesin-1 motor was next 
investigated. Metaphase cytosols could potentially prevent interaction between these subunits 
and thereby render the motor inactive. The most obvious approach to answer this question 
would be to repeat the experiment described in section 3.2.1, where ER is recovered following 
incubation with interphase cytosol or metaphase cytosols, and immunoblot with an anti-KLC 
antibody. If the level of KLC on the ER was reduced following metaphase cytosol treatment, this 
would indicate that KLC is released from the ER membrane. However, no anti-KLC antibody 
which works well for immunoblotting was available and moreover this approach would not 
confirm whether the interaction between KHC and KLC was changed. For example, the 
interaction between KHC and KLC may be broken but this would not necessarily affect the  
86 
 
Figure 3.4 – Neither rat KHC nor kinesin-2 is released from rat liver ER membranes following incubation with metaphase cytosols  
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binding of either subunit to the membrane since both are thought to contain a cargo binding 
region [30, 198, 201].  
 
It was therefore decided to test the range of available anti-KLC antibodies to determine whether 
any are capable of specifically immunoprecipitating rat KLC but not Xenopus laevis KLC. 
Immunoprecipitations from rat liver ER or interphase cytosol prepared from Newmeyer Xenopus 
laevis egg extract were performed using the monoclonal anti-KLC antibodies L1 and L2, or with 
mouse IgG as a negative control. Samples were run on a SDS-PAGE gel and immunoblotted 
with the anti-KHC antibody, uKHC. KHC was detected in both L1 immunoprecipitates indicating 
this antibody recognises both rat and Xenopus laevis KLC (Figure 3.5 A). However, when the 
L2 antibody was used, KHC was detected in the rat liver ER sample, but not the interphase 
Xenopus laevis egg extract cytosol sample (Figure 3.5 A). This indicates the L2 antibody is 
capable of immunoprecipitating rat KLC but not Xenopus laevis KLC. Consequently, the KHC-
KLC interaction of rat kinesin-1 could be investigated without results being contaminated by 
Xenopus laevis kinesin-1, which is not believed to contribute to rat liver ER motility in this assay 
(Figure 3.4) [30].  
 
To determine whether the rat liver ER KHC-KLC interaction is disrupted in the metaphase 
assay, ER was incubated with interphase cytosol or mitotic metaphase cytosol, or A/S for 1 hour 
at room temperature. A/S was used as a negative control since it is a commonly used buffer in 
motility assays [217], and is known to have no inhibitory effects upon kinesin-1-dependent ER 
motility in vitro [30]. Rat liver KLC was then specifically immunoprecipitated with the L2 
antibody, and mouse IgG was used as a negative control, and samples were immunoblotted for 
KHC. The level of KHC detected from the rat KLC immunoprecipitate was unchanged following 
incubation with interphase or mitotic metaphase cytosol compared to the A/S incubation control. 
This indicates neither interphase nor mitotic metaphase cytosol causes dissociation of the 
kinesin-1 complex on the rat liver ER membrane (Figure 3.5 B).  
3.2.3 Phosphorylation of rat kinesin-1 
It is now well established that changes to the phosphorylation status of microtubule motors is a 
major means of regulating their activity and indeed phosphorylation of DLIC has been shown to 
correlate with release of cytoplasmic dynein-1 from cargo in mitotic metaphase Xenopus laevis 
egg extracts [89]. Moreover, several studies have revealed that kinesin-1 activity can be 
regulated by phosphorylation and dephosphorylation of both KHC [91] and KLC [90, 93, 277] 
(see section 1.3.1). It was therefore feasible that changes to the phosphorylation status of rat 
kinesin-1 following incubation with either interphase or metaphase cytosol is influencing kinesin-
1 activity and thereby responsible for the cell cycle regulation of rat liver ER motility.  
 
It was decided to first determine whether Xenopus laevis kinesin-1 phosphate turnover differs 
between interphase and metaphase cytosols. If no difference was detected then any signal 
observed when rat liver ER was incubated with Xenopus laevis egg extract cytosols could be 
confidently attributed to changes in rat kinesin-1 phosphorylation status, rather than cytosol 
contamination. Both interphase and metaphase cytosols were prepared from CSF and  
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Figure 3.5 – The interaction between rat KHC-KLC on ER membranes is not disrupted by Xenopus laevis egg extract cytosols 
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Newmeyer Xenopus laevis egg extracts which were then incubated with 
32
P-γ-ATP for 30 
minutes at room temperature. Kinesin-1 was immunoprecipitated from these samples with the 
anti-KHC antibody SUK4 that recognises the motor domain of KHC [278], and IP with mouse 
IgG was used as a negative control. Importantly, the IP was performed under conditions in 
which the Xenopus laevis KHC-KLC interaction is known not to be disrupted (Figure 3.4 A), 
meaning KLC will be present in the KHC immunoprecipitate. A doublet band at approximately 
120 kDa was observed in each of the SUK4 antibody immunoprecipitates in the colloidal 
Coomassie stained gel (Figure 3.6 A), corresponding to Xenopus laevis KHC. These bands are 
not observed in the mouse IgG control samples and indicate that kinesin-1 was specifically 
immunoprecipitated with the SUK4 antibody. Moreover, the intensity of the doublet band 
appeared comparable in each of the SUK4 immunoprecipitates, indicating that a similar level of 
kinesin-1 had been immunoprecipitated in each case. No difference in the radiation signal 
between interphase and metaphase cytosols, or between Newmeyer and CSF extracts was 
observed (Figure 3.6 B), suggesting that the amount of 
32
P-γ-ATP kinesin-1 incorporates under 
each condition is similar and that kinesin-1 phosphate turnover does not change between 
interphase and metaphase cytosol, or between meiosis and mitosis.  
 
To ensure this negative result was not simply due to failure of the extracts to activate correctly 
and convert between interphase and metaphase, a sample of each cytosol was immunoblotted 
for DLIC. In both Newmeyer and CSF Xenopus laevis egg extracts DLIC ran at approximately 
67 kDa in metaphase cytosols compared to approximately 62 kDa in interphase cytosols (Figure 
3.6 C). This suggested DLIC is (hyper)phosphorylated specifically in metaphase samples and 
that each extract was successfully converted between cell cycle states. Histone kinase assays 
were also performed with each of the cytosols as another means of confirming the cell cycle 
status (data not shown). Since Xenopus laevis kinesin-1 phosphate turnover does not differ 
between interphase and metaphase cytosol, any difference in kinesin-1 phosphorylation on rat 
liver ER could now be attributed more confidently to modification of rat kinesin-1, rather than 
contamination from extract cytosols.  
 
This data also indicated that the phosphorylation status of Xenopus laevis kinesin-1 in egg 
extracts does not change in a cell cycle-dependent manner. However, it could be argued that 
since the radiolabel was not present at the actual point of conversion between cell cycle states, 
the level of steady-state phosphate turnover, as well as the number of phosphorylated sites, 
could influence the result. For example, if phosphate turnover at a newly phosphorylated site 
was low it may not be detected in the 30 minutes timeframe used. To more conclusively show 
Xenopus laevis kinesin-1 phosphorylation does not change in a cell cycle-dependent manner, 
interphase Xenopus laevis egg extract was converted to mitotic metaphase by treatment with 
cyclin B1 Δ90 protein, or alternatively sustained in interphase by treatment with water, in the 
presence of 
32
P-γ-ATP for 30 minutes at room temperature. In contrast to the previously 
described experiment membranes were included in this assay. Kinesin-1 and cytoplasmic 
dynein-1 were immunoprecipitated using the SUK4 and IC74 (anti-DIC) antibodies respectively, 
and IP with mouse IgG was used as a negative control. A doublet of similar intensity at 
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Figure 3.6 – Xenopus laevis kinesin-1 phosphate turnover does not differ between interphase and metaphase  
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approximately 120 kDa was present in each of the SUK4 immunoprecipitate samples, indicating 
that a comparable amount of kinesin-1 was immunoprecipitated in each case (Figure 3.7 A). A 
single band at approximately 85 kDa was present in each of the IC74 immunoprecipitates, 
corresponding to DIC (Figure 3.7 A). An intense band above the 220 kDa marker was also 
observed, which is thought to be DHC.  
 
Following cyclin B1 Δ90 treatment there was an intense radiation signal in the DIC 
immunoprecipitate at approximately 67 kDa that was not observed in the water treated sample, 
which corresponded to the specific metaphase phosphorylation of DLIC (Figure 3.7 B). This 
indicates the extract was correctly converted from interphase into metaphase and supports the 
observation of Niclas and co-workers that DLIC is specifically phosphorylated in mitotic 
metaphase Xenopus laevis egg extracts [89]. In contrast, a band at approximately 120 kDa is 
present in the SUK4 immunoprecipitate following cyclin B1 ∆90 treatment which is not observed 
in the water treated sample. This may indicate phosphorylation of Xenopus laevis KHC is 
occurring specifically in mitosis. Other bands are also apparent which are more intense in the 
cyclin B1 ∆90 treatment, including a band above the 220 kDa marker. These may reflect the 
mitotic phosphorylation of proteins which interact with kinesin-1. 
 
To determine whether the phosphorylation status of kinesin-1 on rat liver ER membrane 
changes specifically following incubation with interphase or mitotic metaphase cytosol, ER was 
incubated with each cytosol for 30 minutes at room temperature in the presence of 
32
P-γ-ATP. 
ER was then separated from the cytosol by pelleting through a sucrose cushion. The SUK4 
antibody was used to immunoprecipitate kinesin-1 from the recovered ER, whereas the IC74 
antibody was used to immunoprecipitate cytoplasmic dynein-1 from each of the cytosols to 
check whether metaphase-specific phosphorylation of DLIC could be observed. A single band 
at approximately 85 kDa was present in each of the IC74 immunoprecipitates in the colloidal 
Coomassie stained gel, corresponding to DIC (Figure 3.8 A). An intense band above the 220 
kDa marker, believed to be DHC, was also observed. The intensity of these bands was similar 
in each of the IC74 immunoprecipitates indicating a similar level of cytoplasmic dynein-1 was 
immunoprecipitated in each case. No bands corresponding to KHC or KLC were observed in 
the SUK4 immunoprecipitates by colloidal Coomassie staining (Figure 3.8 A). This is likely due 
to the low level of kinesin-1 on the rat liver ER membrane (see section 3.2.5).  
 
When the gel was exposed to film, there was an intense band at approximately 70 kDa in the 
DIC immunoprecipitate from mitotic metaphase cytosol which was not observed in the 
interphase cytosol sample (Figure 3.8). This band corresponded to the metaphase-specific 
phosphorylation of DLIC and indicated each cytosol is in the correct cell cycle state. This data 
suggests DLIC in metaphase Newmeyer Xenopus laevis egg extracts continues to incorporate 
phosphate at a relatively high rate following conversion. No differences in the radiation signal in 
SUK4 immunoprecipitates following incubation with interphase or mitotic metaphase cytosol 
was observed (Figure 3.8 B), suggesting that kinesin-1 on rat liver ER membranes does not 
incorporate phosphate under either condition.  
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 Xenopus laevis kinesin-1 is not phosphorylated in a cell cycle-dependent manner 
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Figure 3.8 – Rat liver kinesin-1 does not become (hyper)phosphorylated following incubation with either interphase cytosol or mitotic metaphase cytosol  
94 
 
3.2.4 Use of K430-BCCP protein  
Kinesin-1 bead assays were used to investigate whether microtubule modifications, or direct 
regulation of the KHC head domain, are responsible for the metaphase inhibition of rat liver ER 
motility. Similar systems have been used successfully in previous studies to determine the 
directionality of membrane movement [16, 218] as well as calculating motor step sizes and run 
lengths [279]. Kinesin bead assays allow the direct observation of cargo which is moved 
exclusively by a single motor. Furthermore, coating beads with recombinant truncated KHC 
protein allows the study of kinesin-1 motor activity in the absence of autoinhibition by KLC 
binding (see section 1.3.3) [280].  
 
In this assay, K430-BCCP protein was recombinantly expressed in Escherichia coli. This protein 
encodes amino acids 1 to 430 of rat KIF5C, tagged at the C-terminus to the N-terminus of an 80 
amino acid fragment of biotin carboxyl carrier protein (BCCP). Amino acids 1 to 430 of KIF5C 
encode the motor domain, neck and neck linker, and a small region of stalk 1 of KHC [281-283]. 
Importantly, this allows the protein to dimerise via coiled coil linkages in the neck domain [284]. 
However, the absence of the more C-terminal portions of KHC means autoinhibition, via 
interaction between the KHC tail and motor domains, is prevented [101]. Consequently the 
motor is constitutively active and unregulated. KIF5C is generally classified as a neuronal KHC 
isoform of kinesin-1, but a recent study has detected KIF5C mRNA in two human lung epithelial 
cell lines [24], thus challenging this thinking. Rat KIF5B, the widely considered ubiquitously 
expressed KIF5 isoform, and KIF5C share 79 % identical amino acid homology within the 
portion of KHC used in this assay. Furthermore, they share 87 % identical amino acid homology 
in residues 1 to 350, which are generally considered to encode the motor domain of kinesin-1 
[283, 285]. A fragment of the naturally occurring BCCP protein is now widely used as an 
alternative tag in recombinant protein expression. The advantage of BCCP in comparison to 
other tags is that it is a smaller protein with a mass of approximately 14 kDa and purification is 
often found to be more efficient with less contamination [270]. Biotin is added to the culture 
medium during induction of K430-BCCP expression, leading to biotinylation of the BCCP tag. 
Streptavidin-coated beads, which bind biotin, can then be used to purify the tagged protein. A 
schematic of these interactions is shown in Figure 3.9 A.  
 
To determine whether the protein could be expressed and purified, the soluble bacterial lysate 
was incubated with streptavidin-coated beads. A sample of the total bacterial lysate along with 
soluble and bead-bound fractions was run on a SDS-PAGE gel and stained with Coomassie. An 
intense band at approximately 65 kDa, corresponding to K430-BCCP protein, was seen in each 
fraction and bound specifically to streptavidin-coated beads (Figure 3.9 B). This shows soluble 
K430-BCCP protein can be produced in Escherichia coli and subsequently purified using 
streptavidin-coated beads. Attempts were also made to express and purify a similar fragment of 
KIF5B, the ubiquitously expressed isoform of KHC. However, the protein was found to be 
insoluble despite attempts to optimise expression and purification procedures (data not shown). 
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Figure 3.9 – K430-BCCP protein binds streptavidin-coated beads 
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3.2.4.1 Microtubule post-translational modifications 
There are several examples in which modifications of microtubules, such as acetylation [113] 
and detyrosination [114], can influence the ability of kinesin-1 to both bind and to move along 
microtubules. It is feasible that such modifications are occurring specifically in the interphase or 
metaphase assay and underlie the inhibition of kinesin-1-driven ER motility. To investigate this 
possibility microscope flow cells were coated with microtubules polymerised from purified pig 
brain tubulin, or from interphase or mitotic metaphase Xenopus laevis egg extract cytosols. Pig 
brain tubulin is a commonly used source of microtubules in motility assays, along which kinesin-
1 is known to move [30], and therefore acts as a positive control. Beads were coated with 
recombinant K430-BCCP protein (Figure 3.9 A) and applied to flow cells in the presence of an 
energy-regenerating system that converts ADP to ATP, catalysed by the presence of creatine 
phosphate and the enzyme creatine phosphokinase. Beads were observed moving along 
microtubules polymerised from each of the three sources and no significant difference in the 
mean frequency of moving beads per field was detected (Figure 3.10). This data reveals the 
KIF5C motor domain can bind and move along microtubules polymerised under both interphase 
and metaphase conditions, indicating modifications to microtubules are not responsible for 
inhibition of kinesin-1-dependent ER motility by metaphase cytosols. The possibility that the 
velocity of movement is reduced specifically under one condition cannot be eliminated, although 
this is not readily obvious by looking at the data by eye. It should also be noted that this data 
does not exclude the possibility that the interaction between kinesin-1 and microtubules is 
disrupted in the metaphase assay but this may be dependent upon the presence of KLC and/or 
more C-terminal portions of KHC, which are absent in this experimental setup.  
3.2.4.1 Direct regulation of rat KHC head and neck domains 
It was next decided to determine whether direct modulation of the rat KHC head and neck 
domains, either activation by interphase cytosol or inhibition by metaphase cytosol, is 
responsible for the cell cycle-dependent regulation of ER motility. To achieve this microscope 
flow cells were coated with microtubules polymerised from purified pig brain tubulin. Beads were 
again coated with K430-BCCP protein and diluted into interphase or mitotic metaphase cytosol, 
or A/S, and applied to flow cells in the presence of an energy-regenerating system. Beads were 
observed moving along microtubules following incubation with interphase or mitotic metaphase 
cytosol or A/S, and no significant change in the mean frequency of moving beads per field was 
detected (Figure 3.11). These results reveal that the KHC motor domain can bind and move 
along microtubules in the presence of both interphase and mitotic metaphase cytosol, indicating 
modification of rat KHC head and neck domains, albeit in the absence of KLC, are not 
responsible for inhibition metaphase inhibition of kinesin-1-driven ER motility.  
3.2.5 Binding partners 
The last possibility to be investigated was that kinesin-1 binding partners, that have an inhibitory 
or activating effect upon kinesin-1 activity, bind specifically in metaphase or interphase cytosol, 
respectively. Initial attempts to identify such proteins involved performing kinesin-1 
immunoprecipitations from rat liver ER which had been recovered following incubation with 
either interphase or metaphase cytosol. It soon became obvious that the level of kinesin-1 on 
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Figure 3.10 – Microtubule modifications are not responsible for inhibition of kinesin-1-dependent motility by mitotic metaphase Xenopus laevis egg extract cytosol 
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Figure 3.11 – KHC head and neck domains are not inhibited directly by mitotic metaphase Xenopus laevis egg extract cytosol 
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the rat liver ER membrane was much lower than in Xenopus laevis egg extracts, which severely 
hampered progress. Furthermore, the process of re-isolating ER membranes following 
incubation with interphase or metaphase cytosol was also found to reduce the level of material 
immunoprecipitated with anti-kinesin-1 antibodies. To illustrate this, kinesin-1 was 
immunoprecipitated with the SUK4 antibody from rat liver ER which had been re-isolated by 
pelleting through a sucrose cushion or flotation through a sucrose gradient. The pelleted ER 
membranes were either resuspended directly in IP buffer or first into A/S, since unpublished 
data suggested this may also influence the amount of kinesin-1 immunoprecipitated (personal 
communication, Dr. Marcin Woźniak). Samples were run on SDS-PAGE gels and stained with 
colloidal Coomassie. The level of material immunoprecipitated from ER membranes following 
re-isolated either by pelleting or flotation, was reduced compared to when crude untreated ER 
was used (Figure 3.12 A). This indicates material is either lost through the process of re-
isolation, or that the ability of kinesin-1 to bind SUK4 is reduced or inhibited following re-
isolation. Additionally, neither the KHC nor the KLC bands, with expected molecular weights of 
120 kDa and 70 kDa respectively, were observed even in the SUK4 immunoprecipitate from 
crude ER (Figure 3.12 A). This suggested attempting to identify kinesin-1 binding partners in the 
ER fraction may be fraught with technical difficulties owing to the low level of motor in the 
sample, which is further reduced by re-isolation procedures.  
 
Several attempts were made to overcome these problems by performing scaled-up experiments 
using a larger starting volume of rat liver ER, or by using different volumes and molarities of 
sucrose in the cushion or gradient during the re-isolation procedure. Since the ratio of ER to 
cytosol used in the in vitro motility assays was 1:10, it was thought that the volume of cytosol 
should be at least double the volume of ER membranes in biochemical experiments. Since only 
approximately 3 ml of extract is produced per batch of eggs, this further limited the amount of 
ER used. Different antibodies were used to immunoprecipitate kinesin-1 and different batches of 
ER membranes were also tested. None of these changes were found to greatly affect the 
outcome (data not shown). 
 
Immunoprecipitations were also performed with the anti-KLC antibody, L2, which has the 
advantage of specifically recognising rat KLC but not Xenopus laevis KLC (Figure 3.5). This 
avoids the need to re-isolate ER following incubation with Xenopus laevis egg extract cytosol. 
The expected KHC and KLC bands at 120 kDa and 70 kDa respectively were not observed in 
any of the L2 immunoprecipitates and no obvious differences between incubation with 
interphase or mitotic metaphase cytosols were apparent (Figure 3.12 B). Bands at 
approximately 300 kDa and 45 kDa were visible when ER had been incubated with Xenopus 
laevis egg extract cytosol, which were not seen with A/S incubation. However, since both these 
bands were also found in the control mouse IgG immunoprecipitates it is probable that they 
represent non-specific binding of Xenopus laevis proteins to the beads, likely to be myosin and 
actin.  
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Figure 3.12 – Isolation of rat liver ER membranes by pelleting or flotation reduces the level of material immunoprecipitated with the SUK4 antibody 
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Due to the outlined technical difficulties in identifying proteins which interact with kinesin-1 it 
became unfeasible to continue with this approach. It was therefore decided to switch tack and 
take a more biased approach to try and identify binding partners which may regulate kinesin-1 
in a cell cycle-dependent manner. To this end, proteins which are known to associate with 
kinesin-1, or modulate motor activity, were screened and those which seemed more likely to 
operate in a cell cycle context were investigated further. Whilst this is not ideal, since a single 
protein is investigated at a time making progress very protracted, it was decided worthwhile to 
explore the most likely candidates further.  
3.2.5.1 p150glued  
p150glued, a subunit of the dynactin complex, is known to be mitotically regulated in both HeLa 
and XTC cell lines where it becomes hyperphosphorylated specifically during M-phase [286]. 
The association of p150glued with mitotic Xenopus laevis egg extract membranes is known to 
be under cell cycle control [89]. Moreover, recent evidence suggests p150glued can bind 
kinesin-1 under certain circumstances and by doing so both positively [81] and negatively 
regulate kinesin-1 activity (personal communication, Dr. Marcin Woźniak). This evidence 
pointed towards p150glued as a potential regulator of kinesin-1 in a cell cycle-dependent 
manner.  
 
To determine if an association between p150glued and KHC could be replicated, IP 
experiments were initially performed using Xenopus laevis egg extracts since they are known to 
have a relatively high concentration of motors making any potential interaction easier to 
observe. KHC was immunoprecipitated with the SUK4 antibody from interphase or meiotic 
metaphase II membrane fractions prepared by flotation, since the interaction is believed to 
occur whilst kinesin-1 is bound to cargo [81] (personal communication, Dr. Marcin Woźniak). 
Immunoprecipitates were immunoblotted for p150glued or KHC. A band at approximately 150 
kDa corresponding to p150glued was detected specifically in the SUK4 immunoprecipitates and 
not the mouse IgG control of both interphase and metaphase membrane fractions (Figure 3.13 
A). This indicates p150glued and kinesin-1 interact in both interphase and meiotic metaphase II 
membrane fractions, although it remains possible that the interaction is mediated through 
another subunit of the dynactin complex. Since the intensity of the p150glued band did not differ 
when interphase or meiotic metaphase II membrane fractions were used this indicated the 
interaction does not change in a cell cycle-dependent manner, at least in meiotic Xenopus 
laevis egg extracts. A similar level of KHC was found in both SUK4 immunoprecipitates when 
immunoblotted with the uKHC antibody, with a double band of similar intensity running at 
approximately 120 kDa, showing a similar level of KHC was immunoprecipitated in both cases 
(Figure 3.13 B). 
 
To determine whether a similar interaction is occurring on rat liver ER membranes specifically in 
the interphase or metaphase assay, kinesin-1 was immunoprecipitated using the anti-KLC 
antibody L2, following incubation of ER for 30 minutes with interphase or meiotic metaphase II 
cytosols, or A/S. Immunoprecipitates were immunoblotted for p150glued or KHC. The L2 
antibody was again used to immunoprecipitate kinesin-1 in order to prevent the need to re-  
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Figure 3.13 – Kinesin-1 and p150glued interact equally in membrane fractions isolated from interphase and meiotic metaphase II Xenopus laevis egg extracts 
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isolate ER membranes following incubation with cytosols. No signal for p150glued was detected 
under any of the conditions tested (Figure 3.14 A). Immunoblotting for KHC revealed a similar 
level of kinesin-1 has been immunoprecipitated in all cases (Figure 3.14 B). This data may 
suggest that no interaction between kinesin-1 and p150glued exists on untreated rat liver ER 
membranes and furthermore, no interaction is induced following incubation with interphase or 
meiotic metaphase II cytosol. Alternatively, it is possible that an interaction does exist but the 
relatively low level of kinesin-1 on rat liver ER membranes means it cannot be detected. Indeed, 
the amount of KHC observed in the kinesin-1 IP from rat liver ER was noticeably lower than 
when interphase or meiotic metaphase II Xenopus laevis egg extract membranes were used 
(Figure 3.13 B). 
 
The next approach taken was to determine whether the total level of p150glued on rat liver ER 
membrane differs following treatment with interphase or metaphase cytosol. ER membranes 
were incubated with interphase or meiotic metaphase II cytosol, or A/S. The ER was then re-
isolated by pelleting membranes through a sucrose cushion, followed by a wash with A/S to 
remove any contaminating non-membranous dynactin which had co-sedimented during 
pelleting. Samples of recovered ER along with interphase and meiotic metaphase II cytosols, 
and untreated rat liver ER membrane, were immunoblotted for p150glued and DIC. No 
p150glued was detected on untreated ER membranes indicating dynactin is absent from 
purified rat liver ER membranes, or is present at a level lower than the threshold of detection for 
the anti-p150glued antibody (Figure 3.15 A). This perhaps explains in part why rat liver ER is 
moved exclusively by kinesin-1 in vitro, whereas in vivo data indicates cytoplasmic dynein-1 
also contributes to ER motility [197]. Following incubation with both interphase and meiotic 
metaphase II cytosol, p150glued was detected on ER membranes suggesting it was recruited 
from the cytosol. The intensity of the band, running at approximately 150 kDa, did not differ 
between interphase and meiotic metaphase II cytosol incubations, indicating the recruitment 
was similar in both cases. Thus, whilst p150glued is recruited from Xenopus laevis egg extract 
cytosols to the ER membrane, this does not differ between cell cycle states and so cannot be 
responsible for metaphase inhibition of motility. 
 
A small amount of recruitment of DIC to the ER membrane following incubation with interphase 
and meiotic metaphase II cytosol was also observed, with a band at approximately 85 kDa 
apparent when using the anti-DIC antibody IC74, although the band intensity was lower than 
that observed for p150glued (Figure 3.15 B). No DIC was detected in untreated ER membranes 
indicating cytoplasmic dynein-1 is absent from purified rat liver ER membranes, or is present at 
a level lower than the threshold of detection for the anti-DIC antibody. A Ponceau S stain 
indicated a similar level of protein was present in each of the membrane samples (Figure 3.15 
C).  
 
Since no evidence to support a role for p150glued in the metaphase inhibition of kinesin-1 was 
found it was decided to switch tack and focus on another potential regulator, E-MAP-115.  
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Figure 3.14 – No interaction between kinesin-1 and p150glued on rat liver ER membranes is detected following incubation with interphase or meiotic metaphase II Xenopus laevis egg extract cytosol 
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Figure 3.15 – Xenopus laevis p150glued is recruited to rat liver ER membranes equally following incubation with interphase or meiotic metaphase II cytosol  
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3.2.5.2 E-MAP-115 
E-MAP-115, also known as ensconsin and MAP7, is a MAP. First identified in 1993 by Masson 
and Kreis in HeLa cells [269], the binding of E-MAP-115 to microtubules is thought to influence 
microtubule dynamics. Binding of the MAP stabilises microtubules and protects them against 
depolymerisation [269]. For several years it has been known that E-MAP-115 is mitotically 
regulated, at least in the HeLa cell line, with the protein becoming hyperphosphorylated at the 
onset of mitosis, an event which coincides with its release from microtubules [118]. This 
regulation of the interaction between E-MAP-115 and microtubules may be important in driving 
changes to microtubule dynamics which are necessary to form the mitotic spindle. After 
prometaphase E-MAP-115 is dephosphorylated and progressively reassociates with 
microtubules resulting in microtubule stabilisation. 
 
A recent study links E-MAP-115 to kinesin-1 regulation. Ensconsin, the Drosophila 
melanogaster homologue of E-MAP-115, has been shown to be required for all studied kinesin-
1 functions in the polarised fly oocyte [119]. Single cell assays indicate ensconsin exerts this 
control by promoting the recruitment of kinesin-1 to microtubules and its motility. Whilst it is not 
known whether E-MAP-115 also controls kinesin-1 activity in a similar manner in mammalian 
systems, these results identified E-MAP-115 as a candidate potentially capable of regulating 
kinesin-1 activity in a cell cycle-dependent manner.  
 
In ovary extracts prepared from Drosophila melanogaster, the microtubule binding and motility 
of full length KHC was perturbed in ensconsin mutant samples compared to the wild-type 
extract control but this effect was not observed when a recombinantly expressed truncated 
version of the motor lacking the C-terminal tail domain was used [119]. This suggests the 
inhibition of kinesin-1 activity in ensconsin mutant flies is either due to direct targeting of the 
more C-terminal portion of the motor, or is dependent upon kinesin-1 adopting a folded 
conformation in which the KHC motor and tail domains interact. These scenarios could explain 
why no effects upon the motility of KHC motor domain along metaphase microtubules was 
previously observed (Figure 3.10). It is unknown how ensconsin exerts these effects upon 
kinesin-1 motility, since no evidence of an interaction between the two proteins was found. 
Because of this, it seemed unlikely that IP experiments similar to those described for p150glued 
would be of any use. Moreover, an antibody which recognises both rat and Xenopus laevis E-
MAP-115 by immunoblotting was not available.  
 
Therefore, to investigate whether E-MAP-115 functions as a regulator of kinesin-1, the effects of 
adding GST-E-MAP-115 protein upon rat liver ER motility in vitro were investigated. Human E-
MAP-115 DNA was isolated from a HeLaM cell cDNA library and cloned into a GST-tagged 
bacterial expression vector. Human E-MAP-115 was used since the initial cell cycle studies 
were based upon this protein [118]. ER was incubated with 0.5 μg of GST-E-MAP-115, or GST, 
for 20 minutes on ice. The final concentration of GST-E-MAP-115 protein in the assay was 
approximately 980 nM. Since the endogenous concentration of E-MAP-115 in Xenopus laevis 
egg extracts is unknown it was not possible to determine accurately how many orders of 
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magnitude more the exogenous protein was present at, in comparison to the native protein. This 
may be important since overexpression of MAPs has been associated with perturbation of 
microtubule structure and dynamics [287, 288], and could thereby perhaps have indirect effects 
upon motor activity. However, the concentration of another MAP, XMAP310, has been reported 
to be approximately 200 nM in Xenopus laevis egg extract [289]. It was therefore assumed that 
the amount of GST-E-MAP-115 added was approximately 5-10 times the level of endogenous 
protein. These treated membranes were added to interphase cytosol prepared from Newmeyer 
Xenopus laevis egg extracts, applied to flow cells which had been pre-coated with microtubules 
polymerised from interphase cytosol and the level of ER motility was monitored using VE-DIC 
microscopy. If E-MAP-115 positively regulates kinesin-1, the addition of further E-MAP-115 
protein may be expected to increase the level of ER motility. In fact, the opposite result was 
observed. Whereas incubation with GST had no apparent effects upon ER motility, GST-E-
MAP-115 almost completely inhibited network formation (Figure 3.16 A). No noticeable 
differences in microtubules were seen when GST-E-MAP-115 was used at this concentration, 
although when higher levels of the protein were tested, microtubules looked abnormal with more 
bundling and less polymerisation observed (data not shown). 
 
To determine whether this inhibitory effect of GST-E-MAP-115 was limited to kinesin-1-driven 
motility, assays were repeated using membranes isolated by pelleting from interphase 
Newmeyer Xenopus laevis egg extracts, which are known to be moved exclusively by 
cytoplasmic dynein-1 [89]. Again, incubation of membranes with GST-E-MAP-115 inhibited 
motility compared to the GST control (Figure 3.16 B). This suggested the effects of GST-E-
MAP-115 upon membrane motility are non-specific, perhaps due to extensive coating of 
microtubules by the MAP, and confident conclusions cannot be drawn from the data.  
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Figure 3.16 – GST-E-MAP-115 inhibits the in vitro motility of rat liver ER membranes and interphase Xenopus laevis egg extract membranes
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4. Discussion – Cell 
cycle regulation of 
kinesin-1 
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Kinesin-1 is involved in controlling the positioning and morphology of a wide range of organelles 
and plays integral roles in trafficking through the secretory and endocytic pathways. It was 
hypothesised that modulation of the activity of this motor may contribute to the large scale 
changes in cargo transport and organelle localisation observed during cell division. Therefore 
the aim of this work was to determine if and how kinesin-1 activity is regulated in a cell cycle-
dependent manner. This study was considered worthwhile and viable given the potentially 
highly significant implications of kinesin-1 regulation during cell division and the relative ease 
with which the question could be probed using established in vitro motility assays.  
4.1 Reconstitution of kinesin-1-driven cargo motility in vitro  
Previous studies have employed motility assays using cytosol and membrane fractions 
prepared from Xenopus laevis egg extracts to reveal that ER motility is inhibited during mitosis 
due to inhibition of cytoplasmic dynein-1 function [89]. Similar assays were used in this study by 
combining rat liver ER membranes with Xenopus laevis egg extract cytosol to investigate 
whether kinesin-1 activity is also regulated in a cell cycle-dependent manner. This approach 
was chosen for several reasons. It is known that rat liver ER membranes are motile in 
interphase Xenopus laevis egg extract cytosol and form a network characterised by three-way 
junctions occurring between tubules [232]. This network is simply visualised using VE-DIC 
microscopy and the level of motility can be easily quantitated by counting the number of three-
way junctions per field. Furthermore, it has been shown that all ER motility in this assay is due 
entirely to the function of kinesin-1 [30], meaning any alteration in cargo movement can be 
attributed to changes in the activity of this motor. Perhaps most importantly in terms of this 
project is the ability to convert the assay easily between cell cycle states by using meiotic, 
mitotic or interphase Xenopus laevis egg extract cytosol. It was felt that the cell cycle 
modulation of kinesin-1 function could be probed more easily using this approach in comparison 
to in vivo studies, where cooperation between motors and rounding up of cells during division 
are inherent problems. In vivo analyses were planned if and when a mechanism for kinesin-1 
regulation was identified in vitro. 
 
To validate any differences in rat liver ER motility between interphase and metaphase and for all 
subsequent biochemical analyses it was necessary to employ rigorous controls to ensure 
Xenopus laevis egg extracts were in the correct cell cycle state and could be reliably converted 
between states. In addition to the conventionally used histone kinase assays to achieve this, a 
new assay was established in which the phosphorylation status of DLIC was monitored over 
time. A noticeable shift in DLIC mobility can be detected by western blotting between 
phosphorylated and dephosphorylated forms. This could then be correlated to changes in cell 
cycle status since DLIC is known to become hyperphosphorylated specifically during 
metaphase [89]. Compared to histone kinase assays this was a simpler and faster means of 
determining extract quality, and found to be technically easier for screening numerous extracts 
concurrently.  
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The release of Xenopus laevis cytoplasmic dynein-1 from ER membranes triggered by 
phosphorylation of DLIC has previously been shown to be responsible for the mitotic inhibition 
of ER motility observed in Xenopus laevis egg extracts [89]. While these results were 
recapitulated here in mitotic extracts, this mechanism did not operate in meiotic extracts. 
Interestingly, a band shift in DLIC mobility by western blotting was observed in CSF extracts, 
suggesting that it is specifically phosphorylated during meiosis as well as mitosis. However, it is 
possible that the sites of phosphorylation differ between extract types, or that the shift is due to 
another post-translational modification. These observations raise questions regarding the cell 
cycle regulation of cytoplasmic dynein-1 in Xenopus laevis egg extracts. Perhaps completely 
different mechanisms are driving inhibition of ER motility in meiotic versus mitotic extracts. 
Alternatively, phosphorylation of DLIC may be sufficient to induce inhibition of ER-bound motor 
activity, and the release of cytoplasmic dynein-1 observed in mitotic extracts is not directly 
responsible for the cessation of ER motility. Further studies are warranted to probe the reasons 
underlying these differing observations.  
 
Experiments using 
32
P-γ-ATP indicated mitotic-specific phosphorylation of Xenopus laevis KHC 
may occur. In terms of Xenopus laevis ER-bound kinesin-1 this is perhaps surprising given the 
motor remains inactive between interphase and metaphase [218]. However, the movement of 
other kinesin-1-driven cargoes may be regulated in a cell cycle-dependent manner in the 
Xenopus laevis egg and it is feasible that modulation of the phosphorylation status of kinesin-1 
may contribute to this. Little is known regarding the specific isoforms of KHC or KLC which are 
expressed in Xenopus laevis, or whether they display any tissue-specific distribution, which may 
complicate any future studies investigating how kinesin-1 is regulated during cell division in this 
organism (see Table 1.1). It would be interesting to determine whether any changes in the 
phosphorylation status of the motor are induced when egg membranes are incubated with XTC 
cytosol, which could explain how the contribution of kinesin-1 to Xenopus laevis ER motility is 
activated during development [218].  
4.2 Significance of metaphase inhibition of rat liver ER motility  
When rat liver ER membranes were combined with metaphase cytosols in motility assays, a 
significant reduction in three-way junctions per field was observed in both meiotic and mitotic 
conditions. It could be argued that a defect in ER tubule fusion, which is known to be inhibited 
during mitosis in semi-intact cell assays [211], could be contributing to this result. However, no 
tubule motility was observed in metaphase assays indicating that cargo motility, and not simply 
membrane fusion, was affected. This data presents evidence that kinesin-1 activity is regulated 
in a cell cycle-dependent manner. Given the pivotal functions of kinesin-1, this finding is exciting 
and may be highly significant, perhaps having widespread implications in cargo transit and 
organelle morphology, motility and positioning during the cell cycle.  
 
If this regulation is replicated in vivo then it has far-reaching consequences. Studies of 
mammalian ER inheritance to date have concentrated on the morphology and positioning of the 
organelle, and little work has examined whether ER motility changes during the cell cycle. A role 
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for cytoplasmic dynein-1 in moving ER tubules in VERO cells has recently been reported [197]. 
Whether ER movement driven by this motor is regulated in mammalian somatic cells in a similar 
manner to that previously described in Xenopus laevis eggs is undetermined. It is likely that the 
contributions of kinesin-1 and cytoplasmic dynein-1 to ER motility in somatic cells are precisely 
controlled allowing spatial and temporal remodelling of the network and it is feasible that this 
regulation extends to the cell cycle.  
 
There are known to be several connections between the ER and microtubule cytoskeleton in 
addition to the motors kinesin-1 and cytoplasmic dynein-1. Whilst the interaction mediated by 
CLIMP-63 is known to be broken during mitosis [207], the implications of this are uncertain 
since a range of other connections between the two networks would presumably remain intact. 
Whether the contributions of TACs or myosin motors to rat liver ER motility are also regulated in 
a cell cycle-dependent manner remains to be determined. Interestingly, it has been reported 
that myosin V-driven ER motility in Xenopus laevis egg extracts is activated specifically during 
mitosis [290]. One conundrum is what advantage the downregulation of microtubule-dependent 
ER motility during cell division may confer. It is conceivable that a reduction in ER movement 
may aid stochastic partitioning between daughter cells, or that dissociation of ER cargo from 
microtubules is required for correct formation of the metaphase spindle. Indeed, rough ER 
membranes have been observed to be excluded from the region occupied by the spindle in 
mitotic HeLa cells [210]. It is also possible that processes, such as cell migration, which require 
ER movement in interphase, are inhibited or downregulated during cell division, meaning 
movement is no longer necessary. Alternatively, decreased ER motility may simply be a 
symptom of a more general reduction in microtubule-dependent cargo movement during the cell 
cycle. 
 
If kinesin-1 function is regulated during cell division in vivo, it is unlikely that the consequences 
would be limited to ER motility. This study focused upon the ER simply because it is a cargo 
whose transport is driven exclusively by kinesin-1 in an in vitro assay which could be easily 
manipulated between cell cycle states. Kinesin-1 is known to contribute to the positioning of a 
range of organelles and trafficking pathways which are altered during cell division (see section 
1.5), and it is possible that regulation of this motor contributes to these changes. Moreover, in 
vitro rat liver Golgi vesicle motility, which is partially driven by kinesin-1 [30], is also potently 
inhibited by metaphase Xenopus laevis egg extract cytosol (Robertson and Allan, unpublished 
data). This supports the theory that large scale changes to microtubule motor transport occur 
during cell division which influence a range of cargoes, and that the effects of kinesin-1 
inhibition during metaphase in vitro are not restricted to ER tubule movement.  
4.3 Mechanism of kinesin-1 cell cycle regulation 
The mechanism responsible for the cell cycle-dependent regulation of kinesin-1-driven ER 
motility was next investigated. A number of scenarios could be envisaged which could explain 
how inhibition of cargo movement may be occurring. It was decided to investigate each of these 
113 
 
possibilities in turn, gathering data which would lead to each one being discounted or pursued 
further. 
 
Several previous studies have revealed that the interaction between kinesin-1 and cargoes can 
be tightly modulated [86, 90]. It was therefore hypothesised that the inhibition of rat liver ER 
motility observed in metaphase cytosols is due to release of kinesin-1 from its cargo. However, 
when ER membranes were recovered following incubation with meiotic or mitotic cytosol no 
difference in the level of membrane-bound KHC was detected by western blotting. Furthermore, 
no recruitment of Xenopus laevis kinesin-1 to the ER membrane in interphase cytosol was 
observed. This assay therefore represents one of the few reported examples in which kinesin-1 
activity is modulated whilst remaining attached to cargo [93]. The concept of regulation of 
membrane-bound motors is becoming increasingly prevalent and is often used to explain how 
bidirectional cargo motility is achieved. Indeed, motors with differing polarities are often found 
simultaneously bound to the same cargoes, and it has been proposed that motility is 
coordinated so that when a given motor is engaged with the microtubule the opposing motor is 
not [273]. This would necessitate the inactivation of motors whilst bound to cargoes. Perhaps in 
certain situations both kinesin-1 and cytoplasmic dynein-1 are simultaneously bound to ER 
cargo and can each be regulated without being released from the membrane, allowing 
coordination of bidirectional tubule motility and rapid remodelling of the network. It should be 
noted that it remains possible that the association of either KHC or KLC with their ER receptors 
is modulated by metaphase cytosol but this is not detected since the KHC-KLC interaction 
remains intact. 
 
Rat liver kinesin-1 was not found to be phosphorylated following incubation with either 
interphase or metaphase cytosol. In this experimental setup 
32
P-γ-ATP was included in the 
incubation of rat liver ER membranes with the appropriate cytosol and kinesin-1 was then 
immunoprecipitated. However, this approach cannot exclude the possibility that the motor is 
specifically dephosphorylated in either situation since a reduced level of phosphate 
incorporation would not be detected. The inclusion of protein phosphatase inhibitors in the 
assay to test this hypothesis would have likely influenced the cell cycle status of the cytosols. 
Ideally, a positive control would have been incorporated in which an ER protein, which is known 
to be phosphorylated specifically following incubation with interphase or metaphase cytosol, 
would have been immunoprecipitated to show that such modifications were detectable within 
the parameters of the experiment. This was not possible since no such protein has been 
identified, although if a CLIMP-63 antibody had been available it would have been interesting to 
determine whether the previously reported mitotic phosphorylation of this protein was replicated 
in vitro [207]. Nevertheless, this data indicated that kinesin-1 phosphorylation does not occur in 
the interphase or metaphase assay, ruling out this as a potential mechanism for the metaphase 
inhibition of rat liver ER motility. 
 
Another possibility is that the kinesin-1 cargo receptor is specifically phosphorylated in the 
interphase or metaphase assay, and this triggers an effect upon motor activity. The influence of 
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cargo phosphorylation upon kinesin-1 activity is poorly understood. However, there are a few 
cases in which changes in the phosphorylation status of cargoes is documented to affect 
binding to kinesin-1. For example, kinesin-1-driven axonal transport of tau is regulated by 
phosphorylation. When tau is phosphorylated by GSK3 this promotes binding of tau to kinesin-1 
and increases the rate of cargo transport in rat cortical neurons [94]. It would be useful to 
investigate whether the phosphorylation states of the kinesin-1 ER receptors change in the 
presence of interphase or metaphase cytosol. Perhaps such modifications are capable of 
conferring changes in kinesin-1 activity without triggering dissociation of the motor from its 
receptor. If the interaction between cargo and motor are relatively weak then any change in 
receptor phosphorylation could have been overlooked in the phosphorylation assays using KHC 
immunoprecipitates documented in this study. Alternatively, perhaps receptor phosphorylation is 
responsible for dissociation of KLC or KHC from the ER cargo. KHC is thought to bind the 
integral ER membrane proteins kinectin [198] and p180 [201], while the ability of exogenously-
added KLC1B to specifically perturb rat liver ER motility in vitro suggests that a KLC receptor is 
also present on rat liver ER membranes [30]. Kinectin exists in several different phosphorylation 
states in vivo with three major isoelectric forms detected in embryonic chick brain samples [84]. 
Within the KHC binding domain of kinectin there are two potential phosphorylation sites for 
casein kinase 2 and tyrosine kinase [200]. The identity of the ER KLC receptor remains 
undetermined.  
 
Beads coated with a truncated version of KHC were used to investigate whether microtubule 
modifications or direct modulation of the KHC motor domain were responsible for the 
metaphase inhibition of ER motility. Despite no perturbation in the frequency of bead motility 
being observed in any of the conditions tested it is possible that the absence of more C-terminal 
portions of KHC, as well as KLCs, is masking any inhibitory effect. Indeed, soluble kinesin-1 is 
known to adopt an autoinhibitory conformation dependent upon interactions between the KHC 
head and tail domains, and between KHC and KLC [101, 102]. Alternatively, perhaps the 
inhibitory mechanism directly targets these absent regions of kinesin-1. For example, binding of 
an inhibitory interacting partner to KLC in metaphase cytosol resulting in motor inhibition, or 
dissociation from microtubules, would not be revealed in this assay. Interestingly, similar 
observations have been made using single cell assays to investigate the influence of ensconsin, 
the Drosophila melanogaster homologue of E-MAP-115, upon kinesin-1-dependent activity in 
the polarised fly oocyte. A fragment of KHC encoding amino acids 1 to 401 is able to bind and 
move along microtubules normally in vitro using concentrated ovary extracts prepared from 
ensconsin mutant flies. However, when full length KHC is used a significant defect in the ability 
of kinesin-1 to bind and translocate along microtubules is exposed when ensconsin function is 
perturbed [119].  
 
To determine whether the inhibition of rat liver ER motility by metaphase cytosol is dependent 
upon the presence of more C-terminal regions of KHC, kinesin-1 bead assays could be 
repeated using full length KHC. Whilst this protein is notoriously difficult to express 
recombinantly, it is possible to purify the protein from brain tissue using sucrose gradients, 
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which beads could then be coated with. Such experiments have been used in the past to 
determine the directionality of membrane motility in similar in vitro assays [218]. The drawback 
to this approach is that KIF5A and KIF5C are supposedly enriched in neuronal tissue making it 
likely that these isoforms, rather than the ubiquitously expressed KIF5B protein, would be 
isolated. Optimisation of bead assays using kinesin-1 purified from non-neuronal tissues could 
be attempted to overcome this difficulty and indeed previous studies have documented the 
isolation of kinesin-1 from rat liver using comparable methods [291]. Additionally, it may be 
prudent to investigate more fully whether the speed at which beads are moving changes under 
a specific condition, since it is possible that the microtubule binding capability of the motor is 
unaffected whereas its processivity or speed of translocation is perturbed. Such calculations 
have been made from VE-DIC movies in previous studies using the RETRAC object tracking 
system [144, 218].  
 
Finally, the association of kinesin-1 with a binding partner specifically in the interphase or 
metaphase assay, which has a concomitant effect upon motor activity, was investigated. 
However, several technical obstacles were encountered which hindered progress. The major 
difficulty in this project has been the relatively low level of kinesin-1 on rat liver ER membranes. 
Despite attempts to scale up experiments using larger volumes of ER membranes, KHC or KLC 
bands could not be detected by colloidal Coomassie in KHC or KLC immunoprecipitate 
samples. Furthermore, during re-isolation procedures necessary to recover ER membranes 
following incubation with Xenopus laevis egg extract cytosols, the level of kinesin-1 
immunoprecipitated was reduced further. This made it impractical to identify binding partners of 
kinesin-1 which could be responsible for the metaphase inhibition of ER motility. Unfortunately, 
despite optimisation attempts, these problems were not overcome during the course of this work 
and it remains undetermined whether specific proteins bind kinesin-1 differentially between the 
interphase and metaphase assays. Perhaps a different tack is required to solve these 
difficulties. Mitotic extracts can be prepared from mammalian cells in a variety of ways. Cells 
can be arrested in prometaphase by the addition of low doses of the microtubule 
depolymerising agent nocodazole or mitotic cells can be isolated by shake-off techniques. If 
kinesin-1 immunoprecipitations were performed from these samples it is possible that KHC and 
KLC bands would be visible by colloidal Coomassie. Although this approach would not be 
directly looking at a cargo which is moved solely by kinesin-1, any differences in binding 
partners between interphase and mitosis could still prove insightful. Furthermore, if any potential 
candidates were identified using this approach, their influence upon ER network formation could 
be relatively easily probed by exogenously adding the protein to the in vitro assay or by 
immunodepleting the protein from Xenopus laevis egg extract cytosol and quantifying network 
formation.  
 
Despite these difficulties two potential regulators of kinesin-1 in a cell cycle context, p150glued 
and E-MAP-115, were investigated further. The p150glued subunit of the dynactin complex, 
which is known to be mitotically regulated [286], was found to associate with the motor in 
Xenopus laevis egg extracts, although it is possible that the interaction is indirect, potentially via 
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another subunit of the dynactin complex. Interestingly, since dynactin has also been reported to 
interact with kinesin-1 [81], kinesin-2 [38] and the kinesin-5 family member Eg5 [82], in addition 
to cytoplasmic dynein-1, it is possible that this adaptor protein plays an important role in 
regulating bidirectional microtubule-dependent cargo transport. Binding of p150glued to kinesin-
1 has been proposed to have both positive [81] and negative regulatory effects upon cargo 
motility (personal communication, Dr. Marcin Woźniak). However, since the interaction between 
p150glued and kinesin-1 was not found to differ between interphase and metaphase its 
importance was not probed further. No interaction between rat kinesin-1 and p150glued was 
detected, although it is possible that the two proteins do interact but due to the relatively low 
level of the motor on the membrane the association is not detected. Recruitment of Xenopus 
laevis p150glued to rat liver ER membranes from both interphase and metaphase cytosol was 
observed, although the significance of this is unsure given cytoplasmic dynein-1 does not 
contribute to cargo motility in this assay. The anti-p150glued antibody used in this experiment 
has been shown to be sensitive to the phosphorylation status of the protein, specifically 
recognising p150glued when dephosphorylated at the serine-19 residue [292]. It could therefore 
be argued that the detection of p150glued on rat liver ER membranes following incubation with 
Xenopus laevis egg extract cytosols is not due to recruitment of Xenopus laevis dynactin to the 
ER membrane, but reflects changes in the phosphorylation status of rat p150glued.  
 
A role for E-MAP-115 in the inhibition of kinesin-1 activity by metaphase cytosol was probed 
due to the reported contributions of this mitotically regulated MAP to kinesin-1 function in the 
polarised Drosophila melanogaster oocyte [118, 119]. The effects of adding recombinantly 
expressed E-MAP-115 to the in vitro motility assay were investigated and the protein was found 
to inhibit cargo movement driven by both kinesin-1 and cytoplasmic dynein-1. However, since 
E-MAP-115 is reported to be a positive regulator of kinesin-1 activity in Drosophila 
melanogaster [119], and has no documented link to cytoplasmic dynein-1 function, confident 
conclusions cannot be drawn from the data. It is possible that the effects observed are an 
indirect consequence of the protein coating microtubules and thereby interfering with all 
microtubule-dependent cargo motility. Ideally, the levels of endogenous E-MAP-115 on 
microtubules would have been probed to determine whether any change occurs between 
interphase and metaphase. This was not possible since an antibody which recognised both rat 
and Xenopus laevis forms of the protein by western blotting was not available. This also meant 
biochemical experiments to determine whether native kinesin-1 and E-MAP-115 interact, similar 
to those described for p150glued and kinesin-1, could not be performed. It would also be 
interesting to determine whether the phosphorylation status of E-MAP-115 changes in a cell 
cycle-dependent manner in Xenopus laevis egg extracts, similar to that observed in the HeLa 
cell line [118]. Such modifications could potentially induce changes in the activity or localisation 
of the MAP between the interphase and metaphase assays, and have a concomitant effect 
upon rat kinesin-1 function. Indeed, E-MAP-115 is known to be a direct target of Par1 kinase in 
the polarised Drosophila melanogaster oocyte, an event which is necessary for the anterior 
localisation of the protein and its ability to control kinesin-1 activity [119].  
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The binding or release of a kinesin-1 interacting partner specifically in the interphase or 
metaphase assay remains the most likely explanation for the cell cycle regulation of ER motility. 
Such differential binding could potentially induce folding or unfolding of the motor on ER 
membranes and thereby control tubule motility. Whilst it is known that three isoforms of KHC 
and at least four variants of KLC are expressed in rat (see Table 1.1), the relative contribution of 
each of these proteins to ER motility in the in vitro assay is uncertain. Given that until recently 
KIF5A and KIF5C were believed to be specifically expressed in neurons the involvement of 
these proteins in ER motility in somatic cells has not been investigated. If each of these different 
isoforms contributes to the movement of rat liver ER tubules in vitro, it is possible that the 
activity of each isoform is being controlled by a distinct mechanism, thus further complicating 
the situation.   
4.4 Further future work 
Soluble kinesin-1 is normally prevented from hydrolysing ATP or engaging with microtubules by 
adopting an autoinhibitory conformation [101, 102]. Since kinesin-1 remains bound to rat liver 
ER membranes in the metaphase assay, it is interesting to speculate how this motor inhibition is 
maintained. One possibility is that the motor can fold into an autoinhibitory conformation whilst 
bound to cargo. If this is true it may have implications in the control of bidirectional cargo motility 
in which the tight control of opposing motors bound simultaneously to the same cargo is 
hypothesised to occur [273]. Such behaviour has not been documented in any previous studies, 
perhaps because it is technically a difficult concept to investigate. Regardless of the 
conformation of kinesin-1 on cargoes, as soon as membranes are solubilised to perform 
biochemical analyses the motor will fold [30].  
 
The assays performed in this study were devoid of actin-based motility due to the presence of 
cytochalasin D, an inhibitor of actin polymerisation. However, the actin cytoskeleton is also 
thought to contribute to the ER movement, with the myosin V motor reported to move smooth 
ER vesicles isolated from squid axons in vitro [203], and myosin V-driven ER motility in 
Xenopus laevis egg extracts reported to be activated specifically during mitosis [290]. To 
determine whether myosin motors are capable of moving rat liver ER membranes, motility 
assays excluding cytochalasin D but including nocodazole could be performed. It would then be 
interesting to determine whether any actin-based rat liver ER motility is also regulated in a cell 
cycle-dependent manner in vitro. 
 
ER membrane fusion mediated by p97 and its cofactor p47 was specifically inhibited in vitro 
when semi-intact Chinese hamster ovary cells were treated with mitotic HeLa cell cytosol [211]. 
This is due to the mitotic phosphorylation of p47 by CDK1. It may prove insightful to determine 
whether this mechanism is replicated when rat liver ER membranes are combined with 
metaphase Xenopus laevis egg extract cytosols. This would lend weight to the theory that ER 
membrane fusion, in addition to tubule motility, is inhibited during cell division. Similar to the 
approach taken by Kano and co-workers, the effects of adding a non-phosphorylated form of 
p47 to the metaphase assay could be observed and protein kinase assays could be performed 
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to determine whether the endogenous protein is specifically phosphorylated in metaphase 
cytosol [211].  
 
Movement of ER tubules driven by cytoplasmic dynein-1 and kinesin-1 is tightly regulated 
during the cell cycle in vitro. Whether this phenomenon is replicated in vivo is unknown. 
Confocal live cell imaging of mitotic cells expressing a fluorescent ER marker could be 
attempted to determine whether changes to ER motility occur in vivo during cell division. 
Previous imaging of ER movement in living cells in this laboratory has revealed that the network 
is highly dynamic and subject to extensive remodelling [197]. Therefore any large scale 
changes in motility during cell division should be noticeable. Such an approach could also 
reveal whether the contribution of TACs or myosin motors to ER movement in somatic cells is 
influenced by cell division. Furthermore, it should be possible to determine whether inward or 
outward movement is specifically altered by carefully analysing tubule motility in a specific 
region of the cell of a set area.
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5. Results – Motility of 
BFA-induced tubules 
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The aim of this work was to determine which microtubule motor(s) is responsible for the motility 
of BFA-induced tubules.  
5.1 Use of in vitro motility assays to investigate BFA-induced tubule motility 
Previous studies have used in vitro motility assays to investigate the motility of BFA-induced 
membrane tubules. The addition of BFA to experiments in which rat liver Golgi membranes are 
combined with interphase Xenopus laevis egg extract cytosol results in the formation of intricate 
membrane networks which are positive for cis-Golgi, TGN and early endosome markers [144]. 
This tubulation is reliant upon microtubules since treatment with the microtubule-depolymerising 
agent nocodazole blocks network formation. This assay was used as a starting point to the 
project since, as previously mentioned, the reconstitution of cargo motility using Xenopus laevis 
egg extracts provides a simplified system in which to study microtubule motor behaviour [272]. 
In vivo analyses would be performed later to complement this in vitro work. Since BFA-induced 
cis-Golgi and TGN tubules move away from the Golgi it is likely that a plus end-directed 
microtubule motor contributes to this movement [138, 293]. Kinesin-1, kinesin-2 and kinesin-3 
family members are believed to be primarily responsible for plus end-directed interphase 
membrane motility [15, 71], and therefore other kinesin families were not studied in this work. A 
motor belonging to the kinesin-3 family, KIF1C, was of particular interest since it is localised to 
the ER and Golgi and has been previously implicated in the motility of BFA-induced cis-Golgi 
tubules, although this data has been refuted [146, 147]. It was decided to perform in vitro 
motility assays with rat liver Golgi membranes following treatment with proteins and antibodies 
which have an inhibitory effect upon kinesin-1, kinesin-2 and kinesin-3 to determine which, if 
any, blocked BFA-induced tubule formation. 
5.1.1 Function-blocking kinesin antibody pre-incubation 
The inhibitory monoclonal kinesin antibodies used were H1, SUK4 and k2.4. The H1 antibody 
was raised against kinesin-1 isolated from bovine brain [294], but was later found to recognise 
at least two polypeptides by western blotting, neither of which are kinesin-1 [144]. Whilst the 
target of H1 remains unknown, the antibody was used as a positive control since it has been 
previously shown to inhibit the motility of BFA-induced tubules in this in vitro assay [144], as 
well as in vivo [143]. SUK4 is an antibody raised against KHC of sea urchin kinesin-1 and was 
found to inhibit sea urchin microtubule translocation in vitro, perhaps through inhibition of the 
interaction between motor and microtubule [278]. The epitope of KHC recognised by SUK4 was 
subsequently mapped to between amino acids 312 and 382 of the KHC motor domain in 
Drosophila melanogaster [295]. SUK4 is now a widely used reagent for inhibiting kinesin-1 
function, being included in studies using cultured cells [296], in vitro motility assays [218] and 
sea urchin embryos [297]. The k2.4 antibody was raised against the 85 kDa kinesin related 
protein (85/95) (KRP(85/95)) subunit of sea urchin kinesin-2 [33], which is homologous to the 
KIF3A motor subunit of mammalian kinesin-2. This antibody has been used to block kinesin-2 
function in a range of studies including those using in vitro motility assays [30], Xenopus laevis 
eggs [298] and sea urchin embryos [299].  
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To determine whether any of these function-blocking antibodies has an inhibitory effect upon 
BFA-induced tubule motility in vitro, rat liver Golgi membranes were incubated with each 
antibody, or with mouse IgG, for 45 minutes on ice. These membranes were then added to 
interphase cytosol prepared from Newmeyer Xenopus laevis egg extracts containing BFA, and 
applied to microscope flow cells which had been coated with microtubules polymerised from 
interphase cytosol in the presence of BFA. After 1 hour, the total length of tubules per field was 
determined. As expected, pre-incubation with the H1 antibody significantly reduced the mean 
total tubule length per field compared to the mouse IgG incubation control (Figure 5.1). Pre-
incubation with either SUK4 or k2.4 antibodies did not significantly affect the mean total length 
of tubules formed compared to the mouse IgG control. This indicates that kinesin-1 and kinesin-
2 do not contribute to the motility of BFA-induced membrane tubules in this in vitro assay.  
5.1.2 Dominant negative kinesin protein pre-incubation 
The inhibitory proteins used to perturb kinesin function were GST-KHCct, GST-KAP3Bct and 
GST-KBP∆250-81. KHCct encodes the C-terminal domain of rat KHC from amino acids 771 to 
963, which has previously been shown to inhibit kinesin-1 activity in vitro [30], in vivo [197] and 
in semi-intact cell assays (personal communication, Dr. Marcin Woźniak). It is believed to cause 
this effect by binding to the motor domain of KHC thereby mimicking the folded autoinhibitory 
conformation, which kinesin-1 is thought to adopt when not bound to cargo (see section 1.3.3) 
[30, 101]. KAP3Bct encodes amino acids 512 to 793 of isoform B of the human KAP3 protein, 
the cargo-binding subunit of kinesin-2, and exerts its dominant negative effect by binding to 
kinesin-2 cargoes, thereby preventing binding of the endogenous motor (personal 
communication, Dr. Marcin Woźniak). Another isoform of KAP3, KAP3A, has also been 
characterised which is generated by alternative splicing within the C-terminus [40]. The purpose 
of these different isoforms is unknown, but it has been speculated that they may each bind a 
different subset of cargoes and thereby perform separate functions [40]. GST-KBP∆250-81 is a 
deletion mutant of the human KIF1B/C binding protein KBP, lacking amino acids 250 to 281. 
The mutant is unable to bind the motor and is thereby thought to inhibit the motor‟s activity [51], 
although the mechanism by which this occurs is unverified. It is unknown how this mutant 
affects binding between endogenous KBP and KIF1B/C. It was presumed that since neither 
KIF1Bα nor KIF1Bβ have been localised to the Golgi, or reported to be involved in cargo 
transport to or from the Golgi, these proteins would be present at a low level, if at all, in the rat 
liver Golgi fraction. Unfortunately, this could not be verified because of a lack of antibodies. 
However, it seemed likely that any effects observed following treatment with GST-KBP∆250-281 
could be attributed solely to inhibition of KIF1C function. 
 
To determine whether any of these function-blocking proteins have an inhibitory effect upon 
BFA-induced tubule motility in vitro, rat liver Golgi membranes were incubated with each 
protein, or GST as a negative control, for 20 minutes on ice and the level of BFA-induced 
membrane motility was analysed identically to the antibody incubation experiments. Following 
incubation with GST a mean total tubule length per field of 56.6 µm was observed (Figure 5.2). 
No significant effect upon network formation was detected following incubation with either GST-
KHCct or GST-KAP3Bct. This again supports the conclusion that neither kinesin-1 nor kinesin-2  
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Figure 5.1 – Perturbation of kinesin-1 or kinesin-2 using function-blocking antibodies has no effect upon the ability of BFA-induced tubules to form in vitro 
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Figure 5.2 – Perturbation of KIF1C using the dominant negative GST-KBP∆250-81 protein inhibits BFA-induced tubule motility in vitro 
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is necessary for BFA-induced tubule formation in this assay. Furthermore, no inhibition of 
motility was detected when GST-KHCct and GST-KAP3Bct were combined (Figure 5.2), ruling 
out the possibility that the motors are working in combination with each other. Pre-incubation 
with GST-KBP∆250-81 reduced the mean total tubule length per field to 16.8 µm, which 
corresponds to a p-value of less than 0.001. Experiments in which BFA was omitted were also 
performed to determine the baseline, uninduced, level of tubule formation in this assay. The 
mean total tubule length of tubules formed following incubation of rat liver Golgi membranes 
with GST or GST-KBP∆250-81 in the absence of BFA was 11.5 μm and 9.2 μm, respectively. 
Therefore the length of tubules formed in response to BFA following incubation with GST-
KBP∆250-81 is comparable to the length of tubules formed in the absence of any BFA, and 
indicates that inhibition of KIF1C reduces tubule motility to the background baseline level. 
These results suggest KIF1C functions in moving BFA-induced membrane tubules in vitro 
independently of any other motors.  
 
It was next decided to investigate whether treatment of Golgi membranes with GST-KBP∆250-
81 in combination with function-blocking antibodies had a greater inhibitory effect upon BFA-
induced membrane motility. The thinking behind this was that if no additive inhibitory effects 
upon tubule length were observed when the activities of multiple motors were blocked 
simultaneously, this would further verify the hypothesis that KIF1C functions in isolation to move 
BFA-induced tubules in vitro.  
 
To this end, membranes were incubated with GST-KBP∆250-81 together with SUK4, k2.4 or 
mouse IgG. As expected, the presence of GST-KBP∆250-81 significantly reduced the length of 
BFA-induced tubules irrespective of the antibody with which it was combined (Figure 5.3). The 
mean total length of tubules per field observed in the GST with mouse IgG control was 54.7 μm 
and this decreased to between 12.7 μm and 16.4 μm in the presence of GST-KBP∆250-81 
together with various antibodies, correlating to p-values of less than 0.001 in each case. 
However, when each of these values was compared to GST-KBP∆250-81 combined with 
mouse IgG as a control, no significant decrease in mean total tubule length per field was 
detected (Figure 5.3). This suggests no additional inhibitory effect is generated by inhibiting 
kinesin-1 or kinesin-2 alongside KIF1C, and indicates BFA-induced tubules are moved solely by 
KIF1C in vitro.  
5.1.3 Golgi vesicle motility 
It could be argued that GST-KBP∆250-81 has an off-target effect, perhaps upon kinesin-1 
and/or kinesin-2, which is responsible for the inhibition of BFA-induced tubule formation 
observed. To determine whether GST-KBP∆250-81 has any effects upon kinesin-1 and/or 
kinesin-2 function, assays were performed which analysed the effect of this protein upon the 
vesicle motility of the rat liver Golgi fraction. It has been previously shown that this movement is 
driven primarily by kinesin-1 and kinesin-2 [30]. Therefore, if GST-KBP∆250-81 affects either of 
these motors it would be expected to influence vesicle motility in this assay. Rat liver Golgi 
membranes were incubated with GST-KBP∆250-81, or GST, for 20 minutes on ice and then 
added to interphase Xenopus laevis egg extract cytosol. After 10 minutes, VE-DIC microscopy  
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Figure 5.3 – Perturbation of kinesin-1 or kinesin-2 using function-blocking antibodies, in combination with KIF1C inhibition, has no additive inhibitory effect upon BFA-induced tubule motility in vitro 
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was used to determine the total number of vesicles moving in 10 minutes. Pre-incubation with 
GST-KBP∆250-81 had no significant effect on the mean number of moving vesicles compared 
to the GST control (Figure 5.4). This data indicates that GST-KBP∆250-81 has no effect upon 
kinesin-1 or kinesin-2 function, at least in vitro. 
 
The effects of kinesin motor inhibition upon BFA-induced tubule formation in vitro are 
summarised in Figure 5.13.  
5.2 In vivo inhibition of BFA-induced tubules 
The in vitro assay data suggested that KIF1C is responsible for the motility of BFA-induced 
membrane tubules. Next, a number of approaches were taken to inhibit KIF1C function in 
HeLaM cells to determine whether this result is replicated in vivo.  
5.2.1 Transient transfection of dominant negative kinesin constructs  
Transient transfection of DNA constructs encoding the dominant negative kinesin proteins used 
in the in vitro motility assay was used in an attempt to determine whether they exerted a similar 
effect upon the formation of BFA-induced membrane tubules in HeLaM cells. These human 
cervical cancer cells are a variant of HeLa cells and were chosen since they are amenable to 
transient transfection and immunofluorescence studies. Furthermore, kinesin motors could be 
potentially depleted using siRNA if required later in the project.  
 
GFP-KHCct, KAP3B-Myc and GFP-KBP∆250-81 were transiently transfected into HeLaM cells 
along with the cis-Golgi marker mApple-Golgi to assess tubulation of the cis-Golgi upon BFA 
treatment, with transfection of GFP being used as a negative control. Additionally, the 
KIF1C∆305-9 construct was included as another means of inhibiting KIF1C. KIF1C∆305-9 is a 
substitution mutant of KIF1C with residue 103 within the P-loop converted from lysine to 
alanine, rendering it incapable of binding ATP whilst retaining the capacity to bind cargo [146]. 
As such it should compete with and replace the endogenous motor on cargo but be immotile 
[146]. The cells were left for 24 hours following transfection and then treated with BFA for 10 
minutes. This was the length of time determined to give the highest percentage of cells 
displaying cis-Golgi BFA tubules in untransfected HeLaM cells (data not shown). Cells were 
then fixed and immunolabelled as necessary. A total of 100 transfected cells on each coverslip 
were scored to determine the percentage of transfected cells displaying mApple-Golgi-positive 
BFA tubules. In GFP transfected cells a mean of 81 % of cells displayed mApple-Golgi-positive 
tubules following BFA treatment (Figure 5.5). No significant change to the percentage of cells 
displaying mApple-Golgi-positive tubules was detected following transient transfection of any of 
the dominant negative kinesin constructs compared to the GFP control. 
 
One drawback of using the dominant negative constructs was that no positive controls could be 
identified in vivo. Whilst GFP-KHCct has been shown to inhibit outward ER motility in VERO 
cells this is only following microinjection of DNA, whilst transient transfection has no effect [197]. 
Expression of an untagged version of the KBP∆250-81 protein has been shown to cause 
mitochondrial clustering in NIH-3T3 cells [51], but this could not be replicated in HeLaM cells  
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Figure 5.4 – Perturbation of KIF1C using the dominant negative GST-KBP∆250-81 protein has no effect upon rat liver Golgi vesicle motility in vitro
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Figure 5.5 – Transfection of constructs which have an dominant negative effect upon kinesin-1, kinesin-2 or KIF1C has no effect upon the ability of cis-Golgi tubules to form in response to BFA in HeLaM cells 
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(data not shown). Moreover, expression of KIF1C∆305-9 in NIH-3T3 blocked redistribution of 
the cis-Golgi marker p58 to the ER in response to BFA [146], but this could not be replicated in 
HeLaM cells when using mApple-Golgi as a cis-Golgi marker (Figure 5.5). There is no 
verification therefore that any of the dominant negative proteins were exerting their expected 
inhibitory effects in this experimental setup. Moreover, it was uncertain whether the level or 
duration of expression of the dominant negative kinesin is also critical to its inhibitory effects. It 
was therefore decided to change tack and to treat HeLaM cells with KIF1C-specific siRNA to 
deplete KIF1C.  
5.2.2 KIF1C siRNA 
This is a notably different approach to that previously used. Dominant negative protein 
overexpression, in which cargo binding remains viable but motor activity is perturbed, means 
cargo is bound to the dominant negative protein and excludes the possibility that another motor 
can compensate for its loss. Contrastingly, depletion of a motor using siRNA could be 
potentially compensated for by other motors and this should be kept in mind.  
5.2.2.1 Optimisation of KIF1C knockdown 
A SMARTpool of KIF1C siRNA was used which contains four duplexes targeted against four 
different regions of human KIF1C. To determine if KIF1C protein levels in HeLaM cells could be 
effectively and specifically depleted with KIF1C siRNA, cell lysates were prepared following 
treatment with KIF1C-specific siRNA, or non-targeting siRNA as a negative control, for 72 
hours. Samples were immunoblotted for KIF1C or tubulin as a loading control using anti-KIF1C 
and anti-TAT1 antibodies, respectively. HeLaM cells were treated with KIF1C-specific siRNA at 
a range of concentrations from 20 nM to 0.5 nM in an attempt to identify the lowest 
concentration which results in the maximal depletion of KIF1C protein. In non-targeting siRNA-
treated, as well as untreated cell samples, a band at approximately 160 kDa corresponding to 
KIF1C was detected (Figure 5.6 A). This was absent from each of the samples treated with 
KIF1C-specific siRNA. In contrast the TAT1 signal (Figure 5.6 A) and Ponceau S staining 
(Figure 5.6 B) remains approximately the same between all samples, indicating an equal 
amount of protein has been loaded in each lane. The KIF1C antibody also produces a non-
specific band at approximately 85 kDa which was found in all lanes. These results indicate that 
KIF1C can be effectively and specifically depleted in HeLaM cells following treatment with a 
KIF1C siRNA SMARTpool at a range of concentrations from 0.5 nM to 20 nM. Therefore in all 
subsequent experiments the KIF1C siRNA SMARTpool was used at a concentration of 0.5 nM. 
5.2.2.2 Fixed cell analysis of KIF1C-depleted cells 
Initially immunofluorescence experiments were performed on KIF1C-depleted cells using 
antibodies against a wide range of organelles and filaments to determine if the absence of 
KIF1C causes any obvious changes to their positioning or morphology. HeLaM cells treated 
with KIF1C-specific siRNA or non-targeting siRNA for 72 hours were fixed and immunolabelled 
for ER, microtubules and mitochondria using the anti-calreticulin, anti-TAT1 and anti-Hsp70 
antibodies, respectively. Actin was also visualised using Alexa594-conjugated phalloidin dye. 
No obvious differences between non-targeting siRNA treated and KIF1C-depleted cells in the 
localisation or morphology of these structures were observed in fixed cells (Figure 5.7). 
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Figure 5.6 - Levels of KIF1C protein in HelaM cells are depleted following treatment with KIF1C siRNA for 72 hours 
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Figure 5.7 - Depletion of KIF1C has no noticeable effects on the position or morphology of a range of cellular structures/organelles in HeLaM cells 
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In an identical experiment transferrin receptor (a marker for the recycling endosome), early 
endosomes, the ERGIC compartment and lysosomes were visualised in control and KIF1C-
depleted HeLaM cells using the anti-transferrin receptor, anti-EEA1, anti-ERGIC53 and anti-
LAMP1 antibodies respectively. Again, no obvious differences between non-targeting siRNA 
treated and KIF1C-depleted cells in the localisation or morphology of these structures were 
observed in fixed cells (Figure 5.8).  
 
Initial experiments revealed that depletion of KIF1C using KIF1C-specific siRNA did not have 
any noticeable effect by eye upon the ability of mApple-Golgi BFA-induced tubules to form in 
comparison to non-targeting siRNA treatment (data not shown), and consequently data was not 
quantified. It was therefore decided to combine the KIF1C siRNA and expression of dominant 
negative kinesins in an attempt to more efficiently perturb KIF1C function. Moreover, it was 
thought if multiple motors contribute to the motility of BFA-induced tubules in vivo, this may be 
exposed by inhibiting combinations of motors simultaneously.  
5.2.3 Combining dominant negative kinesin expression with KIF1C depletion  
5.2.3.1 cis-Golgi tubulation 
HeLaM cells were treated with KIF1C-specific siRNA for 48 hours, or non-targeting siRNA as a 
negative control, and then transfected with GFP, GFP-KHCct, KAP3B-Myc, KIF1C∆305-9 or  
GFP-KBP∆250-81, along with mApple-Golgi to assess cis-Golgi tubulation, and left for a further 
24 hours. The cells were treated with BFA for 10 minutes, which was the length of time 
determined to give the highest percentage of cells displaying cis-Golgi tubules in untreated 
HeLaM cells. Coverslips were fixed and immunolabelled as necessary, and the percentage of 
transfected cells displaying mApple-Golgi-positive BFA tubules was determined. To analyse the 
data, the non-targeting siRNA treated cells combined with GFP transfection was used as the 
control, where a mean of 77.7 % of cells displayed mApple-Golgi-positive tubules following BFA 
treatment. No significant change in the percentage of cells displaying mApple-Golgi-positive 
tubules was detected following transient transfection of any dominant negative kinesin 
constructs, irrespective of whether KIF1C levels were also depleted using siRNA (Figure 5.9). 
 
It was next determined whether microtubule dynamics are playing a role in moving tubules away 
from the cis-Golgi in response to BFA. In this scenario tubules could perhaps attach to the plus 
tips of growing microtubules, to form a so-called tip attachment complex, and thereby move 
outwards, even under conditions in which motors are inhibited [300, 301]. This possibility could 
explain the failure to observe any inhibition of cis-Golgi BFA tubule motility even when multiple 
motors are inhibited. Perhaps under conditions in which microtubule dynamics are inhibited a 
dependence of cis-Golgi BFA-induced tubule motility upon a particular motor(s) would be 
revealed.  
 
It was decided to use low doses of the microtubule-depolymerising agent nocodazole to inhibit 
microtubule dynamics. Live cell imaging of the plus-end microtubule tracking protein EB3 was 
used to determine the optimal concentration at which to use nocodazole. HeLaM cells were 
transiently transfected with tomato-EB3 and GFP-tubulin for 24 hours and live cell imaging of 
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Figure 5.8 – Depletion of KIF1C has no noticeable effects on the position or morphology of a range of endocytic/secretory pathway markers in HeLaM cells 
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Figure 5.9 - Depletion of KIF1C in conjunction with transfection of various dominant negative kinesin constructs has no effect upon the ability of cis-Golgi BFA-induced tubules to form in HelaM cells  
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the proteins in cells treated with a variety of concentrations of nocodazole was performed. A 
concentration of 100 nM of nocodazole was determined to inhibit microtubule dynamics, as 
adjudged by loss of tomato-EB3 signal, without stimulating microtubule depolymerisation (data 
not shown). 
 
The ability of cis-Golgi tubules to form was then assessed under conditions in which dynamic 
microtubules were inhibited and motor function was perturbed. HeLaM cells were treated with 
KIF1C-specific siRNA for 48 hours, or non-targeting siRNA as a negative control, and then 
transfected with GFP, GFP-KHCct, KAP3B-Myc, KIF1CΔ305-9 or GFP-KBPΔ250-81 along with 
mApple-Golgi to assess cis-Golgi tubulation, and left for a further 24 hours. Cells were treated 
with 100 nM nocodazole for 5 minutes to prevent microtubule dynamics, or an equal volume of 
the solvent DMSO. Cells were then treated with BFA for 10 minutes (with or without 100 nM 
nocodazole), and then fixed and immunolabelled as necessary. The ability of mApple-Golgi 
tubules to form in response to BFA under all of the conditions tested was analysed as 
previously described. Non-targeting siRNA treatment combined with GFP transfection and 
DMSO treatment was designated the control for statistical analysis, where 80.0 % of cells 
displayed mApple-Golgi tubules following BFA treatment (Figure 5.10). No significant change in 
the percentage of cells displaying mApple-Golgi-positive tubules was detected following 
transient transfection of any of the dominant negative kinesin constructs, irrespective of whether 
KIF1C levels are depleted using siRNA or microtubule dynamics have been inhibited using 
nocodazole. This data indicates microtubule dynamics are not necessary for the motility of cis-
Golgi BFA-induced tubules in HeLaM cells.  
 
Due the failure to observe any effects upon the tubulation of the cis-Golgi in response to BFA, it 
was decided to investigate tubulation of other components of the secretory and endocytic 
pathways.  
5.2.3.2 TGN and endosomal tubulation 
TGN, endosomal and lysosomal markers have been reported to exhibit tubules in response to 
BFA [136, 302, 303]. Furthermore, tubules formed in response to BFA in vitro have been shown 
to be positive for cis-Golgi, recycling endosome and TGN markers [144]. It was therefore 
hypothesised that the effects of GST-KBP∆250-81 upon BFA-induced tubule formation in vitro 
previously observed (Figure 5.2), may reflect a role of KIF1C in the tubulation of these 
compartments, rather than the cis-Golgi. To investigate this possibility the effects of combining 
KIF1C depletion with transient transfection of dominant negative kinesins upon the tubulation of 
early endosomes, recycling endosomes and TGN in HeLaM cells were studied. Experiments 
were performed as previously described except cells were not transfected with mApple-Golgi 
but were immunolabelled with a range of antibodies raised against markers of these different 
compartments, including an anti-EEA1 antibody to label tubules derived from early endosomes. 
The effects of combining KIF1C depletion together with expression of dominant negative 
kinesins upon BFA-induced tubules were studied rather than investigating each treatment 
separately since, as previously mentioned, it was thought KIF1C function would be more 
robustly inhibited if simultaneously targeted by two different approaches. 
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Figure 5.10 - Inhibition of microtubule dynamics does not affect the ability of cis-Golgi BFA tubules to form in non-targeting siRNA treated or KIF1C-depleted HelaM cells transfected with various dominant negative kinesin constructs  
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It was first determined whether tubulation of these various compartments could be observed in 
HeLaM cells following BFA treatment. HeLaM cells were treated with BFA for 8 minutes, 10 
minutes or 12 minutes, or the same volume of methanol as a negative control, and 
immunolabelled using the anti-EEA1, anti-transferrin receptor or anti-TGN46 antibodies, 
respectively. Treatment with BFA for these lengths of time was adjudged to give the highest 
percentage of untransfected cells displaying tubules positive for each marker (data not shown), 
and were used in all subsequent experiments. Anti-EEA1 is an antibody raised against the 
human early endosomal antigen-1 protein and is a widely used marker for early endosomes in a 
range of cell lines, including HeLa cells (e.g. [176]). Anti-transferrin receptor is an antibody 
raised against the recycling endosome marker, transferrin receptor [304, 305]. Anti-TGN46 is an 
antibody raised against the human TGN localised protein TGN46, and is a widely used marker 
of the TGN in human cell lines (e.g. [306]). Tubules positive for each of these markers were 
apparent following treatment with BFA (Figure 5.11). Since lysosomal tubulation in response to 
BFA has also been reported [136, 302, 303], preliminary experiments in which HeLaM cells 
were treated with BFA and stained with the lysosomal antibody anti-LAMP1 were also 
performed. However, no tubules were observed using this antibody despite cells being 
incubated with BFA for up to 6 hours (data not shown). Consequently the effects of kinesin 
inhibition upon BFA-induced lysosomal tubulation were not investigated further.  
 
The effects of motor inhibition upon BFA-induced tubulation of early endosomes were first 
investigated. HeLaM cells were treated with KIF1C-specific siRNA for 48 hours, or non-targeting 
siRNA as a negative control, and then transfected with GFP, GFP-KHCct, KAP3B-Myc, 
KIF1C∆305-9 or GFP-KBP∆250-81 and left for a further 24 hours. Cells were treated with BFA 
for 8 minutes or an equal volume of methanol. Coverslips were fixed and immunolabelled with 
the early endosomal antibody anti-EEA1. When initially observing coverslips stained with the 
anti-EEA1 antibody following BFA treatment, it was apparent that a lower percentage of cells 
displayed tubules compared to when the cis-Golgi marker mApple-Golgi was used (Figure 5.9). 
Therefore it was thought any subtle effects of kinesin inhibition upon the number of cells 
displaying BFA-induced EEA1-positive tubules would be harder to detect. For this reason a 
higher number of cells per condition were scored compared to experiments using mApple-Golgi 
as a marker. A total of 300 transfected cells per treatment were scored according to whether 
EEA1-positive tubules could be seen. The percentage of transfected cells displaying EEA1-
positive tubules was then calculated. To statistically analyse the data, the non-targeting siRNA 
treated cells combined with GFP transfection was designated as the control, where a mean of 
23.8 % of cells displayed EEA1-positive tubules in the absence of BFA, compared to 30.7 % of 
cells in the presence of BFA (Figure 5.12). The mean percentage of cells displaying EEA1-
positive tubules in the absence of BFA treatment did not change significantly following transient 
transfection of any dominant negative kinesin constructs, irrespective of whether KIF1C levels 
are also depleted using siRNA.  
 
However, the expression of GFP-KHCct significantly reduced the mean percentage of cells 
displaying EEA1-positive tubules following BFA treatment from 30.7 % to 20.2 % in non- 
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Figure 5.11 – Treatment with BFA induces tubulation of recycling endosomes, the TGN and early endosomes in HeLaM cells
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Figure 5.12 - Transfection of GFP-KHCct or GFP-KBP∆250-81 inhibits the formation of BFA-induced early endosomal tubules in HeLaM cells irrespective of whether KIF1C protein levels have been depleted using 
siRNA
140 
 
targeting siRNA treated cells with a p-value of 0.016 (Figure 5.12). This value was further 
reduced to 12.4 % when GFP-KHCct expression was performed in conjunction with KIF1C-
specific siRNA treatment, which corresponds to a p-value of less than 0.001 from the non-
targeting siRNA treatment combined with GFP transfection control. It was determined that 
depletion of KIF1C in combination with GFP-KHCct transfection significantly reduced the mean 
percentage of cells displaying EEA1-positive tubules in comparison to non-targeting siRNA 
treatment with the same transfection, correlating to a p-value of 0.043. This data suggests 
kinesin-1 and KIF1C motors function, perhaps in combination, in moving BFA-induced early 
endosomal tubules.  
 
The expression of GFP-KBPΔ250-81 also significantly reduced the mean percentage of cells 
displaying EEA1-positive tubules following BFA treatment from 30.7 % to 20.9 % in non-
targeting siRNA treated cells (Figure 5.12). This value was not significantly reduced when GFP-
KBPΔ250-81 expression was performed in conjunction with KIF1C-specific siRNA treatment. 
This data supports a role for KIF1C in the movement of early endosomal BFA-induced tubules.  
 
The expression of KAP3B-Myc or KIF1CΔ305-9 had no significant effect upon the mean 
percentage of cells displaying EEA1-positive tubules compared to the GFP control, irrespective 
of whether KIF1C levels had also been depleted using siRNA. This suggests kinesin-2 does not 
play a role in moving early endosomal tubules in response to BFA. The lack of any effect of 
KIF1C305-9 expression is surprising given the previously described data suggests KIF1C plays 
a role in the movement of BFA-induced early endosomal tubules [146]. Perhaps KIF1CΔ305-9 
is not a potent inhibitor of KIF1C function in vivo, or its dominant negative effects are very 
dependent upon the level or duration of expression.  
 
When identical experiments were performed using anti-transferrin receptor and anti-TGN46 
antibodies to investigate tubulation of recycling endosomes and TGN respectively in response 
to BFA, a higher percentage of cells exhibited tubules in the order of 75-85 % (data not shown). 
This made it easier to judge whether there were obvious changes to the number of cells 
displaying tubules when function or expression of the various kinesins was perturbed. No 
obvious differences in the number of cells displaying tubules could be observed by eye and data 
was not quantified.  
 
The effects of dominant negative kinesin expression along with KIF1C-specific siRNA treatment, 
upon tubulation of the cis-Golgi, TGN, early endosomes and recycling endosomes as adjudged 
using the mApple-Golgi marker and anti-TGN46, anti-EEA1 and anti-transferrin receptor 
antibodies respectively, are summarised in Figure 5.13. The only statistically significant 
changes were observed upon EEA1-positive tubules following GFP-KHCct or GFP-KBPΔ250-
81 expression as already discussed (Figure 5.12). 
 
The difficulty in identifying an effect of GFP-KBP∆250-81 expression upon the ability of BFA-
induced tubules to form in vivo was surprising given such apparently potent inhibition with GST- 
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Figure 5.13 – Summary of the effects of motor disruption upon BFA-induced tubule formation in vitro and in vivo 
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KBP∆250-81 was observed in vitro (Figure 5.3). It has been reported that KBP binds to another 
member of the KIF1 family, KIF1Bα, in vivo. It was therefore hypothesised that the effects 
observed in the in vitro assay upon BFA-induced tubule formation in the presence of GST-
KBP∆250-81 could perhaps be due to inhibition of KIF1Bα, rather than KIF1C. Since KIF1Bα 
has been reported to localise to mitochondria in NIH-3T3 cells [51], it was felt the level of 
KIF1Bα in the rat liver Golgi fraction would be low, but this could not be tested due to the lack of 
an anti-KIF1B antibody which works for immunoblotting. Attempts were made to deplete KIF1B 
and the other member of the KIF1 family, KIF1A, using specific siRNA SMARTpools in HeLaM 
cells. No obvious effects upon the ability of BFA-induced tubules to form were observed by eye. 
Treatments with combinations of siRNA SMARTpools targeted against KIF1A, KIF1B or KIF1C 
were also tested, but again no obvious effects upon BFA-induced tubule formation was 
observed by eye (data not shown). However, due to a lack of KIF1A and KIF1B antibodies 
which work for immunoblotting, it was not possible to check whether the protein level of each of 
these motors had been effectively depleted following siRNA treatment. 
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6. Discussion – Motility 
of BFA-induced tubules 
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Tubules emanating from several compartments located with the endocytic and secretory 
pathways are generated in a microtubule-dependent fashion in response to the fungal 
metabolite BFA [135-139]. Despite attempts by several previous studies to decipher the 
motor(s) responsible for this motility, its identity remains unknown. The aim of this work was to 
assess the contributions of kinesin-1, kinesin-2 and KIF1C to these processes.  
6.1 Reconstitution of BFA-induced tubule formation in vitro 
The process of BFA-induced tubule formation has previously been reconstituted in vitro by 
combining a rat liver Golgi fraction with interphase Xenopus laevis egg extract cytosol in the 
presence of BFA [144]. A slightly modified version of this assay was used initially in this study, 
where Golgi membranes were treated with kinesin function-blocking antibodies or dominant 
negative proteins prior to mixing with cytosol. This approach was chosen for several reasons. 
The behaviour of microtubule motors has often proved easier to study initially in vitro [30], and 
previously this assay has been used successfully to show that the motor(s) responsible for BFA-
induced tubule motility is regulated in a cell cycle-dependent manner [144]. Additionally, the 
perturbation of kinesin motors is more complex in vivo, where the level or duration of an 
inhibitory treatment is more of a concern and there is the inherent problem of cooperation 
between motor proteins potentially masking phenotypes. Moreover, this assay allows BFA-
induced tubules positive for cis-Golgi, early endosomal and TGN markers to be observed 
simultaneously. If an effect upon tubule motility was observed in vitro, it was planned in vivo 
studies would then be incorporated to determine whether the findings could be replicated.  
 
Initially the function-blocking antibodies SUK4 and k2.4 were used to perturb kinesin-1 and 
kinesin-2 function respectively in vitro and found to have no significant effect upon the 
generation of BFA tubules. The lack of a role for kinesin-1 in moving BFA-induced tubules in 
vitro is in agreement with previously published work [144]. These antibodies have been 
successfully used in similar assays to reveal a role for kinesin-1 in Xenopus laevis ER motility 
during development [218], and for kinesin-2 in rat liver Golgi vesicle motility (personal 
communication, Dr. Marcin Woźniak). These observations indicate that SUK4 and k2.4 are able 
to effectively inhibit motor function in vitro and allay fears that the negative result obtained could 
simply be due to the antibody having a weak inhibitory effect. This supports the work of Feiguin 
and co-workers in which suppression of KHC levels in cultured rat hippocampal neurons is 
observed to have no effect upon the BFA-induced redistribution of cis/medial/trans-Golgi 
contents back to the ER [145]. In agreement with previous studies, the H1 antibody was found 
to strongly inhibit tubule formation, although the target of the antibody remains to be determined 
[143, 144]. Immunoprecipitations could be performed from the rat liver Golgi fraction using the 
H1 antibody to attempt to identify which protein(s) the antibody recognises. Immunoprecipitates 
could be run on SDS-PAGE gels and stained with colloidal Coomassie, and any interesting 
bands could be analysed using mass spectrometry.  
 
All the data reported here looks at the extent of tubule formation after 1 hour of incubation in the 
flow cell. It is possible that perturbation of kinesin-1 or kinesin-2 function delays tubule formation 
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or reduces the speed at which tubules move, which may not be apparent at the 1 hour time 
point. Although no defect in tubule motility was apparent by eye, quantification of the network 
length at earlier time points, together with analysis of tubule speed, could be performed to 
comprehensively characterise the contribution of these motors to this process. Similar speed 
calculations have been made from VE-DIC movies in previous studies using the RETRAC 
object tracking system [144, 218]. The effects of KIF1C inhibition in this experiment could not be 
investigated since no antibody which is known to specifically perturb KIF1C function has been 
identified. The addition of the available anti-KIF1C antibody, which was raised against amino 
acids 850-900 of the human protein, had no effect upon BFA-induced tubule formation in vitro 
(data not shown).  
 
Incubations with dominant negative kinesin proteins were next used to complement the 
function-blocking antibody data. GST-KHCct and GST-KAP3Bct were used to perturb kinesin-1 
and kinesin-2 function, respectively. These proteins have been used successfully in previous 
assays to reveal a role for kinesin-1 in rat liver ER motility [30], and for kinesin-2 in rat liver Golgi 
vesicle motility (personal communication, Dr. Marcin Woźniak). Again, despite no effect of 
kinesin-1 or kinesin-2 inhibition upon network formation being observed after 1 hour, a delay in 
network formation or alteration in tubule speed cannot be excluded.  
 
The GST-KBPΔ250-81 protein, which has been previously shown to perturb KIF1Bα function in 
vivo and in vitro, was found to significantly inhibit BFA-induced tubule formation [51]. Since 
KIF1Bα is reported to be primarily localised to mitochondria, it was felt that perturbation of the 
Golgi localised KIF1C, which also binds KBP, was more likely to be responsible for this 
inhibition. However, it was not possible to verify the levels of KIF1Bα or KIF1C on rat liver Golgi 
membranes since no antibody which recognised the rat forms of the proteins was available. No 
effects of GST-KBPΔ250-81 upon Golgi vesicle motility were observed revealing that this 
protein has no off-target effects upon kinesin-1 or kinesin-2. However, it cannot be verified that 
the inhibition of BFA-induced tubule formation observed in the presence of GST-KBPΔ250-81 is 
due exclusively to perturbation of KIF1C function. Since no additional inhibitory effect was 
detected when combinations of motors were inhibited simultaneously it was concluded that the 
motor perturbed by GST-KBPΔ250-81, likely KIF1C, was solely responsible for the motility of 
BFA-induced tubules in vitro. 
 
Another drawback of using GST-KBPΔ250-81 is that it is not fully understood how the protein 
exerts its dominant negative effects. Although it has been demonstrated that KBPΔ250-81 is 
unable to bind KIF1B (and presumably KIF1C) [51], it is uncertain how this would disrupt 
binding of endogenous KBP to the motor. Furthermore, if KBP binds KIF1C in vivo it may be 
expected that KBP would localise to the Golgi, since the motor has been reported to be 
enriched here [146, 147]. However, only mitochondrial staining was observed in 
immunofluorescence studies using an anti-KBP antibody in NIH-3T3 cells [51]. Ideally another 
KIF1C dominant negative protein would have been incorporated into the assay, to verify that the 
phenotype observed with GST-KBPΔ250-81 is a direct consequence of KIF1C inhibition.  
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The binding of cargoes to KIF1C is expected to occur via the more C-terminal portion of the 
motor [50, 51] and therefore addition of this fragment of the protein to the assay may potentially 
compete with and displace the endogenous motor from rat liver Golgi membranes. Another 
approach may be to overexpress the region of the Golgi receptor responsible for binding KIF1C. 
However, since this protein is yet to be identified this was not possible. The only documented 
KIF1C dominant negative protein is the ATPase-deficient mutant KIF1CΔ305-9 [146] and there 
is no precedence for recombinantly expressing this protein. Indeed, at over 1,100 amino acids it 
is likely that bacterial expression of the protein would prove problematic. It is probable that if 
recruitment of KIF1C from Xenopus laevis egg extract cytosol to the rat liver Golgi membrane is 
responsible for BFA tubule motility, this would be unmasked by immunodepletion of the motor 
using an anti-KIF1C antibody. However, since an antibody which recognises the Xenopus laevis 
form of the protein by immunoblotting was not available, it was not possible to determine 
whether any such recruitment is occurring and furthermore any depletion of KIF1C from the 
cytosol could not be verified.  
6.2 Motility of BFA-induced tubules in vivo 
The motility of BFA-induced tubules in HeLaM cells was next investigated to determine whether 
the phenotypes observed in vitro were replicated in vivo. Initially, tubulation of the cis-Golgi was 
probed using the mApple-Golgi construct since the effects of BFA upon this compartment have 
been well characterised previously. Similar to the in vitro assay, a variety of dominant negative 
proteins were used to disrupt kinesin motor function. Additionally KIF1CΔ305-9, an ATPase 
deficient mutant previously shown to perturb BFA-induced redistribution of the cis-Golgi to the 
ER in NIH-3T3 cells [146], was included as another means of interfering with KIF1C activity. The 
thinking behind this was that the effects of KIF1CΔ305-9 expression could be compared to 
those of GFP-KBPΔ250-81 and thereby hopefully provide confirmation that both proteins target 
KIF1C.  
 
One disadvantage of using these dominant negative proteins to perturb kinesin function was 
that no positive controls could be identified, despite the morphology of several organelles and 
cytoskeletal filaments being screened (data not shown). This meant there was no verification 
that the appropriate motor was being specifically and robustly inhibited by each reagent. 
Furthermore, it was unsure whether the duration or length of expression of the dominant 
negative kinesin was also linked to its inhibitory effects. Indeed it has been previously shown 
that perturbation of ER tubule motility by GFP-KHCct only occurs when the DNA is 
microinjected into the nucleus leading to high levels of the protein being rapidly expressed, 
whereas following transiently transfection no phenotype is observed [197]. Attempts were made 
to microinject both the GFP-KBPΔ250-81 construct and GST-KBPΔ250-81 protein into HeLaM 
cells transfected with mApple-Golgi, to identify whether the rapid expression of high levels of the 
dominant negative reagent perturb BFA-induced tubules forming from the cis-Golgi. However, 
mApple-Golgi tubules were found to form normally in microinjected cells (data not shown). This 
lack of positive controls is surprising given the wide range of cargoes kinesin-1, kinesin-2 and 
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KIF1C are documented to move. Furthermore, previously reported changes in organelle 
positioning, such as mitochondrial clustering induced by expression of an untagged version of 
KBP∆250-81 in NIH-3T3 cells [51], were not observed. The inability to recapitulate such 
phenotypes in this study is not understood. It is possible that the effects are cell type-specific, or 
as previously mentioned are sensitive to the duration and length of expression. Alternatively, 
perhaps a higher level of motor cooperation or redundancy occurs in HeLaM cells meaning 
phenotypes are masked when motors are inhibited individually. 
 
Early on in this study it was decided to combine transient transfection of dominant negative 
proteins with siRNA-mediated depletion of KIF1C. This decision was taken for several reasons. 
During initial experiments looking at the effects of dominant negative protein expression upon 
cis-Golgi tubulation it became apparent that none of these reagents had a striking phenotype 
upon tubule formation. Since the in vitro assay data presented here and work from a previous 
study [146] suggested a role for KIF1C in tubule formation, perturbation of this motor rather than 
kinesin-1 or kinesin-2 was focussed upon. Due to the lack of positive controls it was felt that 
KIF1C function should be disrupted by several approaches, in an attempt to ensure any 
negative results were not simply due to the failure of the dominant negative proteins to have a 
complete inhibitory effect in vivo. It was thought that KIF1C function would be more robustly 
perturbed when targeted simultaneously by two separate methods. Moreover, if several motors 
contribute to BFA-induced tubule motility this may only be exposed if multiple motors are 
inhibited simultaneously. No changes in the morphology or positioning of a wide range of 
organelles and cytoskeletal filaments were detected in fixed HeLaM cells depleted of KIF1C, 
compared to those treated with a scrambled siRNA control. However, it remains possible that 
perturbation in the motility of these structures may be identified if observed in living cells. It 
should also be noted that it cannot be verified that all cells were completely depleted of KIF1C. 
Ideally, the level of KIF1C present in each of the cells observed would have been assessed. 
Attempts were made to use the anti-KIF1C antibody in immunofluorescence studies to 
determine the relative levels of KIF1C protein in each of the cells scored in every experiment. 
However, the KIF1C antibody was found to give a weak signal even in control cells which 
localised to no particular cellular compartment, despite attempts to optimise fixation conditions. 
Furthermore, this staining did not disappear upon depletion of KIF1C and it was therefore 
concluded that the antibody does not work by immunofluorescence. To more accurately 
determine the level of KIF1C remaining after siRNA treatment, attempts are being made in the 
laboratory to perform quantitative PCR. If it can be shown that the amount of KIF1C DNA is 
reproducibly reduced to a similarly low level following siRNA treatment, this would more 
conclusively show that each of the cells observed is depleted of KIF1C to a similar level.  
 
Despite investigating the effects of overexpression of the dominant negative proteins in the 
background of KIF1C depletion, no effects upon the percentage of cells displaying tubules 
positive for mApple-Golgi (cis-Golgi marker), TGN46 (TGN marker) or transferrin receptor 
(recycling endosome marker) were detected. The inhibition of microtubule dynamics using low 
doses of nocodazole also had no significant effects upon cis-Golgi tubulation, indicating that 
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microtubule polymerisation does not contribute to tubule extension. It should be noted that in 
each of these experiments cells were scored in a binary fashion according to whether tubules 
were present or absent. It is possible that the frequency of tubules per cell, the length of 
tubules, or the speed of tubule translocation varies between conditions. This data presented 
here is in agreement with the study of Nakajima and co-workers, in which BFA-induced trans-
Golgi tubules were observed to form normally in lung fibroblasts isolated from a KIF1C knockout 
mouse [147]. However, the data is at odds with that reported by Dorner and co-workers in which 
transient transfection of KIF1CΔ305-9 was found to inhibit redistribution of the cis-Golgi marker 
p58 to the ER in response to BFA in NIH-3T3 cells [146]. The reason for this discrepancy is not 
known although it is possible that KIF1CΔ305-9 is not a potent inhibitor of KIF1C function in 
HeLaM cells, or that perturbation is sensitive to the level or duration of expression. It should 
also be noted that this paper provides no quantification or statistical analysis of the inhibitory 
effect. 
 
The percentage of HeLaM cells displaying BFA-induced tubules positive for the early 
endosomal marker EEA1 was significantly influenced by kinesin motor inhibition. Expression of 
GFP-KHCct reduced the percentage of cells in which EEA1-positive tubules were observed, 
and this value was further lowered when combined with KIF1C depletion. This data indicates 
kinesin-1 and KIF1C both contribute to the movement of early endosomal tubules formed in 
response to BFA. The fact that a partial effect upon tubule formation is not observed when 
KIF1C depletion is combined with the control GFP transfection suggests the function of KIF1C 
in this process may only be exposed when kinesin-1 is also inhibited.  
 
If KIF1C does contribute to tubule motility it may be expected that expression of KIF1CΔ305-9 
would also generate a phenotype. Such an effect was not observed and the reason for this is 
not fully understood. As previously mentioned the effects of KIF1C inhibition upon early 
endosomal tubulation may only be exposed when performed in conjunction with inhibition of 
another motor. Alternatively, KIF1CΔ305-9 may not be a potent inhibitor of KIF1C function in 
HeLaM cells. Contrastingly, expression of GFP-KBPΔ250-81 significantly reduces the 
percentage of cells displaying EEA1-positive tubules irrespective of whether KIF1C levels have 
also been depleted. This suggests GFP-KBPΔ250-81 is a more potent inhibitor of KIF1C 
function than KIF1CΔ305-9 or that it disrupts the function of another motor(s) in vivo aside from 
KIF1C. 
 
The observation that perturbation of kinesin-1 function has no significant effect upon the 
percentage of cells displaying BFA-induced transferrin receptor-positive tubules is seemingly at 
odds with data presented by Lin and co-workers. In this study, disruption of kinesin-1 activity in 
Chinese hamster ovary cells by microinjection of a function-blocking antibody was found to slow 
the recycling of transferrin to the cell surface, suggesting this motor is involved in the movement 
of transferrin, and perhaps other cargoes, away from the recycling endosome to the plasma 
membrane [169]. However, the reagent used was a pan-kinesin antibody meaning the inhibitory 
effects observed cannot be attributed solely to disruption of kinesin-1 function. 
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It remains to be determined whether the tubulation induced by BFA in vivo represents an 
accentuated version of a transport pathway which operates routinely in untreated cells. Tubule 
motility is apparent in vitro when rat liver Golgi membranes are combined with Xenopus laevis 
egg extract cytosol, even when BFA is excluded [232], although both tubule morphology and the 
rate of tubule extension differ between the two conditions [144, 232]. Several studies have 
observed tubules emanating from the Golgi and early endosomes in the absence of the drug. 
Induced and uninduced tubules appear to be morphologically distinct with the latter being 
shorter, more branched and less abundant [135, 151, 307]. The rate at which cis-Golgi tubules 
move in control and BFA-treated HeLa cells is identical, perhaps indicating the same machinery 
operates in each setting [151]. It is interesting to speculate upon the purpose of these tubules in 
untreated cells. Tubulation appears to be an inherent and prominent property of Golgi 
membranes. Indeed, tubules are known to connect adjacent Golgi stacks allowing extensive 
remodelling of organelle structure, and tubules arising from the Golgi are frequently observed to 
detach and move towards the cell periphery [151]. Interestingly, live cell imaging of GFP-KDEL 
receptor-positive tubules has revealed that following translocation towards the cell periphery the 
fluorescence signal abruptly and rapidly disappears [151]. This suggests that cargo has been 
delivered and deposited at a specific cellular destination, likely the ER, and indicates Golgi-
derived tubules in untreated cells may have a carrier function within a membrane trafficking 
pathway.  
6.3 Discrepancies between in vivo and in vitro results 
The in vitro data presented here supports a role for KIF1C in moving BFA-induced tubules in 
agreement with previously published data [146], although doubts remain over the specificity of 
the KBPΔ250-81 dominant negative protein. This is at odds with the work of Nakajima and co-
workers in which the retrograde movement of cis- and trans-Golgi markers back to the ER in 
response to BFA is unaffected in the KIF1C knockout mouse. The mechanism of motor 
perturbation may provide one explanation for this inconsistency. The use of dominant negative 
proteins should prevent compensation by other motors, and furthermore, cargo motility was 
studied shortly after motor inhibition. The absence of KIF1C in the knockout mouse can be 
potentially compensated for by other motors and the time between motor perturbation and 
experimentation is longer meaning cells can possibly adjust to the loss of the motor. 
 
The interpretation of the in vivo data presented here is a little more complex. The only 
significant effect observed was a contribution of both KIF1C and kinesin-1 towards the 
movement of early endosomal tubules. One difficulty in ascertaining the effects of motor 
inhibition upon EEA1-positive tubules is that even in control samples a portion of cells display 
tubules and this was not dramatically increased following incubation with BFA, despite attempts 
to optimise the length of drug treatment to maximise the percentage of cells displaying tubules. 
This meant large amounts of cells had to be scored to ensure accurate results were obtained. 
There is no precedence for labelling BFA-induced tubules emanating from early endosomes 
with an anti-EEA1 antibody, and the analysis of tubule formation may have proved easier if a 
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different marker had been used. For example, cells could have been pulsed with fluorescently-
conjugated transferrin protein and providing BFA treatment and fixation were performed 
promptly, early endosomes would be labelled. One concern of using the anti-EEA1 antibody is 
that recruitment of the protein to endosomes is dependent upon the phospholipid 
phosphatidylinositol 3-phosphate [308]. Therefore it is feasible that changes in the 
phosphoinositide balance across the endosomal network may also influence the number of 
EEA1-positive tubules. Labelling early endosomal BFA-induced tubules using other markers 
would provide a means of overcoming this problem.  
 
Although a role for KIF1C is in agreement with the in vitro data, perturbation of kinesin-1 
function had no significant effect upon rat liver Golgi BFA tubule formation. The reason for this 
discrepancy is not known although it is possible that the reconstitution of microtubule-driven 
membrane motility in vitro provides a simplified representation of the in vivo system. Indeed rat 
liver ER tubule motility is driven exclusively by kinesin-1 in vitro [30], but cytoplasmic dynein-1 
also contributes to ER movement in VERO cells [197]. Perhaps a role for kinesin-1 is only 
exposed when looking at early endosomal tubules in isolation which is not possible in the in 
vitro assay where networks positive for cis-Golgi, TGN and early endosomal markers are 
generated. Another key difference between the two assays is that the presence of the actin 
depolymerising agent cytochalasin D in vitro prevents any actin-based movement of BFA-
induced tubules, whereas this remains viable in vivo. A function for myosin II in the BFA 
response has been previously reported since the perturbation of myosin II function results in a 
delay in retrograde trafficking from the Golgi to the ER following BFA treatment in HeLa cells 
[150]. Interestingly, tubules positive for the cis/medial Golgi marker mannosidase II are still 
observed when myosin II is inhibited, and it remains undetermined which stage of Golgi-to-ER 
trafficking myosin II contributes to. Alternatively, it is possible that the in vitro assay is not 
faithfully mimicking the in vivo process. It should be noted, however, that it is a common 
observation of this laboratory that motor perturbation in vitro generates very obvious defects in 
cargo movement, whereas the situation proves considerably more complex and difficult to 
replicate in vivo. 
6.4 Future work 
As previously mentioned the in vitro assay used in this study is devoid of actin-based motility 
due to the inclusion of cytochalasin D. It is feasible that the contribution of myosin motors is 
masking the effects of kinesin inhibition upon BFA-induced tubule motility in vivo, which are 
exposed in the in vitro assay. To investigate this possibility the in vitro assays could be repeated 
in the absence of cytochalasin D, to determine whether the addition of GST-KBPΔ250-81 still 
reduces network formation to the background baseline level. If this was found to be the case it 
would indicate that myosin motors do not contribute to tubule movement in vitro and the 
motor(s) inhibited by GST-KBPΔ250-81 is solely responsible for moving BFA-induced tubules in 
this assay. In a complementary approach in vivo studies could be performed in the presence of 
cytochalasin D, where perhaps more severe effects of microtubule motor inhibition upon BFA-
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induced tubule formation may be revealed, although this may prove problematic due to the 
rounding up of cells.  
 
If an anti-KIF1C antibody which works by immunofluorescence could be identified it would be 
interesting to determine whether colocalisation with a particular subset of BFA-induced tubules 
is observed. If KIF1C staining was present on EEA1-positive tubules, but absent from cis-Golgi 
and TGN tubules, this would support the hypothesis that the motor is specifically involved in 
moving early endosomal BFA-induced tubules. Similar experiments could be performed using 
anti-kinesin-1 antibodies to determine whether the motor is localised to a specific subset of 
BFA-induced tubules. 
 
Doubts remain over the specificity of the GST-KBPΔ250-81 protein in vitro. It has been showed 
that human KBP binds to KIF1Bα between amino acids 270 and 350 located at the C-terminus 
of the motor domain [51]. Since the KIF1 proteins are extremely homologous within this region it 
is likely that the interaction with KBP is not limited to KIF1Bα and KIF1C, but extends to all KIF1 
isoforms. It is therefore feasible that the inhibitory effect exerted by GST-KBPΔ250-81 in vitro is 
due to perturbation of any of the KIF1 isoforms and not specifically KIF1C. Furthermore, 
expression at the mRNA level of each of the KIF1 family members has been reported in the 
human lung epithelial cell lines A549 and NHBE [24], despite the assumption that KIF1A is 
specifically expressed in neurons [55], indicating they may be ubiquitously expressed. It would 
be interesting to determine whether other KIF1 isoforms function in moving BFA-induced 
tubules in HeLaM cells, a scenario which could explain the inconsistencies between the in vivo 
and in vitro data. Although preliminary experiments indicate siRNA-mediated depletion of KIF1A 
or KIF1B either in isolation or in combination has no effect upon the ability of BFA-induced 
tubules to form, the efficiencies of the knockdowns needs to verified using quantitative PCR or 
immunoblotting.  
 
Previous studies indicate the speed at which BFA-induced tubules move in vivo is much faster 
to that observed in vitro. An average rate of BFA-induced cis-Golgi tubule movement of 0.6 µm 
per second has been measured in HeLa cells [151], which is considerably faster than the 
average rate of 0.25 µm per second measured in vitro [144]. The reason for this discrepancy is 
unknown, although it may be linked to the lower temperature at which the in vitro assay is 
performed. Alternatively, this inconsistency may suggest that factors normally act to assist 
motor activity in vivo, which are absent in the in vitro situation. It would therefore be interesting 
to determine whether binding partners of the KIF1 motors differ between the assays which could 
explain this disparity. 
 
As previously mentioned the tubulation of the Golgi induced by BFA may represent an 
enhanced version of a constitutive recycling pathway which operates from the Golgi back to the 
ER. If this is the case it is probable that the motor(s) responsible for moving BFA-induced 
tubules also functions within this transport pathway. It may therefore prove insightful to 
investigate whether Golgi tubulation in untreated cells is perturbed when the function of various 
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kinesin motors, either in isolation or in combination with each other, is disrupted with a particular 
emphasis on KIF1C. If conditions can be identified under which tubule formation is blocked or 
reduced, the effects upon cargo movement could be probed further in an attempt to ascertain 
those cargoes whose retrograde trafficking to the ER is dependent upon Golgi tubulation. 
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7. Unifying Discussion 
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Kinesin motors constitute a diverse superfamily of microtubule motors and perform essential 
functions within the cell, being implicated in the transport of a wide range of cargoes as 
described in section 1. The concept of regulation of microtubule motor activity is becoming 
increasingly prevalent as a means of controlling cargo movement and preventing the 
mislocalisation of motors. The aim of this work was to analyse the function of kinesin motors in 
two particular settings. Firstly, the regulation of kinesin-1 in a cell cycle-dependent manner was 
investigated and secondly, the contributions of kinesin-1, kinesin-2 and KIF1C to BFA-induced 
tubule motility were probed. The reconstitution of microtubule motor-driven cargo motility in 
vitro, by combining fractions enriched in ER or Golgi isolated from rat liver with Xenopus laevis 
egg extract cytosol, formed the basis of this work. 
 
Rat liver ER tubule motility, which has been previously shown to be driven exclusively by 
kinesin-1 in vitro [30], was significantly reduced in mitotic and meiotic Xenopus laevis egg 
extract cytosol. A number of potential scenarios which could potentially underlie this inhibition of 
cargo movement were investigated and discounted, and the exact mechanism responsible 
remains elusive. Interestingly, the level of kinesin-1 associated with ER membranes was 
unchanged between interphase and metaphase, indicating the activity of the motor is modulated 
whilst membrane-bound. It is hypothesised that the differential interaction of kinesin-1 with a 
binding partner which has an activating or inhibitory effect upon motor activity occurs specifically 
in one situation, although this could not be fully investigated due to technical difficulties. This 
data provides the first evidence that kinesin-1 activity changes during the cell cycle, at least in 
vitro. If such behaviour is replicated in vivo it may have far-reaching consequences, and could 
potentially contribute to changes in organelle positioning and reduction in the flux of cargoes 
through trafficking pathways which occur during cell division. 
 
BFA is a fungal metabolite which disrupts COPI coat formation leading to perturbation of ER-to-
Golgi transport and microtubule-dependent tubulation of several organelles located within the 
secretory and endocytic pathways. Both kinesin-1 and KIF1C, a member of the kinesin-3 family, 
have previously been implicated in the movement of BFA-induced tubules [143, 146], although 
this data has since been contested [144, 147]. Due to the uncertainty regarding the identity of 
the motor(s) responsible for BFA tubule motility it seemed pertinent to reassess the 
contributions of kinesin-1, kinesin-2 and KIF1C to this process. KIF1C was found to exclusively 
drive BFA-induced tubule motility in vitro. However, this result was not fully replicated in HeLaM 
cells, where inhibition of kinesin-1, kinesin-2 or KIF1C through various means was found to 
have no effect upon BFA-induced tubules derived from the cis-Golgi, TGN, or recycling 
endosome. The reason for this discrepancy is uncertain, although it is possible that the in vitro 
assay provides a simplified version of the in vivo situation. However, the ability of early 
endosomal tubules to form in response to BFA was found to be affected by inhibition of kinesin-
1 and KIF1C. These observations raise the possibility that BFA-induced tubules emanating from 
particular compartments are moved by specific subsets of motors which perhaps operate in 
combination with each other, meaning a single motor is not wholly responsible for all tubule 
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motility. This thinking could explain, at least in part, the conflicting data previously published 
regarding the involvement of KIF1C in this process.  
 
The discrepancies observed between the in vivo and in vitro data highlight the concept of 
cooperation and coordination between motor proteins. In this scenario a cargo is not moved 
exclusively by a single motor, but multiple motors operate in synergy with each other to drive 
movement (reviewed in [230]). For example, the activities of kinesin-2 and cytoplasmic dynein-1 
are reported to be coordinated on Xenopus melanosomes, dependent upon an extracellular 
signal regulated-kinase pathway [309, 310]. If crosstalk between motors occurs, it is possible 
that a level of redundancy is in operation meaning the loss or perturbation of a particular motor 
can be compensated for. This may explain in part the difficulties encountered in replicating the 
in vitro data in vivo, and the lack of positive controls for motor inhibition in HeLaM cells. When 
movement is reconstituted in vitro, motor compensation is perhaps not such an issue since a 
single motor is often exclusively responsible for the motility of a specific cargo. The efficiencies 
of the dominant negative reagents in vivo remain unclear, and the expression of these 
constructs over 24 hours in cells is in contrast to the in vitro assay, where cargo motility was 
assessed soon after motor inhibition. It is possible that the length of time between motor 
perturbation and the observation of cargo motility is critical to detect any cargo transport 
defects. Indeed, a portion of outward ER tubule movement has been shown to be inhibited 
when observed 4 hours after microinjection of constructs encoding KHCct, whereas 24 hours 
after transient transfection, the protein had been degraded and no perturbation of ER motility 
was observed [197]. Similarly, knockdown of KIF1C expression in this study was performed 
over 72 hours, meaning cells may have the opportunity to compensate and adjust to the loss of 
the motor. These difficulties make the analysis of cargo transport defects in vivo inherently more 
problematic, and may contribute to the more subtle changes in BFA tubule formation observed 
in HeLaM cells following inhibition of kinesin motors.  
 
Future studies similar to those undertaken in this work may benefit from various technological 
improvements. For example, the in vitro assay could be developed by attempting to combine rat 
liver fractions with interphase and metaphase cytosols prepared from rat cells. This would 
remove the heterogeneity that exists within the current system where rat and Xenopus laevis 
samples are combined. Nevertheless, the in vitro assays cannot completely mimic the in vivo 
situation. Studies in which combinations of kinesin motors are depleted simultaneously in 
cultured cells may provide further insight into how motors cooperate and coordinate with each 
other, and may reveal further, perhaps unexpected, phenotypes which warrant investigation. 
Ideally, the effects of kinesin perturbation upon cargo transport in whole animals would also be 
probed. This approach may involve the manipulation of gene expression in mice or rats, 
perhaps using gene knockout technology. Whilst it is likely that the perturbation of various 
kinesin motors simultaneously will prove embryonically lethal, it may still be possible to isolate 
particular tissues and culture cells derived from these animals. These samples could then be 
used to provide further insight the contribution of these motors to various processes, including 
BFA-induced tubule formation and cargo transport during cell division. 
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